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ABSTRACT
In Part I, nickel-catalyzed asymmetric carbon-carbon bond-forming reactions are
described. A nickel/Pybox system effectively catalyzes regio- and enantioselective
cross-couplings between racemic secondary allylic chlorides and readily available
alkylzinc halides. This method is applied to generate two stereo centers in a formal total
synthesis of fluvirucinine A1.
In Part II, the use of planar-chiral compounds as ligands or catalysts in organic
synthesis is described. A C2-symmetric planar-chiral bipyridine is an efficient ligand for
copper-catalyzed asymmetric [4+1]-cycloadditions between enones and diazoacetates to
form 2,3-dihydrofurans. The highly substituted dihydrofurans are not only obtained in
good stereoselectivity but also readily converted to other useful molecules. This method
is applied to the first catalytic enantioselective synthesis of a deoxy-C-nucleoside.
The synthesis of new C2-symmetric planar-chiral catalysts is described. The
diastereoslective functionalization of ferrocene using a chiral directing group enables
the formation of a number of amines in enantiopure form. These catalysts are tested as
several asymmetric catalysts.
Thesis Supervisor: Gregory C. Fu
Title: Professor of Chemistry
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Part I
Nickel-Catalyzed Asymmetric Cross-Couplings
Chapter 1
Nickel-Catalyzed Regio- and Enantioselective Cross-Couplings of
Secondary Allylic Chlorides with Alkylzinc Halides
A. Introduction
Metal-catalyzed asymmetric allylic alkylations (AAA) are one of the most
investigated C-C bond-forming reactions.' A number of catalysts based on various
transition metals have been developed, and the most successful results have been
obtained with palladium, copper,2 and nickel.3 Among these, palladium-catalyzed
allylations are not only the most well-studied but are also applied to syntheses of
numerous complex molecules. The mechanism is believed to occur through a Pd-rc-allyl
complex, followed by direct attack of the nucleophile on the alkyl chain in the outer
sphere of the complex to form a new C-C bond (eq 1). Although this transformation is
highly efficient and stereoselective, the substrates are mainly limited to symmetrical
allylic eletrophiles and soft nucleophiles (e.g., sodium malonate).
R PdLn R R 1 NaCH(CO2Me)2 Rec R
R - PdL (1)PdLn dL MeO2C C02Me
In contrast, asymmetric allylations catalyzed by copper and nickel incorporate hard
nucleophiles, such as Grignard reagents or dialkylzincs. However, these highly reactive
nucleophiles present certain limitations such as low functional-group compatibility. In
addition, dialkylzinc reagents are not easily accessible but required in a large excess
(e.g., 2-6 equiv) making the reaction inefficient.
1 For reviews, see: (a) Pfaltz, A.; Lautens, M. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz,
A., Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 2, Chapter 24. (b) Trost, B. M.; Van Vranken, D.
L. Chem. Rev. 1996, 96, 395-422. See also: Kar, A.; Argade, N. P. Synthesis 2005, 2995-3022.
2 For reviews, see: (a) Alexakis, A.; Malan, C.; Lea, L.; Tissot-Croset, K.; Polet, D.; Falciola, C. Chimia 2006,
60, 124-130. (b) Yorimitsu, H.; Oshima, K. Angew. Chem., Int. Ed. 2005, 44, 4435-4439. For reactions with
organozinc reagents, use of RZnX has been reported to be problematic (for examples, see: Diibner, F.;
Knochel, P. Angew. Chem., Int. Ed. 1999, 38, 379-381 and Goldsmith, P. J.; Teat, S. J.; Woodward, S. Angew.
Chem., Int. Ed. 2005, 44, 2235-2237).
3 For examples, see: (a) Consiglio, G.; Morandini, F.; Piccolo, O. J. Chem. Soc., Chem. Commun. 1983, 112-
114. (b) Gomez-Bengoa, E.; Heron, N. M.; Didiuk, M. T.; Luchaco, C. A.; Hoveyda, A. H. J. Am. Chem. Soc.
1998, 120, 7649-7650.
In the case of copper-catalyzed reactions, primary allylic electrophiles are coupled
with hard nucleophiles with SN2' regioselectivity to form terminal olefins, which can be
converted to disubstituted olefins by olefin metathesis (eq 2).
R
RiN X
X= CI, Br, OAc
OP(O)(OEt) 2
EtMgBr or Et2Zn
Cu cat.
EtEt metathesis
R
Et
R R2 (2)
Nickel-catalyzed AAA is believed to form a t-allyl complex similar to the Pd cases.
However, the nucleophile initially coordinates to the Ni center instead of to the alkyl
chain, and the new C-C bond is formed after reductive elimination (eq 3). Since both
reactants interact closely with the metal center when the new bond is formed,
Ni-catalysis might be expected to have better control than palladium catalysis over the
enantioselectivity. Nonetheless, only a few examples with good stereoselectivity have
been reported, and these employed an excess of the Grignard reagent, with rather
limited scope of electrophiles. There has been only moderate progress with more
functional-group tolerant nucleophiles (e.g., alkylboron reagents).4
RNiLn R Nu-M R
X ,NiLn NiLn
X Nu"
Reductive
R Elimination R, * R
- NiLn Nu
To complement these existing methods, development of an
alkylation incorporating more functional-group tolerant hard
secondary electophiles in high regio- and stereoselectivity is needed.
asymmetric allylic
nucleophiles with
4 For examples, see: (a) Chung, K.-G.; Miyake, Y.; Uemura, S. J. Chem. Soc., Perkin Trans. 1 2000, 15-18. (b)
Chen, H.; Deng, M.-Z. J. Organomet. Chem. 2000, 603, 189-193. (c) Novak, A.; Fryatt, R.; Woodward, S.
Comptes Rendus Chimie 2007, 10, 206-212.
Previously, our group has developed nickel-catalyzed enantioselective Negishi
cross-couplings of secondary a-bromo amides and benzylic bromides (eq 4 and eq 5;
DMI = 1,3-dimethyl-2-imidazolidinone).5 In these reactions, racemic substrates reacted
with primary alkylzinc halides (1.3-1.6 equiv),6 which show good functional-group
compatibility, to form the desired cross-coupling products in good yield and
enantioselectivity. With these results as a starting point, we have developed a regio-
and enantioselective allylic alkylation method complementary to existing methods.
O0
Bn,~ Et
Ph Br
racemic
Br
racemic
Hex-ZnBr
1.3 equiv
Hex-ZnBr
1.6 equiv
10% NiCI2.glyme
13% (S)-(i-Pr)-Pybox
DMI/THF (7:1)
0 C
10% NiBr2-diglyme
13% (S)-(i-Pr)-Pybox
DMA, 0 oC
0
Bn, N Et
Ph Hex
96% ee
90% yield
Hex
96% ee
89% yield
(4)
O N O
N N
i-Pr i-Pr
(S)-(i-Pr)-Pybox
(5)
5 (a) Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594-4595. (b) Arp, F. O.; Fu, G. C. J. Am. Chem. Soc.
2005, 127, 10482-10483.
6 Huo, S. Org. Lett. 2003, 5, 423-425.
B. Results and Discussion
Unlike cross-couplings of a-bromoamides and benzylic bromides, allylic alkylation
can have a regioselectivity issue. To simplify the initial investigation, we examined the
reaction of "symmetrical" 4-chloropent-2-ene. Under the conditions that we had
developed for a-bromoamides and benzylic bromides, the allylic cross-coupling
product was obtained in promising yield and enantioselectivity (eq 6).
CI 10% nickel complex Hex
BrZn-Hex 13% (S)-(i-Pr)-Pybox (6)
0 oC
racemic 1.3-1.6 equiv
NiCI2*glyme, DMI/THF 64% ee, 94% yield
NiBr 2*diglyme, DMA 66% ee, 72% yield
Under the standard conditions in eq 7, we tested other allylic electrophiles (entries 2
and 3, Table 1). The allylic bromide produced the product with the same
enantioselectivity as the allylic chloride but with slightly lower yield, probably due to
its lower stability (entry 1 vs. 2). However, the allylic acetate, which is a typical
substrate for Pd-catalyzed AAA, generated only a trace amount of product (entry 3).
Investigation of other reaction parameters revealed that a DMF/DMA co-solvent
system and lower temperature were slightly beneficial to enantioselectivity but
detrimental to yield (entries 4 and 5). When these two conditions were combined, the ee
increased to 78%, but the yield dropped to only 7% (entry 6).
Table 1. Evaluation of Reaction Parameters in Negishi Reactions of Secondary Allylic
Electrophiles
10% NiCl 2.glyme
HexnBr 13% (S)-(i-Pr)-Pybox HexHex-ZnBr ,
DMA, rt, 16h Me Me
0.1 M 1.2 equiv
racemic "standard conditions"
entry change from the standard conditions yield (%)a ee (%)b
1 none 85 66
2 Br instead of Cl 77 66
3 OAc instead of Cl <2 -
4 0 OC instead of rt 46 72
5 DMA/DMF = 1 : 1 53 69
6 0 oC, DMA/DMF = 1 : 1 7 78
a Yield determined by GC versus an internal standard. b ee determined
by chiral GC.
Thorough investigation of the reaction parameters, halide salts additives proved to
be crucial to increase the reaction rate with little impact on ee (Table 2).' Almost
identical results were obtained with various halide salts regardless of the identity of the
cation or the anion, suggesting that simple ion exchange is not the origin of the
increased reactivity. However, when a salt containing a non-coordinating anion was
used, the yield increased only slightly, and the ee decreased to 66% (entry 8), indicating
the importance of the coordinating ability of the anion. The yield could be further
improved by increasing the amount of NaCl to two equiv (entry 3).8 In terms of the role
of halide salts, it is possible that halide salts enhance the reaction rate by increasing the
ionic strength of the reaction medium or by activating the alkylzinc reagent.
' For a review of halide effects in transition-metal catalysis, see: Fagnou, K.; Lautens, M. Angew. Chem.,
Int. Ed. 2002, 41, 26-47.
8 Use of more than 2 equiv of NaCl was not beneficial to the reaction results, probably due to the limited
solubility of NaCl under the reaction conditions.
Table 2. Effect of Halide Salt Additives on the Efficiency of a Negishi Reaction of a
Secondary Allylic Chloride
ClI
Me . Me
0.1 M
racemic
Hex-ZnBr
1.2 equiv
10% NiCI2-glyme
13% (S)-(i-Pr)-Pybox
DMA/DMF (1:1)
0 C, 16 h
0.5 equiv salt
Hex
Mel Me
entry additive yield (%)a ee (%)b
1 none 7 78
2 NaCI 34 77
3 NaCI (2.0 equiv) 93 76
4 NaBr 34 76
5 LiBr 27 76
6 KBr 35 76
7 CsBr 36 76
8 NaBF 4  15 66
Yield determined by GC versus an internal standard.
ee determined by chiral GC.
Under these conditions, various Pybox ligands with different electronic and steric
properties were examined (Table 3). When (i-Pr)-Pybox derivatives with different
electronic properties9 were tested, more electron-rich ligands generally exhibited lower
reactivity (entries 1-4). When the steric environments around the coordination sites
were modified by introducing other alkyl groups on the oxazoline rings, most of
ligands gave enantioselectivity higher than 80% producing the best selectivity with
BnCH 2-Pybox (entry 9), which was synthesized from commercially available
compounds in two steps.l0 Even though the yield was slightly higher with a thioether
containing ligand for this specific substrate (entry 8), BnCH 2-Pybox gave better results
over a wide range of substrates.
9 The para-substituted Pybox ligands were prepared according to a reported procedure: Nishiyama, H.;
Yamaguchi, S.; Kondo, M.; Itoh, K. J. J. Org. Chem. 1992, 57, 4306-4309.
0 The ligands in entries 5-9 of Table 3 were prepared from pyridine-2,6-dinitrile and aminoalcohols
which were obtained by reduction of corresponding amino acids: Chelucci, G.; Deriu, S.; Pinna, G. A.;
Saba, A.; Valenti, R. Tetrahedron: Asymmetry 1999, 10, 3803-3809.
Table 3. Evaluation of Pybox Ligands with Different Electronic and Steric Properties on
a Negishi Reaction of a Secondary Allylic Chloride
CI
Me, Me
0.1 M
racemic
Hex-ZnBr
1.2 equiv
10% NiCI2-glyme
13% Ligand
2 equiv NaCI
DMA/DMF (1:1)
-10 OC, 16 h
Hex
Me~ Me
entry Ligand yield (%)a ee (%)b
1 X X =H 91 76
2 CI 80 75
3 N OMe 72 77
i-Pr i-Pr NMe 2  3 66
5RL - i-R 2 8q
Bn 93 81
CH 2Cy 73 84
CH 2CH 2SCH 3 95 85
9 CH 2Bn 89 86
6
7
8
a Yield determined by GC versus an internal standard.
b ee determined by chiral GC.
After re-evaluation of the reaction parameters with BnCH 2-Pybox, the optimized
conditions for enantioselective Negishi reactions of secondary allylic chlorides were
obtained (eq 7). The diminished reactivity with lower catalyst loading could be
recovered by adding more NaCi to the reaction mixture under more dilute conditions.
CI 5.0% NiCI2 .glyme R
R R3 R-ZnBr 5.5% (S)-BnCH 2-Pybox
R2  1.2 equiv 4.0 equiv NaCI R2
0.033 M DMA/DMF (1:1)
0
(7)
racemic -10 oC, 16 h
(S)-BnCH 2-Pybox
Under these standard conditions, various "symmetrical" allylic chlorides
successfully react with a range of alkylzinc bromides (Table 4). Since racemic allylic
electrophiles are used, we can postulate a mechanism involving a kinetic resolution of
substrates to produce the highly enantio-enriched products. However, the combination
of high yields and high ee's establishes that the two enantiomers of the substrate are
transformed to the same enantiomer of the product with good enantioselectivity. With a
sterically more demanding R' substituent, the stereoselectivity of the reaction decreases
(entries 1-5). Therefore, unbranched alkyl-substituted allylic chlorides generally furnish
good ee's (entries 1-4), but a diisopropyl-substituted substrate provides diminished
stereoselectivity (entry 5). Increased steric demand on the nucleophile by 13-branching
also slows down the reaction rate, but in this case the reactivity can be recovered by
employing a higher DMA/DMF ratio (entry 3; 9:1).11 Excellent enantioselectivity can be
obtained with the Ni/Pybox catalyst for a 1,2,3-trisubstituted allylic chloride (entry 6).
Several functional groups, including an unactivated primary alkyl chloride (entry 4),
can be incorporated without complication.
" Under the same conditions as in eq 7, 30% of the product was obtained. The reaction was complete after
72 h, furnishing 80% of the product.
Table 4. Enantioselective Negishi Reactions of "Symmetrical" Allylic Chlorides with
Alkylzinc Reagents (eq 7)
entry allylic chloride R-ZnBr yield (%)a ee (%)
Cl
1 Rl"1  R1  n-Hex-ZnBr 95 b 87
R 1 = Me
2 MeZnBr 93 90
3c -P.r O ZnBr 81 85
4 n-Pr Cl- ZnBr 81 79
5 i-Pr TBSO/\ ZnBr 57 69
Cl MeO
6 Me Me ZnBr 54 98
Me 3
All data are the average of two experiments. a Isolated yield.
bThe product is volatile. The yield was determined by GC versus
an internal standard. cSolvent: DMA/DMF (9:1).
Next, we examined enantioselective cross-couplings of unsymmetrical allylic
chlorides, with which regioselectivity can be an issue (Table 5). Indeed, when two
substituents are similar in size as in an n-butyl and a methyl group, regioselectivity is
modest (1.9:1 selectivity in favor of reaction closer to the methyl group; entry 1);
however, the combined yield is excellent, and the ee's are high for both regioisomers.
For an array of other unsymmetrical allylic electrophiles, the reaction proceeds with
outstanding regioselectivity (>20:1; entries 2-7). For an i-Pr/Me and a t-Bu/Me-
substituted substrate, regioisomeric mixtures of the allylic chlorides 12 produce the cross-
coupling products with excellent regioselectivity (entries 2 and 3). This contrasts with
Cu-catalyzed allylic substitutions, which require regioisomerically pure allylic
12 For i-Pr/Me and t-Bu/Me substrates, the ratios were respectively 1.4:1 and 2.4:1 in favor of chloride
proximal to the methyl group.
electrophiles due to a strong preference to form regioisomers through SN2' substitution. 2
Various electron-withdrawing groups can be incorporated on the allylic electrophile,
and the cross-couplings of these conjugated allylic electrophiles proceed to form a new
C-C bond predominantly at the y position with high enantioselection ( 90% ee; entries
4-7).
Table 5. Enantioselective Negishi Reactions of Unsymmetrical Allylic Chlorides with
Alkylzinc Reagents (eq 7)
entry allylic chloride R-ZnBr yield (%)a ee (%)
CI
1 b,c Rl * Me Ph /\- ZnBr 97 83
R1 = n-Bu
2c  i-Pr nBr 95 84
0ZnBr
3c  t-Bu Me02C - ZnBr 85 81
4 CO2Et Me ZnBr 86 96
Me
5 CONEt 2  Et-ZnBr 57 91
6 CON(OMe)Me TBSO0*- ZnBr 91 93
7 PO(OEt)2  n-Hex-ZnBr 63 90
All data are the average of two experiments. Regioselectivity: >20:1,
except for entry 1. a Isolated yield. b Regioselectivity: 1.9:1; ee of the
minor regioisomer: 88%. cThe allylic chloride is a mixture of
regioisomers.
Negishi reactions of aryl-substituted allylic chlorides require slight modification of
the standard conditions in eq 7 to obtain better reactivity (eq 8). With commercially
available (i-Pr)-Pybox, the cross-couplings of aryl-substituted electrophiles proceed
with excellent regioselectivity (>20:1) and ee (294%), albeit with modest yield. The
regioselectivity of these reactions are complementary to Cu-catalyzed substitutions,
which form a new C-C bond proximal to an aryl group.
Table 6. Enantioselective Negishi Reactions of Aryl-substituted Allylic Chlorides with
Alkylzinc Reagents
Cl
Ar N, Me
0.033 M
racemic
R-ZnBr
1.2 equiv
10% NiCl2-glyme
11% (S)-(i-Pr)-Pybox
2.0 equiv NaCI
DMA/DCE (7:3)
-20 OC, 36 h
R
Arl,, 2 Me
entry Ar R-ZnBr yield (%)a ee (%)
1 Ph Hex-ZnBr 56 97
2 3-(CN)C 6H4  Cl " ZnBr 37 94
3 4-CIC 6H4  MeO ZnBr 55 97
All data are the average of two experiments. Regioselectivity: >20:1.
a Isolated yield.
We have applied this Ni/Pybox-catalyzed enantioselective cross-couplings to a
formal synthesis of fluvirucinine A1, which is a core unit of the antibiotic fluvirucin A1
with inhibitory activity against influenza A virus. 13 Two total syntheses of fluvirucinine
A1 have been reported, including one by Suh in 1999.14 In his report, Suh and his
coworkers prepared fluvirucinine A1, via aldehyde 1 as shown in Scheme 1. Using
stoichiometric chiral-auxiliary chemistry, they installed one stereocenter and used this
to introduce the second stereocenter through diastereoselective transformations.
0 0
NN)N ,O 3 steps
Me Ph
prepared in two steps
from commercially
available compounds
i. LiAI(OEt) 3H
ii. 4 MgBr
n
Me
Bn
3 steps
IVI
Me Li 1
Me LiHMDS
N . toluene, reflux
2 steps
Me
4 steps
Me
,HO
Me
Dbz
fluvirucinine A1
Scheme 1. Suh's Synthesis of Fluvirucinine A
13 (a) Naruse, N.; Tenmyo, O.; Kawauo, K.; Tomita, K.; Ohgusa, N.; Miyaki, T.; Konishi, M.; Oki, T. J. Antibiot.
1991, 44, 733-740. (b) Naruse, N.; Tsuno, T.; Sawada, Y.; Konishi, M.; Oki, T. J. Antibiot. 1991, 44, 741-740. (c)
Naruse, N.; Konishi, M.; Oki, T.; Inouye, Y.; Kakisawa, H. J. Antibiot. 1991, 44, 756-761. (d) Tomita, K.; Oda,
N.; Hoshino, Y.; Ohgusa, N.; Chikazawa, H. J. Antibiot. 1991, 44, 940-948.
14 (a) Suh, Y.-G.; Kim, S.-A.; Jung, J.-K.; Shin, D.-Y.; Min, K.-H.; Koo, B.-A.; Kim, H.-S. Angew. Chem., Int.
Ed. 1999, 38, 3545-3547. (b) Liang, B.; Negishi, E. Org. Lett. 2008, 10, 193-195.
Me
uI I
hA,RAA
IVl1
We envisioned that aldehyde 1 could be efficiently assembled using our Ni/Pybox-
catalyzed Negishi reaction of allylic electrophiles (Scheme 2). Through two cross-
coupling reactions of three components, two tertiary stereoenters can be installed from
racemic allylic chlorides in a catalytic enantioselective fashion.
Me BrZn
O_,
Me,,N
NHCbz
fluvirucinine Al
CI 0
Me ,O R
0
Scheme 2. Retrosynthesis of Intermediate 1
The cross-coupling of racemic allylic chloride 2, which can be prepared in two steps
from commercially available ethyl (E)-4-oxo-2-butenoate, proceeds to form 3 in excellent
yield, regioselectivity, and ee. Direct reduction of intermediate 3 to a saturated primary
alcohol using various reagents, including copper hydride, was low yielding. But this
problem can be solved by adding LiAlH 4 directly to the reaction mixture after
hydrogenation is complete. Intermediate 4, obtained after bromination, can be
converted to the organozinc reagent and coupled with a secondary allylic chloride in
good yield, regio- and stereoselectivity. Reduction of intermediate 5 produces the
corresponding primary alcohol, and direct amination of the alcohol15 followed by acidic
workup to remove the acetal group furnishes aldehyde 1 in 8 steps overall.
'5 (a) Wood, M. R.; Kim, J. Y.; Books, K. M. Tetrahedron Lett. 2002, 43, 3887-3890. (b) Nicolaou, K. C.;
Snyder, S. A.; Longbottom, D. A.; Nalbandian, A. Z.; Huang, X. Chem. Eur. J. 2004, 10, 5581-5606.
.-J
Me
BrZn
OEt 2 0
racemic
NiCl2-glyme
(R)-PhCH 2CH 2Pybox
DMA/DMF (1:1)
4 equiv NaCI, -10 oC
Me
EtO 2C 0
3 0)
93% yield
96% ee
1. H2, Pd/C
THF; LiAIH 4
2. Ph3PBr 2
imidazole
89%
(two steps)
Me
4
Zn, 12; NiCI2'glyme Me
(R)-PhCH 2CH2Pybox
DMA/DMF (1:1)
4 equiv NaCI, -10 oC
CI ' Me
Me
ra,
KiLOEt
82% yield
82% yield
>9Oo ee, ;:r1 Ur
1. H2 , Pd/C, THF;
LiAIH 4
2. 0 0 51
CbzN' NEt3
then HCI, THF
58%
(two steps)
Figure 2. Synthesis of Intermediate 1
C. Conclusions
In conclusion, we have developed an effective Ni/Pybox catalyst for regio- and
enantioselective Negishi cross-couplings of racemic secondary allylic chlorides. This
method complements previously developed asymmetric allylic alkylations catalyzed by
other metals in several aspects. First, reactions with only a slight excess (1.2 equiv) of
alkylzinc reagents as functional-group tolerant hard nucleophiles furnish the desired
product in good yield and ee. Second, the regioselecivity of the reaction is independent
of the regioisomeric ratio of the allylic chlorides. In addition, we have applied this
method in two key steps of a formal synthesis of fluvirucinine A1.
D. Experimental
1. General
HPLC analyses were carried out on an Agilent 1100 series system with Daicel
Chiralpak® columns in hexane/isopropanol mixtures. GC analyses were performed on
a Hewlett-Packard HP 6850 Series system with a Chrompack capillary column (CP
Chirasil-Dex CB; 25m x 0.25 mm x 0.25 mm).
N,N-Dimethylacetamide (DMA; anhydrous in a Sure-Seal® bottle; Fluka), N,N-
dimethylformamide (DMF; anhydrous in a Sure-Seal® bottle; Fluka), NaCl (anhydrous,
Aldrich), Zn (Alfa-Aesar) and NiC12-glyme (Strem), were used as received. BnCH2-
Pybox was prepared according to a literature procedure. 10
2. Preparation of Allylic Alcohols
OH
Me(MeO)N YI Me
0
(±)-(E)-4-Hydroxy-N-methoxy-N-methylpent-2-enamide. Activated 4A molecular
sieves (2.0 g) and LiOH-H20 (369 mg, 8.8 mmol) were added to a solution of diethyl (N-
methoxy-N-methylcarbamoylmethyl)phosphonate (2.11 g, 8.8 mmol) in dry THF (6
mL), and the mixture was stirred under argon for 20 min at 40 'C. Then, the mixture
was cooled to 0 oC, and 2-(tert-butyldimethylsilyloxy)propanal in THF (5 mL) was
added. The mixture was stirred for 1 h at 0 oC and then overnight at room temperature.
Next, water (30 mL) was added to the mixture, and the aqueous solution was extracted
with Et20O (30 mL x 3). The organic layer was dried over MgSO 4, filtered, and
concentrated. The product was dissolved in i-PrOH (15 mL), and the solution was
cooled to 0 'C. Concentrated HC1 (0.8 mL) was added dropwise, and the resulting
mixture was stirred overnight at room temperature. Next, solid NaHCO3 was added
until gas evolution ceased. Water (20 mL) and CH 2C12 (20 mL) were added, and the
aqueous layer was extracted with CH2C12 (20 mL x 2). The organic layer was dried over
Na2SO 4, filtered, and concentrated. The product was purified by flash chromatography
with hexane/Et20O (1:3) to give the title compound (622 mg, 3.9 mmol; 44%).
1H NMR (CDC13, 400 MHz) 8 6.98 (dd, J = 15.4, 4.6 Hz, 1H), 6.60 (d, J = 15.5 Hz, 1H),
4.56-4.49 (m, 1H), 3.71 (s, 3H), 3.25 (s, 3H), 2.19 (d, J = 4.2 Hz, 1H), 1.34 (d, J = 6.6 Hz,
3H);
13C NMR (CDC13, 100 MHz) 6 166.9, 150.1, 117.0, 67.6, 62.0, 32.6, 23.1;
IR (film) 3406, 2973, 2937, 1662, 1622, 1424, 1386, 1151, 1002, 855, 802, 706 cm-;
LCMS calcd for C7H 14NO3 (M+H ) 160.1, found 160.0.
OH
Et2N N Me
(±)-(E)-N-N-Diethyl-4-hyroxypent-2-enamide. The above procedure was followed.
'H NMR (CDC13, 400 MHz) 8 6.86 (dd, J = 15.0, 4.6 Hz, 1H), 6.38 (d, J = 15.0 Hz, 1H),
4.51-4.40 (m, 1H), 3.39 (q, J = 7.0 Hz, 2H), 3.35 (q, J = 7.0 Hz, 2H), 2.28 (br s, 1H), 1.29 (d,
J = 6.6 Hz, 3H), 1.15 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 6 165.9, 148.6, 118.7, 67.7, 42.4, 41.0, 23.2, 15.0, 13.3;
IR (film) 3383, 2975, 2934, 2875, 1662, 1603, 1485, 1449, 1363, 1278, 1138, 1074, 976,
852, 808, 717 cm- ;
LCMS calcd for C9H18NO 2 (M+H +) 172.1, found 172.1.
3. Preparation of Allylic Chlorides
Representative Procedure A: A mixture of the allylic alcohol (17.1 mmol) and
pyridine (0.14 mL, 1.7 mmol) was added dropwise to PC13 (0.55 mL, 6.3 mmol) at 0 oC.
The reaction mixture was slowly warmed to room temperature, and then it was stirred
for 2 h. The top (organic) layer was separated, and the product was isolated by
fractional distillation.
Representative Procedure B: C12PPh 3 (6.0 g, 18 mmol) was added dropwise to a
solution of the allylic alcohol (15.0 mmol) and imidazole (1.22 g, 18.0 mmol) in CH2C12
(30 mL). The reaction mixture was stirred for 2 h at room temperature, and then the
solvent was removed and the residue was purified by flash chromatography.
CI
n-Pr, n-Pr
(+)-(E)-6-Chloronon-4-ene. This compound was prepared according to
Representative Procedure A (distilled at ~31 'C at 0.5 mm Hg).
1H NMR (CDC13, 400 MHz) 6 5.68 (dt, J = 15.2, 6.7 Hz, 1H), 5.52 (ddt, J = 15.2, 8.7, 1.3
Hz, 1H), 4.36 (dt, J = 8.7, 7.0 Hz, 1H), 2.10-1.96 (m, 2H), 1.87-1.70 (m, 2H), 1.51-1.36 (m,
4H), 0.93 (t, J = 7.4 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H);
13C NMR (CDC 3, 100 MHz) 6 133.6, 131.4, 63.8, 41.1, 34.2, 22.3, 20.1, 13.8, 13.7;
IR (film) 2961, 2933, 2874, 1666, 1466, 1380, 965 cm 1;
GCMS calcd for C9H17C1 (M+) 160, found 160.
Cl
i-Pr N i-Pr
(±)-(E)-5-Chloro-2,6-dimethylhept-3-ene. This compound was prepared according
to Representative Procedure A (distilled at ~26 'C at 0.5 mm Hg).
'H NMR (CDC 3, 400 MHz) 6 5.65 (dd, J = 15.5, 6.5 Hz, 1H), 5.52 (ddd, J = 15.3, 9.1,
1.2 Hz, 1H), 4.20 (dd, J = 9.1, 5.8 Hz, 1H), 2.32 (doublet of octets, J = 6.7, 1.2 Hz, 1H), 1.96
(doublet of octets, J = 6.7, 0.8 Hz, 1H), 1.01 (dd, J = 6.8, 0.8 Hz, 6H), 0.99 (dd, J = 9.2, 6.7
Hz, 6H);
"
3C NMR (CDC13, 100 MHz) 6 141.2, 126.5, 70.7, 35.6, 30.8, 22.38, 22.35, 19.4, 19.1;
IR (film) 2963, 2934, 2873, 1665, 1468, 1386, 1368, 970, 713 cm-1;
GCMS calcd for C9H17C1 (M+) 160, found 160.
CI
MeN Me
Me
(±)-(E)-4-Chloro-3-methylpent-2-ene. This compound was prepared according to
Representative Procedure A (distilled at ~32 'C at 20 mm Hg).
1H NMR (CDC13, 400 MHz) 6 5.59 (q, J = 6.8 Hz, 1H), 4.60 (q, J = 6.7 Hz, 1H), 1.72
(pentet, J = 1.1 Hz, 3H), 1.63 (dq, J = 6.8, 1.0 Hz, 3H), 1.59 (d, J = 6.8 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 136.9, 122.6, 65.1, 24.0, 13.5, 11.3;
IR (film) 2991, 2927, 2864, 1666, 1445, 1375, 1232, 1076, 830, 761, 655 cm-1;
GCMS calcd for C6H11C1 (M+) 118, found 118.
CI
n-Bu Me
(±)-(E)-2-Chlorooct-3-ene. This compound was prepared according to
Representative Procedure A as a 1.2:1 mixture of the title compound and (±)-(E)-4-
chlorooct-2-ene (distilled at ~46 OC at 6 mm Hg).
1H NMR (CDC13, 400 MHz) 6 5.76-5.51 (m, 2H, mixture), 4.54 (pentet, J = 6.9 Hz,
0.55H, major), 4.34 (dt, J = 8.6, 7.0 Hz, 0.45H, minor), 2.04 (q, J = 6.8 Hz, 1.10H, major),
1.85-1.74 (m, 0.90H, minor), 1.72 (dd, J = 6.4, 1.5 Hz, 1.35H, minor), 1.59 (d, J = 6.6 Hz,
1.65H, major), 1.47-1.27 (m, 4H, mixture), 0.94-0.87 (m, 3H, mixture);
13C NMR (CDC13, 100 MHz) 8 132.8, 132.5, 132.3, 128.4, 63.5, 58.8, 38.8, 31.8, 31.2,
28.9, 25.7, 22.37, 22.36, 17.7, 14.2, 14.1;
IR (film) 3033, 2959, 2930, 2873, 2862, 1668, 1466, 1452, 1378, 1221, 1012, 964 cm-;
GCMS calcd for CsH,,C1 (M') 146, found 146.
CI
i-Pr Me
(+)-(E)-2-Chloro-5-methylhex-3-ene. This compound was prepared according to
Representative Procedure A as a 1.4:1 mixture of the title compound and (±)-(E)-4-
chloro-5-methylhex-2-ene (distilled at -30 oC at 6 mm Hg).
1H NMR (CDCl3, 400 MHz) 6 5.74-5.63 (m, 1H, mixture), 5.60-5.50 (m, 1H, mixture),
4.54 (pentet, J = 6.7 Hz, 0.6H, major), 4.21 (dd, J = 9.1, 5.7 Hz, 0.4H, minor), 2.30 (doublet
of octets, J = 6.7, 1.0 Hz, 0.6H, major), 1.96 (octet, J = 6.7 Hz, 0.4H, minor), 1.73 (dd, J =
6.3, 1.4 Hz, 1.3H, minor), 1.59 (d, J = 6.6 Hz, 1.7H, major), 1.00-0.97 (m, 6H);
13C NMR (CDC13, 100 MHz) 6 139.5, 130.6, 129.5, 129.1, 70.6, 58.9, 35.5, 30.6, 25.7,
22.22, 22.21, 19.4, 19.1, 17.8;
IR (film) 2966, 2931, 2873, 1665, 1467, 1386, 1212, 1013, 966 cm-1;
GCMS calcd for C7H 13C1 (M') 132, found 132.
CI
t-Bu ~ Me
(+)-(E)-5-Chloro-2,2-dimethylhex-3-ene. This compound was prepared according to
Representative Procedure A as a 2.4:1 mixture of the title compound and (±)-(E)-4-
chloro-5,5-dimethylhex-2-ene (distilled at -45 'C at 30 mm Hg).
1H NMR (CDC13, 400 MHz) 6 5.70 (dd, J = 15.5, 0.7 Hz, 0.7H, major), 5.69-5.56 (m,
0.6H, minor), 5.49 (dd J = 15.5, 8.1 Hz, 0.7H, major), 4.54 (dq, J = 6.7, 0.7 Hz, 0.7H,
major), 4.15 (d, J = 9.2 Hz, 0.3H, minor), 1.73 (dd, J = 6.0, 1.0 Hz, 0.9H, minor), 1.59 (d, J
= 6.6 Hz, 2.1H, major), 1.02 (s, 6.3H, major), 1.00 (s, 2.7H, minor);
13C NMR (CDCl3, 100 MHz) 6 143.3, 129.6, 129.5, 127.4, 75.0, 59.2, 36.1, 33.0, 29.5,
26.9, 25.9, 17.8;
IR (film) 3035, 2963, 2868, 1660, 1477, 1464, 1446, 1365, 1266, 1222, 1195, 1010, 967, 646
-1
cm ;
GCMS calcd for CsH 15C1 (M ) 146, found 146.
CI
Et2N- Me
0
(±)-(E)-4-Chloro-N,N-diethylpent-2-enamide. The compound was prepared
according to Representative Procedure B (eluant for chromatography: pentane/Et20O
1:1).
1H NMR (CDC13, 400 MHz) 8 6.91 (dd, J = 14.8, 6.9 Hz, 1H), 6.44 (dd J = 14.8, 1.1 Hz,
1H), 4.68 (doublet of pentets, J = 6.8, 1.1 Hz, 1H), 3.50-3.38 (m, 4H), 1.67 (d, J = 6.8 Hz,
3H), 1.23 (t, J = 7.2 Hz, 3H), 1.17 (t, J = 7.1 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 8 165.0, 144.5, 121.4, 56.1, 42.5, 41.1, 25.0, 15.1, 13.3;
IR (film) 2977, 2933, 1663, 1617, 1432, 1276, 909, 733 cmi;
GCMS calcd for C9H 16CINO (M+) 189, found 189.
Cl
Me(MeO)N Me
(±)-(E)-4-Chloro-N-methoxy-N-methylpent-2-enamide. The compound was
prepared according to Representative Procedure B (eluant for chromatography:
pentane/ Et20 1:1).
1H NMR (CDC13, 400 MHz) 8 6.97 (dd, J = 15.2, 7.1 Hz, 1H), 6.62 (d J = 15.2 Hz, 1H),
4.68 (doublet of pentets, J = 6.9, 1.0 Hz, 1H), 3.73 (s, 3H), 3.26 (s, 3H), 1.66 (d, J = 6.8 Hz,
3H);
13C NMR (CDC13, 100 MHz) 6 166.0, 146.0, 119.4, 62.1, 55.7, 32.6, 24.8;
IR (film) 2975, 2938, 1667, 1638, 1444, 1420, 1385, 1180, 1000, 978, 707 cm-1;
GCMS calcd for C7H 12C1NO 2 (M+) 177, found 177.
CI
(EtO) 20P % Me
(+)-(E)-Diethyl 3-chlorobut-l-enylphosphonate. The compound was prepared
according to Representative Procedure B (eluant for chromatography: Et20).
1H NMR (CDCl3, 400 MHz) 6 6.78 (ddd, J = 21.1, 16.8, 10.6 Hz, 1H), 5.93 (ddd, J =
18.2, 16.9, 1.3 Hz, 1H), 4.60 (triplet of pentets, J = 6.6, 1.7 Hz, 1H), 4.12 (pentet, J = 7.1 Hz,
4H), 1.65 (d, J = 6.8 Hz, 3H), 1.36 (dt, J = 7.0, 0.5 Hz, 6H);
13C NMR (CDCl3, 100 MHz) 8 151.3 (d, Jcp= 6.4 Hz), 118.1 (d, Jcp= 186.3 Hz), 62.21 (d,
Jcp= 6.4 Hz), 62.17 (d, Jcp= 6.3 Hz), 56.1 (d, Jcp= 5.1 Hz), 24.3, 16.6, 16.5;
IR (film) 2984, 2933, 2908, 1633, 1445, 1393, 1246, 1025, 968, 847 cm'-;
GCMS calcd for C8H16C103P (M+) 226, found 226.
4. Negishi Cross-Coupling Reactions
Preparation of the organozinc reagents:5 A 25-mL Schlenk tube was charged with
zinc powder (1.47 g, 22.5 mmol) and heated to 70 'C under high vacuum for 30 min.
After back-filling with argon, iodine (95 mg, 0.38 mmol) and DMA (to give a total
volume of 15 mL) were added, and the resulting mixture was stirred until the red color
of iodine had faded. Then, the allylic chloride (15 mmol; freshly distilled) was added.
The colorless reaction mixture was allowed to stir for 12 h at 70 oC, and then the
mixture was cooled to room temperature. The gray solution was passed through an
Acrodisc® and stored under nitrogen in a dry container.
These solutions of organozinc halides can be stored at room temperature for several
weeks without deterioration.
General Procedure: In the air, a 40-mL glass vial was charged with NiC12"glyme
(11.0 mg, 0.050 mmol), (R)-BnCH 2-Pybox (23.4 mg, 0.055 mmol), and NaCl (234 mg, 4.0
mmol) and fitted with a septum cap. The vial was evacuated and then back-filled with
Ar (three cycles). DMA (13.8 mL) and DMF (15.0 mL) were added, followed by the
allylic chloride (1.0 mmol). The resulting mixture was cooled to -10 OC. Next, the
organozinc solution (-1.0 M in DMA; 1.2 mL, 1.2 mmol) was added in a single portion
to the mixture, which was stirred for 24 h at -10 oC. The reaction mixture was then
diluted with water (30 mL) and extracted with Et20O (30 mL x 3). The organic layer was
dried over MgSO, and concentrated, and the residue was purified by flash
chromatography.
A second run was conducted with (S)-BnCH 2-Pybox.
n-Hex
Me - Me
(S,E)-4-Methyldec-2-ene (Table 4, entry 1). The compound was prepared according
to the General Procedure with (±)-(E)-4-chloropent-2-ene (105 mg, 1.0 mmol) and the
organozinc reagent (~1.2 M in DMA; 1.00 mL, 1.2 mmol). The yield was determined by
GC versus n-hexadecane as an internal standard: run 1, 94% yield, 87% ee; run 2, 96%
yield, 87% ee.
The ee was determined by chiral GC: CP Chirasil-Dex CB, t, (major) 5.4 min, tr
(minor) 5.3 min; temperature: 90 'C; 1.0 mL/min.
Me Me
(+)-(S,E)-2-(3-Methylhex-4-enyl)-1,3-dioxolane (Table 4, entry 2). The compound
was prepared according to the General Procedure with (±)-(E)-4-chloropent-2-ene (105
mg, 1.0 mmol) and the organozinc reagent (~1.4 M in DMA; 0.86 mL, 1.2 mmol). After
purification by flash chromatography (hexanes/Et20O 10:1), the title compound was
isolated as a colorless oil: run 1, 155 mg (91%; 89% ee); run 2, 160 mg (94%; 91% ee).
[a]22D = +12.6 (c = 2.34, CHCI3);
1H NMR (CDC13, 400 MHz) 6 5.39 (ddq, J = 15.2, 6.2, 0.5 Hz, 1H), 5.26 (ddq, J = 15.2,
7.7, 1.3 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 4.01-3.92 (m, 2H), 3.89-3.81 (m, 2H), 2.07 (septet,
J = 7.0 Hz, 1H), 1.73-1.57 (m, 5H), 1.43-1.28 (m, 2H), 0.97 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 137.1, 123.7, 105.0, 65.04, 65.03, 36.9, 32.0, 31.4, 21.1,
18.1;
IR (film) 2955, 2927, 2878, 1453, 1410, 1377, 1142, 1044, 967 cm-;
GCMS calcd for C10H 180 2 (M+) 170, found 170.
The ee was determined by chiral GC: CP Chirasil-Dex CB, t, (major) 50.7 min, tr
(minor) 51.2 min; temperature: 80 'C; 1.0 mL/min.
n-Pr ~ n-Pr
(+)-(S,E)-4-(2-Propylhept-3-enyl)tetrahydro-2H-pyran (Table 4, entry 3). The
compound was prepared according to the General Procedure with (±)-(E)-6-chloronon-
4-ene (161 mg, 1.0 mmol) and the organozinc reagent (-1.8 M in DMA; 0.66 mL, 1.2
mmol). After purification by flash chromatography (hexanes/Et20O 30:1), the title
compound was isolated as a colorless oil: run 1, 180 mg (80%; 86% ee); run 2, 182 mg
(81%; 84% ee).
[a]22D = +23 (c = 2.1, CHC13);
1H NMR (CDC13, 400 MHz) 8 5.31 (dt, J = 15.2, 6.8 Hz, 1H), 5.05 (ddt, J = 15.2, 9.1, 1.1
Hz, 1H), 3.96-3.91 (m, 2H), 3.34 (ddt, J = 14.9, 12.1, 2.2 Hz, 2H), 2.08-1.97 (m, 1H), 1.98
(dq, J = 6.8, 1.1 Hz, 2H), 1.65-1.60 (m, 1H), 1.52-1.48 (m, 2H), 1.41-1.11 (m, 10H), 0.89 (t, J
= 7.3 Hz, 3H), 0.86 (t, J = 7.1 Hz, 3H);
13C NMR (CDC3 , 100 MHz) 6 135.0, 130.4, 68.40, 68.36, 43.1, 39.4, 38.4, 34.9, 34.2,
32.8, 32.5, 23.0, 20.5, 14.4, 13.8;
IR (film) 2958, 2872, 2840, 2757, 2712, 1465, 1445, 1386, 1378, 1236, 1153, 1108, 1014,
970, 849 cm-1;
GCMS calcd for ClH 280 (M+) 224, found 224.
The ee was determined by chiral GC: CP Chirasil-Dex CB, tr (major) 38.3 min, t
(minor) 37.6 min; temperature: 108 'C; 1.0 mL/min.
n-PrK" n-Pr
(+)-(S,E)-12-Chloro-6-propyldodec-4-ene (Table 4, entry 4). The compound was
prepared according to the General Procedure with (±)-(E)-6-chloronon-4-ene (161 mg,
1.0 mmol) and the organozinc reagent (-0.9 M in DMA; 1.3 mL, 1.2 mmol). After
purification by flash chromatography (hexanes), the title compound was isolated as a
colorless oil: run 1, 196 mg (80%; 78% ee); run 2, 200 mg (81%; 79% ee).
[a]22D = +1.1 (c = 3.0, CHC13);
1H NMR (CDC13, 400 MHz) 8 5.31 (dt, J = 15.2, 6.7 Hz, 1H), 5.26 (ddt, J = 15.2, 8.8, 1.3
Hz, 1H), 3.53 (t, J = 6.8 Hz, 2H), 1.97 (dq, J = 7.0, 1.2 Hz, 2H), 1.90-1.80 (m, 1H), 1.77
(pentet, J = 7.1 Hz, 2H), 1.43-1.36 (m, 4H), 1.35-1.13 (m, 10H), 0.89 (t, J = 7.3 Hz, 3H), 0.87
(t, J = 6.9 Hz, 3H);
13C NMR (CDC13 , 100 MHz) 8 135.3, 130.2, 45.4, 42.8, 38.1, 35.7, 34.9, 32.9, 29.2, 27.3,
27.1, 23.1, 20.6, 14.4, 13.9;
IR (film) 2957, 2928, 2859, 1465, 1378, 969, 727 cm-1;
GCMS calcd for C15H 29Cl (M+) 244, found 244.
The ee was determined of 8-chloro-2-propyloctyl 4-nitrobenzoate [obtained by
ozonolysis, reduction, and then benzoylation] by HPLC on an IA column
(hexanes/isopropanol 99:1, 0.5 mL/min) with tr (major) 19.9 min, tr (minor) 20.8 min.
- OTBS
(+)-(R,E)-tert-Butyl(4-isopropyl-7-methyloct-5-enyloxy)dimethylsilane (Table 4,
entry 5). The compound was prepared according to the General Procedure with (±)-(E)-
5-chloro-2,6-dimethylhept-3-ene (161 mg, 1.0 mmol) and the organozinc reagent (-~1.0 M
in DMA; 1.2 mL, 1.2 mmol). After purification by flash chromatography (hexanes/Et20O
20:1), the title compound was isolated as a colorless oil: run 1, 172 mg (58%; 69% ee);
run 2, 167 mg (56%; 69% ee).
[a]22D = +0.6 (c = 3.9, CHC13);
1H NMR (CDC13, 400 MHz) 8 5.30 (dd, J = 15.3, 6.7 Hz, 1H), 5.26 (ddd, J = 15.3, 9.2,
1.1 Hz, 1H), 3.59 (t, J = 6.6 Hz, 2H), 2.26 (doublet of octets, J = 6.6, 1.2 Hz, 1H), 1.70-1.63
(m, 1H), 1.58-1.52 (m, 2H), 1.51-1.34 (m, 2H), 1.24-1.15 (m, 1H), 0.98 (dd, J = 6.7, 1.1 Hz,
6H), 0.90 (s, 9H), 0.95 (d, J = 6.7 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H), 0.05 (s, 6H);
13C NMR (CDC13, 100 MHz) 8 139.0, 129.1, 63.7, 49.1, 32.2, 31.5, 31.2, 28.8, 26.2, 23.1,
21.0, 19.2, 18.6, -5.0;
IR (film) 2957, 2930, 2860, 1472, 1464, 1385, 1361, 1255, 1102, 973, 836, 775 cm 1;
GCMS calcd for C18H 38OSi (M +) 298, found 298.
The ee was determined by chiral GC: CP Chirasil-Dex CB, t, (major) 17.6 min, t,
(minor) 18.0 min; temperature: 120 'C; 1.0 mL/min.
OMe
Me Me
Me
(+)-(S,E)-1-(4,5-Dimethylhept-5-enyl)-4-methoxybenzene (Table 4, entry 6). The
compound was prepared according to the General Procedure with (±)-(E)-4-chloro-3-
methylpent-2-ene (118 mg, 1.0 mmol) and the organozinc reagent (-1.1 M in DMA; 1.1
mL, 1.2 mmol). After purification by flash chromatography (hexanes/Et20O 30:1), the
title compound was isolated as a colorless oil: run 1, 128 mg (55%; 97% ee); run 2, 123
mg (53%; 99% ee).
[a]22D = +5.7 (c = 2.3, CHC 3);
1H NMR (CDC13, 400 MHz) 6 7.14-7.10 (m, 2H), 6.88-6.84 (m, 2H), 5.25 (q, J = 6.5 Hz,
1H), 3.82 (s, 3H), 2.62-2.49 (m, 2H), 2.14 (sextet, J = 7.0 Hz, 1H), 1.60 (dd, J = 6.6, 0.9 Hz,
3H), 1.52 (s, 3H), 1.53-1.45 (m, 2H), 1.44-1.36 (m, 1H), 1.34-1.25 (m, 1H), 0.99 (d, J = 6.9
Hz, 3H);
13C NMR (CDCl3, 100 MHz) 6 157.8, 140.0, 135.2, 129.4, 117.9, 113.8, 55.4, 42.9, 35.3,
34.7, 30.1, 20.0, 13.4, 12.0;
IR (film) 2995, 2956, 2930, 2958**, 1613, 1584, 1513, 1463, 1442, 1300, 1246, 1177, 1040,
828 cm-1;
GCMS calcd for C16H240 (M+) 232, found 232.
The ee was determined by chiral GC: CP Chirasil-Dex CB, t, (major) 113.9 min, tr
(minor) 118.3 min; temperature: 110 'C; 1.0 mL/min.
Ph
n-Bu /- Me
(+)-(S,E)-(4-Methyldec-5-enyl)benzene (Table 5, entry 1). The compound was
prepared according to the General Procedure with a 1.2:1 mixture of (I)-(E)-2-chlorooct-
3-ene and (±)-(E)-4-chlorooct-2-ene (147 mg, 1.0 mmol) and the organozinc reagent (-1.2
M in DMA; 1.0 mL, 1.2 mmol). After purification by flash chromatography
(hexanes/Et20O 30:1), the title compound and (R)-(E)-(4-(prop-l-enyl)octyl)benzene were
obtained as a 1.9:1 mixture: run 1, 220 mg (95%; major, 84% ee; minor, 89% ee); run 2,
227 mg (99%; major, 82% ee; minor, 89% ee).
The characterization data of the mixture is reported.
[a]22D = +11.8 (c = 1.43, CHC 3);
1H NMR (CDC13, 400 MHz) 8 7.32-7.28 (m, 2H, mixture), 7.20-7.18 (m, 3H, mixture),
5.41-5.35 (m, 1H, mixture), 5.25 (dd, J = 15.3, 7.6 Hz, 0.7H, major), 5.14 (ddq, J = 15.2, 8.8,
1.6 Hz, 0.3H, minor), 2.64-2.56 (m, 2H, mixture), 2.10 (septet, J = 6.9 Hz, 0.7H, major),
2.12-1.94 (m, 1H, mixture), 1.93-1.88 (m, 0.3 H, minor), 1.72-1.59 (m, 3H, mixture), 1.37-
1.16 (m, 7H, mixture), 0.99-0.88 (m, 5H, mixture);
13C NMR (CDC13, 100 MHz) 8 143.2, 143.1, 136.32, 136.26, 128.9, 128.6, 128.4, 125.8,
124.6, 43.0, 37.0, 36.9, 36.34, 36.28, 35.5, 35.4, 32.5, 32.1, 29.7, 29.5, 23.1, 22.4, 21.2, 18.2,
14.4, 14.2;
IR (film) 3063, 3027, 2957, 2927, 1605, 1496, 1454, 1377, 968, 747, 698 cm-1;
GCMS calcd for C17H26 (M+) 230, found 230.
The ee was determined of 2-methyl-5-phenylpentyl benzoate (from the major
regioisomer) and of 2-(3-phenylpropyl)hexyl benzoate (from the minor regioisomer)
[obtained by ozonolysis, reduction, then benzoylation] by HPLC on an OD-H column
(hexanes/isopropanol 95:5, 1.0 mL/min) with tr (major enantiomer of the major
regioisomer) 5.4 min, tr (minor enantiomer of the major regioisomer) 7.5 min; tr (major
enantiomer of the minor regioisomer) 4.8 min, tr (minor enantiomer of the minor
regioisomer) 6.2 min.
o0
(+)-(S,E)-2-(3,6-Dimethylhept-4-enyl)-1,3-dioxolane (Table 5, entry 2). The
compound was prepared according to the General Procedure with a 1.4:1 mixture of
(±)-(E)-2-chloro-5-methylhex-3-ene and (±)-(E)-4-chloro-5-methylhex-2-ene (133 mg, 1.0
mmol) and the organozinc reagent (-1.4 M in DMA; 0.86 mL, 1.2 mmol). After
purification by flash chromatography (hexanes/Et20O 20:1), the title compound was
isolated as a colorless oil: run 1, 188 mg (95%, 86% ee); run 2, 189 mg (95%, 82% ee).
[a]22 D = +12.4 (c = 1.23, CHCl 3);
1H NMR (CDC13, 400 MHz) 6 5.34 (dd, J = 15.4, 6.6 Hz, 1H), 5.18 (ddd, J = 15.4, 6.8,
1.0 Hz, 1H), 4.84 (t, J = 4.8 Hz, 1H), 3.99-3.93 (m, 2H), 3.89-3.83 (m, 2H), 2.28-2.16 (m,
1H), 2.06 (septet, J = 6.9 Hz, 1H), 1.71-1.56 (m, 2H), 1.46-1.31 (m, 2H), 0.98-0.95 (m, 9H);
13C NMR (CDC13, 100 MHz) 6 136.6, 132.7, 105.0, 65.0, 36.8, 32.0, 31.5, 31.2, 23.0, 22.9,
21.2;
IR (film) 2957, 2927, 2870, 1458, 1409, 1142, 1046, 972, 882 cm-1;
GCMS calcd for C12H2202 (M+) 198, found 198.
The ee was determined of 4-(1,3-dioxolan-2-yl)-2-methylbutyl benzoate [obtained by
ozonolysis, reduction, then benzoylation] by HPLC on an OD-H column
(hexanes/isopropanol 99:1, 1.0 mL/min) with t, (major) 7.8 min, tr (minor) 8.9 min.
,.CO 2Me
t-Bu- Me
(+)-(S,E)-Methyl 5,8,8-trimethylnon-6-enoate (Table 5, entry 3). The compound
was prepared according to the General Procedure with a 2.4:1 mixture of (±)-(E)-5-
chloro-2,2-dimethylhex-3-ene and (±)-(E)-4-chloro-5,5-dimethylhex-2-ene (147 mg, 1.0
mmol) and the organozinc reagent (~0.9 M in DMA; 1.3 mL, 1.2 mmol). After
purification by flash chromatography (hexanes/Et2O 20:1), the title compound was
isolated as a colorless oil: run 1, 182 mg (86%, 81% ee); run 2, 177 mg (83%, 80% ee).
[a]22D = +17.1 (c = 2.06, CHC13);
1H NMR (CDC13, 400 MHz) 6 5.34 (dd, J = 15.6, 0.8 Hz, 1H), 5.08 (dd, J = 15.6, 7.9 Hz,
1H), 3.63 (s, 3H), 2.25 (t, J = 7.5 Hz, 2H), 2.00 (septet, J = 7.0 Hz, 1H), 1.63-1.47 (m, 2H),
1.30-1.16 (m, 2H), 0.94 (s, 9H), 0.91 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 174.5, 140.4, 130.3, 51.6, 36.8, 36.7, 34.3, 32.8, 30.0, 23.0,
21.2;
IR (film) 2957, 2907, 2868, 1744, 1462, 1363, 1197, 1170, 974 cm-;
GCMS calcd for C13H 240 2 (M+) 212, found 212.
The ee was determined of 6-methoxy-2-methyl-6-oxohexyl benzoate [obtained by
ozonolysis, reduction, and then benzoylation] by HPLC on an OD-H column
(hexanes/isopropanol 99:1, 1.0 mL/min) with tr (major) 8.1 min, tr (minor) 9.0 min.
Me
Me
EtO2 C Me
(+)-(S,E)-Ethyl 4,8-dimethylnona-2,7-dienoate (Table 5, entry 4). The compound
was prepared according to the General Procedure with (±)-(E)-ethyl 4-chloropent-2-
enoate (163 mg, 1.0 mmol) and the organozinc reagent (-~1.4 M in DMA; 0.86 mL, 1.2
mmol). After purification by flash chromatography (hexanes/Et20O 20:1), the title
compound was isolated as a colorless oil: run 1, 180 mg (86%, 97% ee); run 2, 181 mg
(86%, 94% ee).
[a]22D = +55 (c = 2.2, CHC13);
1H NMR (CDC13, 400 MHz) 8 6.87 (dd, J = 15.7, 8.0 Hz, 1H), 5.78 (dd, J = 15.7, 1.2 Hz,
1H), 5.07 (triplet of septets, J = 7.1, 1.4 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 2.31 (septet, J =
5.9 Hz, 1H), 1.96 (q, J = 7.5 Hz, 2H), 1.68 (d, J = 1.0 Hz, 3H), 1.59 (s, 3H), 1.47-1.35 (m,
2H), 1.29 (t, J = 7.1 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 167.1, 154.7, 132.1, 124.1, 119.9, 60.3, 36.2, 25.9, 25.8,
19.5, 17.9, 14.5;
IR (film) 2967, 2917, 2873, 2855, 1722, 1652, 1452, 1368, 1301, 1268, 1178, 1039, 985 cm
1.
GCMS calcd for C13H 220 2 (M+) 210, found 210.
The ee was determined by HPLC on an AS-H column (hexanes, 1.0 mL/min) with tr
(major) 9.7 min, tr (minor) 12.1 min.
Et
Et2 NOCi Me
(+)-(S,E)-N,N-Diethyl-4-methylhex-2-enamide (Table 5, entry 5). The compound
was prepared according to the General Procedure with (±)-(E)-4-chloro-N,N-
diethylpent-2-enamide (190 mg, 1.0 mmol) and the organozinc reagent (-0.9 M in DMA;
1.3 mL, 1.2 mmol). After purification by flash chromatography (hexanes/Et20O 1:1), the
title compound was isolated as a colorless oil: run 1, 102 mg (56%, 89% ee); run 2, 105
mg (57%, 92% ee).
[a]22D = +27 (c = 1.3, CHC 3);
1H NMR (CDC13, 400 MHz) 8 6.87 (dd, J = 15.0, 8.0 Hz, 1H), 6.13 (dd, J = 15.1, 1.0 Hz,
1H), 3.45-3.34 (m, 4H), 2.20 (septet, J = 6.8 Hz, 1H), 1.44-1.33 (m, 2H), 1.18 (t, J = 7.1 Hz,
3H), 1.13 (t, J = 7.1 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 8 166.2, 151.5, 119.0, 42.3, 41.0, 38.6, 29.2, 19.6, 15.5, 13.4,
11.9;
IR (film) 2966, 2932, 2875, 1660, 1619, 1447, 1430, 1379, 1361, 1279, 1261, 983 cm 1;
GCMS calcd for C11H21NO (M ) 183, found 183.
The ee was determined by HPLC on an AD-H column (hexanes/isopropanol 99:1,
0.5 mL/min) with tr (major) 40.3 min, tr (minor) 38.2 min.
, OTBS
Me(MeO)N < Me
O
(+)-(S,E)-7-(tert-Butyldimethylsilyoxy)-N-methoxy-N,4-dimethylhept-2-enamide
(Table 5, entry 6). The compound was prepared according to the General Procedure
with (±)-(E)-4-chloro-N-methoxy-N-methylpent-2-enamide (178 mg, 1.0 mmol) and the
organozinc reagent (~1.0 M in DMA; 1.2 mL, 1.2 mmol). After purification by flash
chromatography (hexanes/Et20O 1:1), the title compound was isolated as a colorless oil:
run 1, 285 mg (90%, 93% ee); run 2, 289 mg (92%, 92% ee).
[a]22D = +12.2 (c = 1.38, CHC13);
1H NMR (CDCl3, 400 MHz) 6 6.87 (dd, J = 15.4, 8.1 Hz, 1H), 6.35 (d, J = 15.4 Hz, 1H),
3.70 (s, 3H), 3.59 (t, J = 6.3 Hz, 2H), 3.24 (s, 3H), 2.35 (septet, J = 6.8 Hz, 1H), 1.55-1.48 (m,
2H), 1.45-1.39 (m, 2H), 1.07 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.04 (s, 6H);
13C NMR (CDCl3, 100 MHz) 6 167.3, 153.3, 117.2, 63.3, 61.8, 36.8, 32.6, 30.7, 26.2, 19.9,
18.6, 15.5, -5.1;
IR (film) 2956, 2931, 2857, 1666, 1635, 1471, 1463, 1412, 1381, 1256, 1099, 1006, 940,
836, 776 cm ;
LCMS calcd for C 16H 34NO3Si (M+H ) 316.2, found 316.2.
The ee was determined of 5-(tert-butyldimethylsilyloxy)-2-methylpentyl benzoate
[obtained by ozonolysis, reduction, then benzoylation] by HPLC on an OD-H column
(hexanes, 1.0 mL/min) with tr (major) 15.4 min, tr (minor) 19.6 min.
n-Hex
(EtO) 20P Me
(+)-(S,E)-Diethyl 3-methylnon-l-enylphosphonate (Table 5, entry 7). The
compound was prepared according to the General Procedure with (±)-(E)-diethyl 3-
chlorobut-l-enylphosphonate (227 mg, 1.0 mmol) and the organozinc reagent (-0.9 M in
DMA; 1.3 mL, 1.2 mmol). After purification by flash chromatography (hexanes/Et20O
1:1), the title compound was isolated as a colorless oil: run 1, 175 mg (63%, 90% ee); run
2, 170 mg (62%, 90% ee).
[a]22D = +20 (c = 1.9, CHC13);
'H NMR (CDC13, 400 MHz) 8 6.70 (ddd, J = 22.2, 17.2, 7.5 Hz, 1H), 5.60 (ddd, J = 21.0,
17.2, 1.1 Hz, 1H), 4.13-4.04 (m, 4H), 2.30 (septet, J = 6.7 Hz, 1H), 1.34 (t, J = 7.1 Hz, 6H),
1.36-1.23 (m, 10H), 1.05 (d, J = 6.6 Hz, 3H), 0.89 (t, J = 6.8 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 159.5, 114.9 (d, JcP = 186.3 Hz), 61.7 (d, JcP = 6.4 Hz),
38.6, 38.4, 35.9, 31.9, 29.5, 27.3, 22.8, 19.3, 16.6, 16.5, 14.3;
IR (film) 2959, 2928, 2857, 1630, 1461, 1250, 1056, 1029, 963 cm 1;
LCMS calcd for C14H300 3P (M+H+) 277.2, found 277.2.
The ee was determined of 2-methyloctyl 3,4,5-trimethoxybenzoate [obtained by
ozonolysis, reduction, then benzoylation] by HPLC on an AD-H column
(hexanes / isopropanol 99:1, 0.5 mL /min) with t, (major) 23.1 min, tr (minor) 21.8 min.
Procedure A for aryl-substituted olefins (eq 8): In the air, a 40-mL glass vial was
charged with NiC12-glyme (22.0 mg, 0.10 mmol), (R)-(i-Pr)-Pybox (33.2 mg, 0.11 mmol),
and NaCi (117 mg, 4.0 mmol) and fitted with a septum cap. The vial was evacuated and
then back-filled with Ar (three cycles). DMA (19.8 mL) and DCE (9.0 mL) were added,
followed by the allylic chloride (1.0 mmol). The resulting mixture was cooled to -10 oC.
Next, the organozinc solution (-1.0 M in DMA; 1.2 mL, 1.2 mmol) was added in a single
portion to the mixture, which was stirred for 36 h at -20 oC. The reaction mixture was
then diluted with water (30 mL) and extracted with Et20O (30 mL x 3). The organic layer
was dried over MgSO, and concentrated, and the residue was purified by flash
chromatography.
n-Hex
Ph Me
(+)-(S,E)-(3-methyldec-l-enyl)benzene (Table 6, entry 1). The compound was
prepared according to the Procedure A with (±)-(E)-(3-chlorobut-l-enyl)benzene (167
mg, 1.0 mmol) and the organozinc reagent (-0.9 M in DMA; 1.3 mL, 1.2 mmol). After
purification by flash chromatography (hexanes), the title compound was isolated as a
colorless oil: run 1, 122 mg (56%, 96% ee); run 2, 119 mg (55%, 95% ee).
[a]22D = 107.91 (c = 2.06, CHC13);
1H NMR (CDC13, 400 MHz) 8 7.38-7.36 (m, 2H), 7.33-7.29 (m, 2H), 7.23-7.18 (m, 1H),
6.35 (d, J = 15.9 Hz, 1H), 6.11 (dd, J = 15.9, 8.0 Hz, 1H), 2.30 (septet, J = 6.8 Hz, 1H), 1.42-
1.35 (m, 2H), 1.34-1.24 (m, 8H), 1.09 (d, J = 6.7 Hz, 3H), 0.90 (t, J = 6.7 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 8 138.2, 137.3, 128.7, 128.1, 126.9, 126.2, 37.5, 37.4, 32.1,
29.7, 27.6, 22.9, 20.9, 14.3;
IR (film) 3082, 3060, 3025, 2957, 2926, 2855, 1649, 1598, 1494, 1455, 965, 746, 692 cm-';
GCMS calcd for C16H24 (M+) 216, found 216.
The ee was determined on 2-methyloctyl 3,4,5-trimethoxybenzoate obtained by
ozonolysis of the title compound followed by benzoylation. The ee was determined by
HPLC on an AD-H column (hexanes/iso-propanol 99:1, flow 0.5 mL/min.) with
tr(major) 24.6 min., tr(minor) 23.4 min.
NC~ Me
(+)-(S,E)-3-(9-chloro-3-methylnon-1-enyl)benzonitrile (Table 6, entry 2). The
compound was prepared according to the Procedure A with (±)-(E)-3-(3-chlorobut-1-
enyl)benzonitrile (192 mg, 1.0 mmol) and the organozinc reagent (~0.9 M in DMA; 1.3
mL, 1.2 mmol). After purification by flash chromatography (hexanes/Et20O = 20:1), the
title compound was isolated as a colorless oil: run 1, 107 mg (39%, 94% ee); run 2, 96 mg
(35%, 94% ee).
[a]2 2D = 50.76 (c = 1.77, CHC13);
1H NMR (CDC13, 400 MHz) 6 7.64 (d, J = 1.6 Hz, 1H), 7.57 (dt, J = 7.8, 1.4 Hz, 1H),
7.49 (dt, J = 7.1, 1.4 Hz, 1H), 7.41 (d, J = 7.7 Hz, 1H), 6.33 (d, J = 15.9 Hz, 1H), 6.18 (dd, J =
15.9, 7.9 Hz, 1H), 3.55 (t, J = 6.7 Hz, 2H), 2.33 (septet, J = 6.7 Hz, 1H), 1.82-1.75 (m, 2H),
1.47-1.34 (m, 8H), 1.10 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 140.0, 139.3, 130.4, 130.3, 129.6, 129.4, 126.3, 119.2,
112.8, 45.4, 37.5, 36.9, 32.8, 29.2, 27.4, 27.0, 20.7;
IR (film) 2956, 2929, 2856, 2230, 1650, 1598, 1577, 1457, 967, 790, 686 cm 1;
GCMS calcd for C1H22C1N (M') 275, found 275.
The ee was determined by HPLC on an OJ-H column (hexanes/iso-propanol 99:1,
flow 0.8 mL/min.) with tr(major) 18.7 min., tr(minor) 19.9 min.
OMe
0CI Me
(+)-(S,E)-l-chloro-4-(6-(4-methoxyphenyl)-3-methylhex-1-enyl)benzene (Table 6,
entry 3). The compound was prepared according to the Procedure A with (±)-(E)-1-
chloro-4-(3-chlorobut-l-enyl)benzene (201 mg, 1.0 mmol) and the organozinc reagent
(~-1.1 M in DMA; 1.1 mL, 1.2 mmol). After purification by flash chromatography
(hexanes/Et20O = 20:1), the title compound was isolated as a colorless oil: run 1, 169 mg
(54%, 97% ee); run 2, 176 mg (56%, 97% ee).
[a]2 2 D = 56.30 (c = 2.20, CHC13);
1H NMR (CDC13, 400 MHz) 6 7.28 (s, 4H), 7.12-7.10 (m, 2H), 6.87-6.84 (m, 2H), 6.30
(d, J = 15.9 Hz, 1H), 6.08 (dd, I = 15.9, 8.0 Hz, 1H), 3.81 (s, 3H), 2.64-2.52 (m, 2H), 2.33
(septet, J = 6.9 Hz, 1H), 1.68-1.57 (m, 2H), 1.48-1.38 (m, 2H), 1.09 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 8 157.8, 137.6, 136.5, 134.9, 132.5, 129.5, 128.8, 127.4,
127.2, 113.9, 55.4, 37.5, 36.7, 35.3, 29.8, 20.8;
IR (film) 3028, 2994, 2954, 2931, 2855, 1612, 1512, 1491, 1246, 1177, 1091, 1038, 968, 807
-1
cm ;
GCMS calcd for C20H23C10 (M+) 314, found 314.
The ee was determined by HPLC on an OJ-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with t,(major) 22.0 min., tr(minor) 26.8 min.
5. Formal Total Synthesis of Fluvirucinine A, (Scheme 3)
Me
Et0 2 C
(+)-(E)-Ethyl 4-chloropent-2-enoate (2). MeMgBr (3.0 M in Et20O; 14 mL, 42 mmol)
was added dropwise over 30 min to a solution of ethyl (E)-4-oxo-2-butenoate (5.13 g,
40.0 mmol) in Et20O (120 mL) at -85 'C. The reaction mixture was stirred for 2 h at -85
oC, and then the bath was removed. A saturated solution of NH 4C1 (100 mL) was
added, and the aqueous layer was extracted with Et20O (100 mL x 3). The organic layer
was dried over MgSO 4, filtered, and concentrated. Flash chromatography
(hexanes/EtO 3:1) provided the allylic alcohol (4.21 g, 73%), which was converted to
the allylic chloride by Representative Procedure A (Section III; 5.28 g, 81%).
1H NMR (CDC13, 400 MHz) 6 6.95 (dd, J = 15.4, 7.0 Hz, 1H), 6.03 (dd, J = 15.4, 1.2 Hz,
1H), 4.63 (doublet of pentets, J = 6.8, 1.2 Hz, 1H), 4.23 (q, J = 7.2 Hz, 2H), 1.66 (d, J = 6.7
Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 166.1, 147.2, 121.9, 60.9, 55.0, 24.4, 14.4;
IR (film) 2983, 1722, 1660, 1446, 1368, 1271, 1181, 1034, 975 cm 1;
GCMS calcd for C7H 1 C10 2 (M') 162, found 162.
.0
0
(+)-(S,E)-Ethyl 6-(1,3-dioxolan-2-yl)-4-methylhex-2-enoate (3). The compound was
prepared according to the General Procedure (Section IV) with (R)-BnCH 2-Pybox, (±)-
(E)-ethyl 4-chloropent-2-enoate (488 mg, 3.0 mmol), and the alkylzinc reagent (-1.2 M in
DMA; 3.0 mL, 3.6 mmol). After purification by flash chromatography (hexanes/Et20
10:1), the title compound was obtained as a colorless oil: run 1, 620 mg (91%, 96% ee);
run 2, 646 mg (94%, 95% ee).
[a]22D = +23 (c = 1.7, CHCl1);
1H NMR (CDC13, 400 MHz) 6 6.85 (dd, J = 15.7, 8.0 Hz, 1H), 5.79 (d, J = 15.7 Hz, 1H),
4.84 (t, J = 4.6 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 4.00-3.92 (m, 2H), 3.89-3.81 (m, 2H), 2.34
(septet, J = 7.0 Hz, 1H), 1.68-1.61 (m, 2H), 1.54-1.48 (m, 2H), 1.29 (dt, J = 7.1, 0.5 Hz, 3H),
1.07 (d, J = 6.7 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 167.0, 154.0, 120.3, 104.5, 65.09, 65.08, 60.4, 36.6, 31.7,
30.2, 19.6, 14.5;
IR (film) 2958, 2926, 1718, 1653, 1458, 1368, 1267, 1178, 1144, 1037, 987 cm-1;
GCMS calcd for C12H 200 4 (M+) 228, found 228.
The ee was determined by HPLC on an IA column (hexanes/isopropanol 99:1, 1.0
mL / min) with tr (major) 10.3 min, tr (minor) 9.6 min.
Me
0
Br 0
(+)-(S)-2-(6-Bromo-3-methylhexyl)-1,3-dioxolane (4). A mixture of (+)-(S,E)-Ethyl 6-
(1,3-dioxolan-2-yl)-4-methylhex-2-enoate (228 mg, 1.0 mmol) and palladium on
activated carbon (10 mg) in THF (3 mL) was stirred overnight under an atmosphere of
H2. Then, LiAlH 4 (1.0 M in Et20O; 1.2 mL, 1.2 mmol) was added, and the reaction
mixture was stirred for 10 min. Next, a saturated solution of Na2SO 4 (0.2 mL) was
added, and the mixture was stirred until a white precipitate formed. Then, the mixture
was filtered through a short plug of silica gel (EtOAc as the eluant) and concentrated.
The unpurified alcohol and imidazole (116 mg, 1.7 mmol) were dissolved in CH2Cl2 (10
mL), and Ph3PBr2 (633 mg, 1.5 mmol) was added to the solution in small portions. After
3 h, the solvent was removed, and the residue was purified by flash chromatography
(hexanes/Et20O 10:1), which furnished the title compound as a colorless oil: run 1, 221
mg (88%); run 2, 224 mg (89%).
[a]22D = +1.5 (c = 1.6, CHCl3);
1H NMR (CDC13, 400 MHz) 8 4.84 (t, J = 4.7 Hz, 1H), 4.00-3.94 (m, 2H), 3.90-3.84 (m,
2H), 3.40 (dt, J = 6.9, 0.8 Hz, 2H), 1.96-1.80 (m, 2H), 1.75-1.60 (m, 2H), 1.53-1.39 (m, 3H),
1.32-1.20 (m, 2H), 0.91 (d, J = 6.4 Hz, 3H);
13C NMR (CDC13, 100 MHz) 8 105.0, 65.1, 35.5, 34.4, 32.3, 31.6, 31.0, 30.6, 19.6;
IR (film) 2955, 2925, 2854, 1462, 1128, 1034 cm-1;
GCMS calcd for C 0H19,BrO 2 (M+) 250, found 250.
Me
Et OI
CO2Et
(+)-(4S,8R,E)-Ethyl 10-(1,3-dioxolan-2-yl)-4-ethyl-8-methyldec-2-enoate (5). The
organozinc reagent derived from (+)-(S)-2-(6-bromo-3-methylhexyl)-1,3-dioxolane was
prepared according to the procedure described above (Section IV). The title compound
was prepared according to the General Procedure (Section IV) with (R)-BnCH 2-Pybox,
this organozinc reagent (~0.9 M in DMA; 0.67 mL, 0.60 mmol), and (±)-(E)-ethyl 4-
chlorohex-2-enoate (88 mg, 0.5 mmol). After purification by flash chromatography
(hexanes/Et20O 5:1), the title compound was obtained as a colorless oil: run 1, 127 mg
(81%, 16:1 dr, >99% ee); run 2, 130 mg (83%, 14:1 dr, 98% ee).
[c]22 D = +13.3 (c = 1.29, CHC13);
1H NMR (CDCl3, 400 MHz) 6 6.72 (dd, J = 15.6, 9.3 Hz, 1H), 5.77 (d, J = 15.6 Hz, 1H),
4.83 (t, J = 4.8 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 4.01-3.93 (m, 2H), 3.90-3.83 (m, 2H), 2.11-
2.00 (m, 1H), 1.73-1.59 (m, 2H), 1.52-1.35 (m, 4H), 1.33-1.07 (m, 7H), 1.30 (t, J = 7.1 Hz,
3H), 0.85 (d, J = 6.2 Hz, 3H), 0.85 (t, J = 7.3 Hz, 3H);
13C NMR (CDC13, 100 MHz) 6 167.0, 153.8, 121.3, 105.1, 65.03, 65.02, 60.3, 44.5, 37.1,
34.5, 32.8, 31.7, 31.3, 27.4, 24.8, 19.6, 14.5, 11.9;
IR (film) 2929, 2874, 1721, 1652, 1462, 1369, 1308, 1266, 1143, 1039, 987, 867 cm 1;
LCMS calcd for C18H 330 4 (M+H ) 313.2, found 313.2.
The ee was determined by HPLC on an IA column (hexanes/isopropanol 99:1, 0.5
mL /min) with tr (major) 19.8 min, tr (minor) 18.1 min.
Me
O
Et I
OH
(+)-(4S,8R)-10-(1,3-Dioxolan-2-yl)-4-ethyl-8-methyldec-2-en-1-ol (Figure 2). A
mixture of (+)-(4S,8R,E)-ethyl 10-(1,3-dioxolan-2-yl)-4-ethyl-8-methyldec-2-enoate (112
mg, 0.34 mmol) and palladium on activated carbon (3 mg) in THF (1 mL) was stirred
overnight under an atmosphere of H 2. Then, LiA1H 4 (1.0 M in Et20O; 0.41 mL, 0.41 mmol)
was added, and the reaction mixture was stirred for 10 min. Next, a saturated solution
of Na2SO 4 (0.2 mL) was added, and the mixture was stirred until a white precipitate
formed. Then, the mixture was filtered through a short plug of silica gel (EtOAc as the
eluant) and concentrated. After purification by flash chromatography (hexanes/Et20O
1:1), the title compound was obtained as a colorless oil: run 1, 91 mg (94%); run 2, 94 mg
(96%).
[a]22D = +0.5 (c = 1.5, CHC 3);
1H NMR (CDC13, 400 MHz) 6 4.84 (t, I = 4.8 Hz, 1H), 4.02-3.94 (m, 2H), 3.90-3.82 (m,
2H), 3.64 (t, J = 6.6 Hz, 2H), 1.74-1.59 (m, 2H), 1.58-1.51 (m, 2H), 1.48-1.40 (m, 2H), 1.32-
1.19 (m, 12H), 1.16-1.04 (m, 1H), 0.88 (d, J = 6.5 Hz, 3H), 0.85 (t, J = 7.1 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 8 105.2, 65.04, 65.02, 63.8, 38.8, 37.5, 33.5, 32.8, 31.7, 31.2,
30.2, 29.2, 26.0, 24.1, 19.8, 11.1;
IR (film) 3423, 2929, 2861, 1461, 1409, 1379, 1143, 1125, 1054 cm-1;
LCMS calcd for C16H33O3 (M+H ) 273.2, found 273.2.
Me
Et
(+)-Benzyl (4S,8R)-4-ethyl-8-methyl-11-oxoundecylcarbamate (1). Under nitrogen,
a mixture of (+)-(4S,8R)-10-(1,3-dioxolan-2-yl)-4-ethyl-8-methyldec-2-en-1-ol (81 mg,
0.30 mmol) and the Burgess-type reagent'" (123 mg, 0.39 mmol) were mixed and heated
at 100 'C for 1 h. The mixture was cooled to room temperature, and then HCI (1 N; 0.6
mL) and THF (1.8 mL) were added, and the mixture was stirred overnight at 60 oC.
Next, a saturated solution of NaHCO3 (5 mL) was added, and the aqueous layer was
extracted with Et20O (10 mL x 3). The organic layer was dried over MgSO 4, filtered, and
concentrated. After purification by flash chromatography (hexanes/Et20O 3:1), the title
compound was obtained as a colorless oil: run 1, 67 mg (62%); run 2, 65 mg (60%). This
compound was identical by 1H NMR with the material reported by Suh. 4 a
[a]22D = +1.0 (c = 2.3, CHC13);
1H NMR (CDC13, 400 MHz) 6 9.77 (t, J = 1.8 Hz, 1H), 7.42-7.30 (m, 5H), 5.10 (s, 2H),
4.81 (s, 1H), 3.18 (q, J = 6.7 Hz, 2H), 2.45-2.39 (m, 2H), 1.71-1.61 (m, 1H), 1.47-1.39 (m,
4H), 1.31-1.18 (m, 10H), 1.15-1.03 (m, 1H), 0.88 (d, J = 6.3 Hz, 3H), 0.83 (t, J = 7.1 Hz, 3H);
13C NMR (CDCl3, 100 MHz) 8 203.3, 156.6, 136.8, 128.7, 128.3, 127.1, 77.4, 66.7, 41.9,
41.7, 38.7, 37.3, 33.4, 32.5, 30.3, 29.9, 29.1, 27.4, 25.9, 24.2, 19.5, 11.0;
IR (film) 3341, 2926, 2857, 1723, 1533, 1456, 1250, 1135, 697 cm-1;
LCMS calcd for C22H36NO3 (M+H ) 362.3, found 362.3.
6. Determination of Absolute Stereochemistry
The stereochemistry of the cross coupling products was assigned by correlation with
(-)-(S)-2-methyloctan-1-ol. 1
Cl
Me' Me
Cl
EtO2 C- Me
or
Cl
Ph -Me
n-Hex-ZnBr 03; NaBH 4
Nil
(R)-BnCH 2Pybox
Shirai, Y.; Seki, M.; Mori, K. Eur. J. Org. Chem. 1999, 3139-3145.
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HO Me
(-)
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Part II
Planar-Chiral Compounds in Asymmetric
Organic Synthesis
Chapter 2
Copper-Catalyzed Asymmetric [4+1] Cycloadditions of Enones with
Diazoacetates to form Dihydrofuran
A. Introduction
2,3-Dihydrofurans are very important molecules that can be found in an array of
bioactive compounds, such as aflatoxin B1 and clerodin (Figure 1).'
aflatoxin B, clerodin
Figure 1. Examples of Bioactive Natural Molecules Containing a 2,3-Dihydrofuran.
They also serve as extremely important synthetic intermediates, since they can be
stereoselectively converted to a range of highly functionalized compounds. Highly
substituted tetrahydrofurans2 are of special interest since they can be found in
numerous bioactive molecules, including lasalocid and deoxy nucleosides (Figure 2).
Me HO-- .O. Base
H c
Me deoxy nucleoside:
lasalocid OH DNA building block
Figure 2. Representative Bioactive Natural Molecules Containing a Tetrahydrofuran.
' For a review and leading references, see: Kilroy, T. G.; O'Sullivan, T. P.; Guiry, P. J. Eur. J. Org. Chem.
2005, 4929-4949.
2 For leading references to the asymmetric synthesis of tetrahydrofurans, see: (a) Hou, X.-L.; Yang, Z.;
Yeung, K.-S.; Wong, H. N. C. Prog. Heterocycl. Chem. 2005, 17, 142-171. (b) Elliott, M. C. J. Chem. Soc.,
Perkin Trans. 1, 2002, 2301-2323. (c) Faul, M. M.; Huff, B. E. Chem. Rev. 2000, 100, 2407-2473.
Although many methods have been developed for the synthesis of 2,3-
dihydrofurans, only a few catalytic asymmetric strategies have been described.3 Evans
has reported a scandium/Pybox catalyst for [3+2] annulation of allenylsilanes (eq 1).3a
Several allenylsilanes substituted with an unbranched alkyl group undergo the
cyclization with good yield and enantioselectivity. However, the efficiency is lower for
substrates with a branched alkyl group or an aryl group. They could substitute the silyl
group with an acyl group via a Friedel-Crafts reaction, but the removal of the silyl
group was not successful.
O
EtO H
0
EtO (1)C
tBuPh2Si C=CH2 CH2CI2, -48 oC, 20 h P SiPh2t-Bu
H3C 91% yield, 92% ee
Mueller has reported a two-step procedure to generate 2,3-dihydrofurans (eq 2 ).3b
After cyclopropanation of dihydrofuran or dihydropyran with 1-(silyloxy)vinyl
diazoacetates, desilylation affords fused dihydrofurans with good stereoselectivity.
Although this two-step strategy presents improved results from a previously reported
one-step procedure by Ishitani,3c only two examples are described, one each from
dihydrofuran and dihydropyran.
3 For other catalytic asymmetric methods for the synthesis of 2,3-dihydrofurans from achiral precursors
that proceed with good enantioselectivity, see: (a) Evans, D. A.; Sweeney, Z. K.; Rovis, T.; Tedrow, J. S. J.
Am. Chem. Soc. 2001, 123, 12095-12096. (b) Mueller, P.; Bernardinelli, G.; Allenbach, Y. F.; Ferri, M.; Grass,
S. Synlett 2005, 1397-1400 (two examples, which differ in a silyl group). (c) Ishitani, H.; Achiwa, K.
Heterocycles 1997, 46, 153-156 (one example).
TIPSO
MeO 2CZ
N2 OC
TIPSO
1% Rh2{(S)-nttl}4 TBAF
-78 oC
MeO 2C H
Me
0
80% yield, 90% ee
Rh2{(S)-nttl 4 = t-Bu O RhN O
NO Rh
0\ 4
In 1967, Spencer reported a CuSO4-catalyzed [4+1] cycloaddition of P-methoxy-a,p-
unsaturated ketones with ethyl diazoacetates to form furans and applied this method to
a total synthesis of methyl vinhaticoate (eq 3).4
0
Me H OMe
, N2CHCO 2EtMe
H CuSO 4
160 OC
Me - H
CO2Me 30%
"'Me
;02 Et
le
The reaction mechanism is believed to involve cyclization of a carbonyl ylide' 6 to
form a 2,3-dihydrofuran intermediate, which loses methanol under the reaction
conditions leading to the furan (eq 4).
4 (a) Storm, D. L.; Spencer, T. A. Tetrahedron Lett. 1967, 8, 1865-1867. (b) Spencer, T. A.; Villarica, R. M.;
Storm, D. L.; Weaver, T. D.; Friary, R. J.; Posler, J.; Shafer, P. R. J. Am. Chem. Soc. 1967, 89, 5497-5499. (c)
See also: Murayama, S. T.; Spencer, T. A. Tetrahedron Lett. 1969, 10, 4479-4482.
5 For leading references to the chemistry of carbonyl ylides, see: (a) Nitrogen, Oxygen and Sulfur Ylide
Chemistry; Clark, J. S., Ed.; Oxford: New York, 2002. (b) McMills, M. C.; Wright, D. Chem. Heterocycl.
Compd. 2002, 59, 253-314. (c) Doyle, M. P.; McKervey, M. A.; Ye, T. Modern Catalytic Methods for Organic
Synthesis with Diazo Compounds; Wiley: New York, 1998. (d) Padwa, A. Helv. Chim. Acta 2005, 88, 1357-
1374.
6 For leading references to catalytic asymmetric reactions of ylides formed from diazo compounds, see:
Davies, H. M. L. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.;
Springer: New York, 2004; pp 83-94. (b) Hodgson, D. M.; Pierard, F. Y. T. M.; Stupple, P. A. Chem. Soc.
Rev. 2001, 30, 50-61.
O[Cu]
0
R1IkOMe I OR1 0O OROMe
Since this study, there have been a few reports of copper-catalyzed cycloadditions of
enones with diazo compounds (eq 5). However, none of these investigations have
explored stereoselective transformations.7
O O
MeO J_ OMe
N2
O Me
Ph" Me
Cu(Il)
benzene, reflux
52%
MeO 2C 0 Me
MeO 2C
h - Me
Ph
(a) Anac, O.; Daut, A. Liebigs Ann. Recueil. 1997, 1249-1254. (b) Anac, O.; Ozdemir, A. D.; Sezer, O. Helv.
Chim. Acta 2003, 86, 290-298. (c) Anac, O.; Guengor, F. S.; Kahveci, C.; Cansever, M. S. Helv. Chim. Acta
2004, 87, 408-415. (d) See also: Paulissen, R.; Hayez, E.; Hubert, A. J.; Teyssie, P. Tetrahedron Lett. 1974, 15,
607-608.
0
IKOR
N2
B. Results and Discussion
To develop an efficient catalytic system for stereoselective synthesis of highly
substituted 2,3-dihydrofurans, we chose chalcone and t-butyl diazoacetate as model
substrates. The basic reaction conditions for more thorough optimization screening
were determined after examination of several reaction parameters, including metal
sources, solvents, temperature, and concentration (eq 6). To minimize carbene
dimerization, the diazo compound was added over 4-6 hours using a syringe pump.
0 1.0% CuOTf C0 2t-Bu
[jP, Ot-Bu 1.3% ligand (6)
PhPh N2  CH2CI2, r.t. Ph "'Ph
0.2 M 1.1 equiv
Under these conditions, we tested a variety of chiral ligands for the copper-catalyzed
cycloaddition of enones with diazoacetates (Figure 3). Although some of the
commercially available chiral ligands provided the desired 2,3-dihydrofuran product in
moderate yield and good diastereoselectivity, the enantioselectivity was low in most of
cases. Fortunately, a bis(azaferrocene) (BISAF)8 and a planar-chiral 2,2'-bipyridine
(bpy*),9 ,10 which have been developed in our group and successfully applied to other
copper-catalyzed reactions, showed promising enantioselectivity.
8 For leading references to previous applications, see: Maier, T. C.; Fu, G. C. J. Am. Chem. Soc. 2006, 128,
4594-4595.
9 For the initial report of the synthesis of this ligand, see: Rios, R.; Liang, J.; Lo, M. M.-C.; Fu, G. C. Chem.
Commun. 2000, 377-378.
'0 For reviews of chiral 2,2'-bipyridine ligands, see: (a) Malkov, A. V.; Kocovsky, P. Curr. Org. Chem. 2003,
7, 1737-1757. (b) Fletcher, N. C. J. Chem. Soc., Perkin Trans. 1, 2002, 1831-1842.
CN
o. 0
N HN
Ph 1 Ph
7% yield
>20:1 dr
ee N.D.
Me Me
N N
Ph 2 Ph
15% yield
>20:1 dr
14% ee
R N R
R = Bn
40% yield, >20:1 dr, <3% ee
R = t-Bu
25% yield, >20:1 dr, 12% ee
Ph Ph
8% yield
>20:1 dr
ee N.D.
0
R
4% yield
>20:1 dr
ee N.D.
R = i-Pr
44% yield, >20:1 dr, <3% ee
R = Bn
30% yield, >20:1 dr, <3% ee
4/%o yieia
>20:1 dr
<3% ee
Me
Me Me
Me Me
Me
R = H, R1 = t-Bu
27% yield, >20:1 dr, 12% ee
R = H, R1 = Ph
28% yield, >20:1 dr, 31% ee
R = Ph, R1 = t-Bu
39% yield, >20:1 dr, 24% ee
Me Me
Me Me
Mee
F N
Me Fe Me
MeMe (-)-BISMe
30% yield
>20:1 dr
37% ee
AF
Me Me
Me Me
Me MeFe
Me Fe Me
Me Me (-)-bpy*
Me
* N.D. = not determined
Figure 3. Copper-catalyzed Asymmetric [4+1] Cycloadditions: Survey of Ligands with
Slow Addition of the Diazoacetate.
Even though slow addition of the diazo compound helps to minimize carbene
dimerization, we decided to pursue a one-portion addition to make the reaction
procedure more convenient. Results when the diazo compound was added in one
portion in the presence of a few representative chiral ligands are shown in Table 1. As
expected, with most of the ligands we obtained a lower yield without the slow addition
56% yield
>20:1 dr
58% ee
of the diazo compound. However, bpy* exhibited promising reactivity, and the
stereoselectivity remained almost the same (entry 4).
Table 1. Copper-catalyzed Asymmetric [4+1] Cycloadditions: Survey of Ligands with
One-Portion Addition of the Diazoacetate.
0
Ph)L Ph
entry
1
2
3
4
5
6
0
j? Ot-Bu
N2
1.1 equiv
ligand
s(oxazoline) 2
!micorrin 1
ISAF
-)-bpy*
) ligand
c CuOTf, no ligar
1.0% CuOTf
1.3% ligand
CH2CI2
r.t.
yield (%)a
12
<2
6
45
10
<2
C0 2 t-Bu
Ph ~"'Ph
dr
>20:1
>20:1
>20:1
>20:1
>2:1
ee (%)
-20b
34
60
All data are the average of two runs. alsolated yield of the
trans diastereomer. The opposite enantiomer is produced.
To improve our initial lead and keep the convenient reaction setup, we examined the
effect of steric demand of the diazoester on these Cu/bpy*-catalyzed asymmetric [4+1]
cycloadditions (Table 2). Diazo compounds containing a small alkyl or aryl group
provided lower ee (entries 2 and 3 versus entry 1). When the steric hindrance of aryl
groups increased, enantioselectivities improved (entries 4-6), and the best combination
of yield, dr, and ee was obtained with the 2,6-diisopropylphenyl ester (entry 5).
Table 2. Impact of the Steric Demand of the Diazoacetate.
1.0% CuOTf
1.3% (-)-bpy*
CH 2CI2
r.t.
CO 2R
Ph ' "'Ph
entry R yield (%)a dr ee (%)
1 t-Bu 45 >20:1 60
2 Et 43 >20:1 37
3 Ph 44 >20:1 37
4 2,6-dimethylphenyl 63 7:1 83
5 2,6-diisopropylphenyl 79 13:1 85
6 2,6-di-t-butyl-4-methylphenyl 47 16:1 85
All data are the average of two runs. alsolated yield of the trans
diastereomer.
We have examined the scope of this copper-catalyzed asymmetric [4+1]
cycloaddition of enones with 2,6-diisopropylphenyl diazoacetate (Table 3). When both
substituents of the enone are unsaturated, the enantioselectivity is the highest. Hence,
enones with phenyl substituents of different electronic properties furnish good ee
(entries 2-6), although an electron-poor substrate shows slightly diminished reactivity
and enantioselectivity (entry 2). With substrates containing a heteroaromatic
substituent, the reactions proceed with good enantioselectivities (entries 7 and 8).
Furthermore, no competing cyclopropanation is observable when an alkenyl substituent
is present (entry 9). Enones with an alkyl group at the p-position exhibit lower
enantioselectivity than those with an unsaturated group. Nonetheless, the desired
dihydrofurans are generally produced in good yield and with excellent
diastereoselectivity (entries 10 and 11).
0
Ph , Ph
O0
1 OR
N2
1.1 equiv
Table 3. Copper-Catalyzed Asymmetric [4+1] Cycloadditions: Enones with Unsaturated
Substituents.
O0
r OAr
N2
1.1 equiv
Ar =
R1
Ph
4-(F3C)C 6H4
4-CIC 6H 4
4-(MeO)C6H 4
Ph
Ph
N-Boc-2-pyrrolyl
Ph
Ph
Ph
Ph
1.0% CuOTf
1.3% (-)-bpy*
CH 2C12
r.t.
2,6-diisopropylphen
yield (%)a
Ph
Ph
Ph
Ph
4-CIC 6H 4
4-(MeO)C 6H4
Ph
3-furyl
CH=CHPh
n-Bu
i-Pr
CO 2Ar
R "'R1
13:1
19:1
19:1
19:1
>20:1
9:1
>20:1
6:1
7:1
>20:1
>20:1
ee (%)
85
76
88
92
88
93
93
87
93
78
50
All data are the average of two runs. alsolated yield of the trans
diastereomer. bThe product was hydrolyzed and then acetylated,
prior to isolation.
This Cu/bpy*-catalyzed cycloaddition may also be applied when R is an alkyl group,
albeit under slightly modified conditions (Table 4). In general, these enones undergo
the cyclization in good yield and with good diastereoselectivity. However, enantiomeric
excesses are around 70% regardless of the R group.
0
0.2M
entry
1
2
3
4b
5
6
7
8
9
10
11
Table 4. Copper-Catalyzed Asymmetric [4+1] Cycloadditions: Enones with Alkyl
Substituents.
0 1.0% CuOTf CO 2Ar0 1.2% (-)-bpy* 0
R-u" R1 -  OAr ----- ,
R R N2 OAr CH 2CI2  R "R 1
N2  r.t.0.0125 M 1.4 equiv
Ar = 2,6-diisopropylphenyl
entry R R1  yield (%)a dr ee (%)
1 n-Hex Ph 69 13:1 75
2 i-Pr Ph 87 16:1 66
3 t-Bu Ph 82 >20:1 69
4 n-Hex Me 80 >20:1 71
5b PhCH2CH2  H 50 N/A 69
All data are the average of two runs. alsolated yield of the trans
diastereomer. bThe product was hydrolyzed and then acetylated,
prior to isolation.
Although various enones produce the desired 2,3-dihydrofurans with good
efficiency as discussed above, some substrates prove to be more challenging for this
cycloaddition under the current reaction conditions. For example, a cyclicketone with
an external double bond produces the desired product in rather modest yield and ee (eq
7). The reaction of an enone with a substituent in the a-position proceeds in good yield
but with poor enantioselectivity (eq 8). In addition, a,p3-unsaturated esters are not
suitable substrates under our standard conditions.
1.0% CuOTf
1.3% (-)-bpy*
CH 2CI2
r.t.
53%
>20:1 dr, 64% ee
Ar = 2,6-diisopropylphenyl
1.0% CuOTf
1.3% (-)-bpy*
CH 2CI2
r.t. Me
76%, 18% ee
As mentioned earlier, the 2,3-dihydrofuran products can be converted to a variety of
other useful compounds without any erosion in stereochemical purity. Therefore,
treatment of the trans isomer of the cycloaddition product with LiAlH 4 furnishes a
primary alcohol in good yield (eq 9). Hydrolysis followed by acetylation produces an
acyclic ester with an a and a 3 stereocenter (eq 10).
O
n-Hex1 pl OA r
Ph
75% ee
Ar = 2,6-diisopropylphenyl
O0
PhOAr
n-Bu
78% ee
LiAIH 4
96%
n-Hex OH
Ph
75% ee
O n-Bu O
1)aq HBF 4  Ph- OAr
2) AC20
DMAP, Et3 N OAc
90% 78% ee
To further demonstrate the utility of our Cu/bpy*-catalyzed [4+1] cycloaddition, we
decided to apply this method to the catalytic asymmetric synthesis of useful molecules
such as a deoxy-C-nucleoside."1 Deoxy-C-nucleosides are mimics of natural building
" For some leading references, see: (a) Kool, E. T. Acc. Chem. Res. 2002, 35, 936-943. (b) Loakes, D. Nucleic
Acids Res. 2001, 29, 2437-2447. (c) Watanabe, K. A. In Chemistry of Nucleosides and Nucleotides; Townsend,
L. B., Ed.; Plenum: New York, 1994; Vol. 3, pp 421-535.
0
0. Ph
0.2 M
O0
ri OAr
N2
1.1 equiv
O
PhMe
Me
O0
i OAr
N2
1.1 equiv
(9)
(10)
blocks of DNA and attract great interest in medicinal chemistry. Thus, a catalytic
asymmetric method for the synthesis of these molecules is highly desirable, especially
from easily accessible substrates.
The 3-hydroxytetrahydrofuran structure of deoxy-C-nucleosides can be easily
constructed via cycloaddition of a P-alkoxy-a,p-unsaturated ketone. However, as shown
in Spencer's report on the formation of furans from 4-methoxy-2,3-dihydrofurans (eq 3),
the resulting dihydrofuran is prone to elimination of alcohol. For minimal elimination
after cycloaddition and facile deprotection at the final step, we have tested several
P-alkoxy-a,p-unsaturated ketones, which can be easily prepared by addition of alcohols
to alkynylketone 3 (eq 11). The trimethylsilylethyl protecting group proved very
efficient in not only the cycloaddition but also in the following step since the group is
deprotected under orthogonal reaction conditions to other functionalization processes.
0 NMO
Ph HO-R CH 2C 2  PhOR (11)
H
3 NMO = N-methylmorpholine
Cycloaddition of an a-diazoacetate to the vinylogous ester furnishes the desired
4-alkoxy-2,3-dihydrofuran, which is used for next transformations without isolation
due to its sensitivity (Scheme 1). Catalytic hydrogenation in the presence of Et3N
produces the corresponding tetrahydrofuran without cleavage of the C2-O bond. After
reduction of the ester, the desired primary alcohol was obtained in 77% yield for three
steps with excellent diastereoselectivity (>20:1). Finally, deprotection of
trimethylsilylethyl group provides the deoxy-C-nucleoside (94% ee). 12
12 For studies of this deoxy-C-nucleoside, see: (a) Initial work: Millican, T. A.; Mock, G. A.; Chauncey, M.
A.; Patel, T. P.; Eaton, M. A. W.; Gunning, J.; Cutbush, S. D.; Neidle, S.; Mann, J. Nucleic Acids Res. 1984,
12, 7435-7453. (b) Matsuda, S.; Romesberg, F. E. J. Am. Chem. Soc. 2004, 126, 14419-14427. (c) Mathis, G.;
Hunziker, J. Angew. Chem. Int. Ed. 2002, 41, 3203-3205. (d) Guckian, K. M.; Schweitzer, B. A.; Ren, R. X.-F.;
Sheils, C. J.; Tahmassebi, D. C.; Kool, E. T. J. Am. Chem. Soc. 2000, 122, 2213-2222.
OPh0 OR OAr
N2
1.1 equiv
R = CH 2 CH 2TMS
Ar = 2,6-diisopropylphenyl
1.0% CuOTf
1.3% (-)-bpy*
CH2CI2
r.t.
O
Ph- OAr
bR
1) H2, Pd/C
Et3 N
2) LiAIH 4
Ph 0 OH
bH
86%
>20:1 dr, 94% ee
BF3*OEt 2 Ph 0 OH
OR
77% (three steps)
>20:1 dr
Scheme 1. Catalytic Enantioselective Synthesis of Deoxy-C-nucleoside.
C. Conclusions
In conclusion, we have reported the first example of diastereo- and enantioselective
copper-catalyzed [4+1] cycloaddition of enones with diazo compounds. Use of sterically
demanding aryl diazoacetates improves the efficiency and stereoselectivity of the
reaction and also enables one-portion addition of the diazo compound. This method
furnishes synthetically useful, highly substituted 2,3-dihydrofuranans from a variety of
enones. The cycloaddition products can be converted to other useful molecules in high
yield without an erosion of stereochemical purity. In addition, we have applied this
method to the first catalytic enantioselective synthesis of a deoxy-C-nucleoside.
D. Experimental
1. General
All reactions were carried out in oven-dried glassware under an atmosphere of
nitrogen. CH 2C12 was purified by passage through a neutral alumina column under
argon. CuOTf-0.5C 6H,CH3 was purchased from Aldrich, and the diazo esters 13 and
bpy*14 were prepared according to literature procedures. All other chemicals were
purchased from commercial suppliers and used as received, unless noted otherwise.
HPLC analyses were carried out on an Agilent 1100 series system with Daicel
Chiralpak® columns in hexane/isopropanol mixtures. Melting points were measured on
a Hoover melting point apparatus and are uncorrected.
2. Preparation of Starting Material
O
NBoc
tert-Butyl 2-((E)-3-phenylacryloyl)-1H-pyrrole-l-carboxylate. A 100-mL flask was
charged with 2-acetylpyrrole (3.27 g, 30.0 mmol), 4-(dimethylamino)pyridine (73 mg,
0.6 mmol), triethylamine (4.2 mL, 30.0 mmol) and THF (30 mL). To this reaction mixture
was added a solution of Boc anhydride (dropwise; 30 mL, 1.OM in THF, 30.0 mmol). The
reaction mixture was stirred overnight, and then a saturated NaHCO3 solution (30 mL)
was added. The resulting mixture was extracted with Et20 (30 mL x 3), and the
combined extracts were dried over MgSO4 and concentrated. The product was purified
by column chromatography (hexanes/EtOAc 5:1), which furnished 5.64 g (90%) of N-
Boc-2-acetylpyrrole.
N-Boc-2-acetylpyrrole (5.64 g, 27.0 mmol) was added to a stirred solution of
LiHMDS solution (1.0 M in THF; 28 mL, 28 mmol) at -78 'C under argon, and the
13 (a) Nicewicz, D. A.; Johnson, J. S. J. Am. Chem. Soc. 2005, 127, 6170-6171. (b) Doyle, M. P.; Austin, R. E.;
Bailey, A. S.; Dwyer, M. P.; Dyatkin, A. B.; Kalinin, A. V.; Kwan, M. M. Y.; Liras, S.; Oalmann, C. J.;
Pieters, R. J.; Protopopova, M. N.; Raab, C. E.; Roos, G. H. P.; Zhou, Q.-L.; Martin, S. F. J. Am. Chem. Soc.
1995, 117, 5763-5775.
14 Rios, R.; Liang, J.; Lo, M. M.-C.; Fu, G. C. Chem. Commun. 2000, 377-378.
resulting mixture was stirred for 2 h. Then, benzaldehyde (2.8 mL, 27.0 mmol) was
added, and the reaction mixture was stirred for an additional 2 h. The reaction was
then quenched by the addition of saturated aq NH4Cl (40 mL), and the mixture was
extracted with Et20O (30 mL x 3). The combined extracts were dried over MgSO 4,
concentrated, and purified by column chromatography (hexanes/EtOAc 5:1), which
furnished N-Boc-2-(3-hydroxy-l-oxo-3-phenylpropyl)pyrrole (6.82 g, 80%).
NEt 3 (9.0 mL, 65 mmol) and MsCl (1.65 mL, 21.7 mmol) were added to a solution of
N-Boc-2-(3-hydroxy-l-oxo-3-phenylpropyl)pyrrole (6.82 g, 21.7 mmol) in THF (20 mL).
This reaction mixture was stirred overnight, and then it was quenched by the addition
of saturated aq NH4C1 (40 mL). The mixture was extracted with Et20O (30 mL x 3), and
the combined extracts were dried over MgSO4, concentrated, and purified by column
chromatography (hexanes/EtOAc 5:1), which furnished tert-butyl 2-((E)-3-
phenylacryloyl)-1H-pyrrole-1-carboxylate (5.89 g, 91%).
mp: 75-76 oC;
1H NMR (CDCl3, 400 MHz) 8 7.66 (d, J = 16.0 Hz, 1H), 7.60-7.57 (m, 2H), 7.43-7.40 (m,
4H), 7.12 (d, I = 16.0 Hz, 1H), 6.86 (dd, J = 3.5, 1.6 Hz, 1H), 6.25 (t, J = 3.3 Hz, 1H), 1.56 (s,
9H);
13C NMR (CDC 3, 100 MHz) 8 182.8, 149.0, 143.7, 135.0, 134.3, 130.6, 129.1, 128.5, 127.4,
125.7, 120.8, 110.5, 85.2, 27.0;
IR (film) 2981, 1748, 1661, 1639, 1606, 1440, 1415, 1315, 1150 cm-;
HRMS (ESI) calcd for C,,H 19NO3Na (M + Na ) 320.1257, found 320.1266.
All other materials have been reported previously.
3. Copper-Catalyzed Asymmetric [4+1] Cycloadditions
All yields, dr's, and ee's are the average of two runs, one with (-)-bpy* and one with
(+)-bpy*. All dr's were determined through analysis of the 1H NMR spectra of the
unpurified reaction mixtures.
General Procedure A. The catalyst was prepared by adding a solution of (-)-bpy*
(8.4 mg ,0.013 mmol) in CH2C 2 (4 mL) to CuOTf-0.5C 6H5CH 3 (2.6 mg, 0.01 mmol) and
stirring the resulting mixture for 20 min. This solution was then added to the enone (1.0
mmol), and the misture was tirred for 5 min. Then, a solution of the diazoacetate (1.1
mmol) in CH 2C12 (1.0 mL) was added. After 1 h of stirring at room temperature, the
reaction mixture was filtered through a plug of silica gel (50% Et20O/hexane as the
eluant).
General Procedure B. The catalyst was prepared by adding a solution of (-)-bpy*
(7.7 mg, 0.012 mmol) in CH 2C12 (10 mL) to CuOTf-0.5C 6H5CH 3 (2.6 mg, 0.010 mmol) and
stirring the resulting mixture for 20 min. This solution was then added to the enone (1.0
mmol) in CH 2C12 (60 mL), and the mixture was stirred for 5 min. Then, a solution of the
diazoacetate (1.4 mmol) in CH 2C 2 (10 ml) was added dropwise. After 1 h of stirring at
room temperature, the reaction mixture was filtered through a plug of silica gel (50%
Et20O/hexane as the eluant).
C 0 2t-Bu
Ph "'Ph
(2R,3S)-tert-Butyl 2,3-dihydro-3,5-diphenylfuran-2-carboxylate (Table 2, entry 1).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and tert-butyldiazoacetate (156 mg, 1.1 mmol). After chromatography on silica gel
(hexanes/ethyl ether 100:1), the title compound was isolated as a cloudy oil: run 1, 145
mg (45%, >90% de, 59% ee); run 2, 145 mg (45%, >90% de, 61% ee). The ee was
determined on an AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with
tr(major) 6.5 min., tr(minor) 7.6 min.
[a]22D = -26.3 (c = 1.00, CH2C12);
1H NMR (C6D6, 400 MHz) 8 7.86-7.83 (m, 2H), 7.37-7.35 (m, 2H), 7.26-7.15 (m, 6H),
5.34 (d, J = 2.8 Hz, 1H), 4.98 (d, J = 5.8 Hz, 1H), 4.59 (dd, J = 5.8, 2.8 Hz, 1H), 1.42 (s, 9H);
13C NMR (C6D6, 100 MHz) 8 170.5, 157.6, 144.1, 131.2, 129.40, 129.36, 128.9, 127.8,
126.4, 99.0, 87.0, 81.6, 54.8, 28.3;
IR (film) 3062, 3029, 2978, 2933, 1751, 1728, 1648, 1602, 1494, 1369, 1156 cm-1;
HRMS (ESI) calcd for C21H2203Na (M + Na ) 345.1461, found 345.1463.
C0 2Et
Ph' "'Ph
(2R,3S)-Ethyl 2,3-dihydro-3,5-diphenylfuran-2-carboxylate (Table 2, entry 2).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and ethyldiazoacetate (126 mg, 1.1 mmol). After chromatography on silica gel
(hexanes/ethyl ether 100:1), a 1:1 mixture of the title compound and chalcone was
isolated as a colorless oil: run 1, 216 mg (43%, >95% de, 37% ee); run 2, 210 mg (42%,
>95% de, 37% ee). The ee was determined on an AD-H column (hexanes/iso-propanol
99:1, flow 1.0 mL/min.) with tr(major) 9.9 min., tr(minor) 8.9 min.
1H NMR (C6D6, 400 MHz) 8 7.74-7.71 (m, 2H), 7.25-7.22 (m, 2H), 7.20-7.03 (m, 6H),
5.24 (d, J = 2.9 Hz, 1H), 4.92 (d, J = 5.7 Hz, 1H), 4.49 (dd, J = 5.7, 2.9 Hz, 1H), 4.00-3.85 (m,
2H), 0.89 (t, J = 7.1 Hz, 3H);
"C NMR (C6D6, 100 MHz) 8 171.3, 157.3, 143.9, 131.0, 129.4, 129.0, 128.2, 126.4, 99.2,
99.5, 86.6, 61.5, 54.5, 14.4;
IR (film) 3028, 2981, 1756, 1734, 1665, 1648, 1494, 1449, 1069, 1029 cm-';
HRMS (ESI) calcd for C19H190 3 (M + H ) 295.1329, found 295.1327.
C0 2Ph
Ph "'Ph
(2R,3S)-Phenyl 2,3-dihydro-3,5-diphenylfuran-2-carboxylate (Table 2, entry 3).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and phenyldiazoacetate (178 mg, 1.1 mmol). After chromatography on silica gel
(hexanes/ethyl ether 100:1), the title compound was isolated as a white solid: run 1, 147
mg (43%, 94% de, 37% ee); run 2, 154 mg (45%, 94% de, 38% ee). The ee was determined
on an AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major) 16.1
min., tr(minor) 18.6 min.
mp: 94-96 oC;
[a]22D = -50.1 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 6 7.87-7.84 (m, 2H), 7.36-7.34 (m, 2H), 7.26-7.15 (m, 6H),
7.13-7.09 (m, 4H), 7.00-6.96 (m, 1H), 5.36 (d, J = 2.9 Hz, 1H), 5.17 (d, J = 5.6 Hz, 1H), 4.69
(dd, J = 5.6, 2.8 Hz, 1H);
'
3 C NMR (C6D6, 100 MHz) 8 169.8, 157.5, 151.5, 143.5, 130.8, 130.0, 129.5, 129.0, 128.2,
128.0, 126.5, 126.4, 122.0, 99.2, 86.4, 54.7;
IR (film) 3062, 3029, 2920, 1778, 1649, 1592, 1493, 1194 cm-';
HRMS (ESI) calcd for C23H 1803Na (M + Na ) 365.1148, found 365.1161.
Me
0 Me
Ph "'Ph
(2R,3S)-2,6-Dimethylphenyl 2,3-dihydro-3,5-diphenylfuran-2-carboxylate (Table 2,
entry 4).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and 2,6-dimethylphenyldiazoacetate (209 mg, 1.1 mmol). After chromatography on
silica gel (hexanes/ethyl ether 100:1), the title compound was isolated as a cloudy oil:
run 1, 233 mg (63%, 74% de, 83% ee); run 2, 230 mg (62%, 73% de, 82% ee). The ee was
determined on an AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with
tr(major) 11.6 min., tr(minor) 14.5 min.
[a]22D = 108 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 8 7.88-7.85 (m, 2H), 7.42-7.40 (m, 2H), 7.29-7.18 (m, 6H),
7.00-6.94 (m, 3H), 5.42 (d, J = 2.9 Hz, 1H), 5.33 (d, J = 5.1 Hz, 1H), 4.86 (dd, J = 5.0, 3.0 Hz,
1H), 2.17 (s, 6H);
13C NMR (C6D6, 100 MHz) 8 169.4, 157.5, 148.9, 143.4, 130.80, 130.78, 129.6, 129.3,
129.0, 128.3, 128.1, 126.6, 126.4, 99.3, 86.4, 54.6, 16.8;
IR (film) 3061, 3028, 2924, 1774, 1754, 1649, 1601, 1493, 1162 cm-';
HRMS (ESI) calcd for C25H2203Na (M + Nat) 393.1461, found 393.1473.
i-Pr/
0 i-Pr
0
Ph "'Ph
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-3,5-diphenylfuran-2-carboxylate (Table
2, entry 5).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After chromatography on
silica gel (hexanes/ethyl ether 100:1), the title compound was isolated as a colorless oil:
run 1, 341 mg (80%, 86% de, 84% ee); run 2, 328 mg (77%, 86% de, 86% ee). The ee was
determined on an AD-H column (hexanes/iso-propanol 99:1, flow 0.7 mL/min.) with
tr(major) 13.9 min., tr(minor) 15.0 min.
[a]22D = -106 (c = 1.00, CH2C12);
1H NMR (C6D6, 400 MHz) 6 7.75-7.73 (m, 2H), 7.33-7.31 (m, 2H), 7.18-7.04 (m, 9H),
5.35 (d, J = 2.9 Hz, 1H), 5.26 (d, J = 4.9 Hz, 1H), 4.83 (dd, J = 4.8, 1.8 Hz, 1H), 3.14 (septet,
J = 6.8 Hz, 2H), 1.16 (d, 12H);
13C NMR (C6D 100 MHz) 6 170.6, 157.4, 146.5, 143.3, 141.1, 130.7, 129.6, 129.0, 127.5,
126.4, 124.7, 99.5, 86.6, 54.4, 28.3, 23.6;
IR (film) 3064, 3029, 2965, 2931, 2870, 1774, 1753, 1649, 1602, 1494, 1449, 1213 cm-1;
HRMS (ESI) calcd for C29H3003Na (M + Na) 449.2087, found 449.2102.
Me
t-Bu/
0 t-Bu
Ph' "'Ph
(2R,3S)-2.6-Di-tert-butyl-4-methylphenyl 2,3-dihydro-3,5-diphenylfuran-2-
carboxylate (Table 2, entry 6).
General Procedure A was followed, with (-)-bpy*, trans-chalcone (208 mg, 1.0 mmol),
and BHT-diazoacetate (317 mg, 1.1 mmol). After chromatography on silica gel
(hexanes/ethyl ether 100:1), the title compound was isolated as a white solid: run 1, 220
mg (47%, 88% de, 85% ee); run 2, 216 mg (46%, 88% de, 84% ee). The ee was determined
on an AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major) 6.5
min., tr(minor) 4.9 min.
mp: 116-118 oC;
[a]22D = -112 (c = 1.00, CH 2C12);
IH NMR (C6D6, 400 MHz) 8 7.90-7.88 (m, 2H), 7.44-7.42 (m, 2H), 7.27-7.15 (m, 8H),
5.47 (d, J = 2.9 Hz, 1H), 5.45 (d, J = 4.9 Hz, 1H), 5.07 (dd, J = 4.8, 2.9 Hz, 1H), 2.24 (s, 3H),
1.48 (s, 9H), 1.46 (s, 9H);
13C NMR (C6D6, 100 MHz) 8 172.5, 157.0, 147.3, 143.8, 143.0, 142.7, 135.2, 134.9, 130.8,
129.6, 129.5, 129.0, 128.2, 128.0, 127.8, 127.6, 126.4, 99.8, 88.0, 53.6, 35.8, 35.7, 32.1, 32.0,
21.8;
IR (film) 3062, 3028, 2964, 2916, 1751, 1649, 1600, 1494, 1449, 1210, 1185 cm 1;
HRMS (ESI) calcd for C32H3603Na (M + Na+) 491.2556, found 491.2541.
O -Pr
4-CF 3C6 H4- "'Ph
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-3-phenyl-5-(4-trifluoromethylphenyl)
furan-2-carboxylate (Table 3, entry 2).
General Procedure A was followed, with (-)-bpy*, trans-4'-(trifluoromethyl)chalcone
(276 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 282 mg (57%, 90% de, 76% ee); run 2, 297 mg (60%, 90%
de, 76% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with tr(major) 7.8 min., tr(minor) 10.0 min.
[a]22D = -90.1 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 6 7.54-7.52 (m, 2H), 7.33-7.27 (m, 4H), 7.18-7.04 (m, 6H),
5.29 (d, J = 2.9 Hz, 1H), 5.23 (d, J = 4.9 Hz, 1H), 4.79 (dd, J = 4.5, 3.1 Hz, 1H), 3.20-3.00 (m,
2H), 1.17 (d, J = 6.9 Hz, 12H);
13C NMR (C6D , 100 MHz) 6 170.3, 156.0, 146.3, 142.8, 140.9, 129.7, 128.3, 128.0, 127.6,
126.6, 126.4, 126.0, 125.9, 124.8, 123.7, 101.9, 86.5, 54.4, 28.3, 23.6;
IR (film) 3066, 3030, 2966, 2932, 2872, 1773, 1755, 1647, 1619, 1493, 1457, 1326, 1165,
1070 cm-;
HRMS (ESI) calcd for C30H 29F30 3Na (M + Na') 517.1961, found 517.1977.
4-CIC 6 H4-^/"'Ph
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-3-phenyl-5-(4-chlorophenyl)furan-2-
carboxylate (Table 3, entry 3).
General Procedure A was followed, with (-)-bpy*, trans-4'-chlorochalcone (243 mg,
1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 360 mg (78%, 92% de, 88% ee); run 2, 350 mg (76%, 88%
de, 87% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with tr(major) 6.5 min., tr(minor) 8.3 min.
[a]22D = -108 (c = 1.00, CH 2C12);
1H NMR (C6D, 400 MHz) 6 7.46-7.43 (m, 2H), 7.30-7.28 (m, 2H), 7.18-7.04 (m, 8H),
5.23 (d, J = 3.3 Hz, 1H), 5.22 (d, J = 5.1 Hz, 1H), 4.79 (dd, I = 4.8, 3.0 Hz, 1H), 3.10 (septet,
J = 6.4 Hz, 2H), 1.16 (d, I = 6.9 Hz, 12H);
13C NMR (C6D 6, 100 MHz) 6 170.4, 156.3, 146.4, 143.1, 141.0, 135.4, 129.6, 129.2, 129.1,
128.5, 128.1, 127.7, 127.5, 124.8, 100.1, 86.5, 54.4, 28.3, 23.7;
IR (film) 3065, 3030, 2965, 2931, 2871, 1773, 1755, 1648, 1598, 1490, 1456, 1163 cm-1;
HRMS (ESI) calcd for C29H29C1O3Na (M + Na') 483.1697, found 483.1720.
i-Pr
0 Ph 0
4-(MeO)C 6H4 < O ""J
OAc i-Pr
(2R,3S)-2,6-Diisopropylphenyl 2-acetoxy-5-(4-methoxyphenyl)-5-oxo-3-phenyl
pentanoate (Table 3, entry 4).
General Procedure A was followed, with (-)-bpy*, trans-4'-methoxychalcone (238 mg,
1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). To the
unpurified reaction mixture were added CH3CN (2 mL) and 10% aq HBF4 (2 mL). The
mixture was stirred for 10 min, and then it was diluted with water and extracted with
Et20O (20 mL x 3). The combined organic layers were washed with water, dried over
Na2SO4, and concentrated. The resulting hydroxyketone was dissolved in CH2Cl2 (10
mL), and NEt3 (0.84 mL, 6.0 mmol), DMAP (24.4 mg, 0.2 mmol), and Ac 20 (0.47 mL, 5.0
mmol) were added to the stirring solution. After 15 min, the reaction mixture was
diluted with water and extracted with CH2C12 (20 mL x 3). The combined organic layers
were washed with brine, dried over Na2SO4, and concentrated. After chromatography
on silica gel (hexanes/ethyl ether 20:1), the title compound was isolated as a white solid:
run 1, 360 mg (85%, 90% de, 92% ee); run 2, 350 mg (83%, 90% de, 91% ee). The ee was
determined on an OD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with
tr(major) 17.8 min., tr(minor) 26.0 min.
mp: 158-161 oC;
[a]22D = -58.8 (c = 1.00, CH 2C 2);
1H NMR (CDCl, 400 MHz) 6 7.97-7.94 (m, 2H), 7.48-7.46 (m, 2H), 7.35-7.31 (m, 2H),
7.27-7.20 (m, 2H), 7.14-7.13 (m, 2H), 6.95-6.91 (m, 2H), 5.64 (d, J = 3.8 Hz, 1H), 4.39 (dt, J
= 10.2, 3.5 Hz, 1H), 3.87 (s, 3H), 3.82 (dd, J = 18.0, 10.4 Hz, 1H), 3.40 (dd, J = 17.8, 3.1 Hz,
1H), 3.10-2.80 (m, 1H), 2.80-2.50 (m, 1H), 2.21 (s, 3H), 1.14 (d, J = 6.8 Hz, 6H), 1.30-0.80
(m, 6H);
13C NMR (C6D6, 100 MHz) 6 195.4, 170.3, 168.2, 163.8, 145.1, 140.2, 130.5, 130.0, 128.8,
128.5, 127.6, 127.0, 124.1, 113.9, 76.0, 55.7, 41.8, 38.9, 27.3, 24.0, 22.8, 20.8;
IR (film) 2964, 2929, 2872, 1765, 1749, 1677, 1597, 1510, 1456, 1257 cm1;
HRMS (ESI) calcd for C32H60O6Na (M + Na ) 539.2404, found 539.2396.
i-Pr/
O i-Pr
Ph ~ ""4-CIC 6 H4
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-3-(4-chlorophenyl)-5-phenyl-furan-2-
carboxylate (Table 3, entry 5).
General Procedure A was followed, with (-)-bpy*, trans-4-chlorochalcone (243 mg,
1.0 mmol) and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 360 mg (78%, 90% de, 86% ee); run 2, 383 mg (83%, 94%
de, 89% ee). The ee was determined on an OD-H column (hexanes/iso-propanol 99:1,
flow 0.7 mL/ min.) with tr(major) 8.1 min., tr(minor) 5.9 min.
[a]22D = -126 (c = 1.00, CH 2C1 2);
'H NMR (C6D, 400 MHz) 6 7.74-7.71 (m, 2H), 7.16-7.00 (m, 10H), 5.23 (d, J= 2.9 Hz,
1H), 5.11 (d, J= 4.9 Hz, 1H), 4.69 (dd, J = 4.7, 3.0 Hz, 1H), 3.12 (septet, 2H), 1.16 (d, J =
6.9 Hz, 12H);
'
3C NMR (C6D6, 100 MHz) 6 170.4, 157.7, 146.4, 141.7, 141.0, 133.9, 130.5, 129.8, 129.7,
129.5, 129.0, 127.5, 126.4, 124.8, 99.0, 86.3, 53.6, 28.3, 23.6;
IR (film) 3065, 3029, 2965, 2931, 2871, 1775, 1752, 1648, 1601, 1577, 1492, 1163 cm'-;
HRMS (ESI) calcd for C29H29CIO 3Na (M + Na+) 483.1697, found 483.1716.
i-Pr/
O i-Pr
Ph "' "4-(MeO)C 6 H4
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-3-(4-methoxyphenyl)-5-phenyl-furan-2-
carboxylate (Table 3, entry 6).
General Procedure A was followed, with (-)-bpy*, trans-4-methoxychalcone (238 mg,
1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 384 mg (84%, 80% de, 93% ee); run 2, 379 mg (83%, 80%
de, 93% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with tr(major) 7.4 min., tr(minor) 9.6 min.
[a]22D = -130 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 6 7.77-7.75 (m, 2H), 7.26-7.24 (m, 2H), 7.16-7.04 (m, 6H),
6.81-6.79 (m, 2H), 5.39 (d, J = 2.9 Hz, 1H), 5.29 (d, J = 5.0 Hz, 1H), 4.84 (dd, J = 5.0, 2.9 Hz,
1H), 3.33 (s, 3H), 3.16 (septet, J = 6.7 Hz, 2H), 1.18 (d, J = 6.9 Hz, 12H);
'
3 C NMR (C6D6, 100 MHz) 8 170.7, 160.0, 157.2, 146.5, 141.1, 135.3, 130.8, 129.6, 129.2,
129.0, 127.5, 126.4, 124.7, 115.0, 99.8, 86.8, 55.2, 53.8, 28.3, 23.7;
IR (film) 3065, 3029, 2965, 2932, 2870, 1773, 1752, 1648, 1610, 1584, 1512, 1462, 1448,
1251, 1145, 1033 cm- ;
HRMS (ESI) calcd for C30H3204Na (M + Na ) 479.2193, found 479.2216.
tert-Butyl 2-((4S,5R)-5-((2,6-diisopropylphenoxy)carbonyl)-4,5-dihydro-4-phenyl
furan-2-yl)-1H-pyrrole-l-carboxylate (Table 3, entry 7).
General Procedure A was followed, with (-)-bpy*, tert-butyl 2-((E)-3-phenylacryloyl)-
1H-pyrrole-l-carboxylate (297 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate
(271 mg, 1.1 mmol). After chromatography on silica gel (hexanes/ethyl ether 100:1), the
title compound was isolated as a colorless oil: run 1, 347 mg (66%, >90% de, 94% ee);
run 2, 368 mg (70%, >90% de, 92% ee). The ee was determined on an OD-H column
(hexanes/iso-propanol 99:1, flow 0.9 mL/min.) with tr(major) 5.2 min., tr(minor) 4.8
min.
[a]22D = -129 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 6 7.54-7.52 (m, 2H), 7.26 (dd, J = 3.2, 1.8 Hz, 1H), 7.21-7.17
(m, 2H), 7.11-7.03 (m, 4H), 6.82 (dd, J = 3.4, 1.8 Hz, 1H), 6.03 (t, J = 3.4 Hz 1H), 5.77 (d, J
= 2.8 Hz, 1H), 5.31 (d, J = 5.8 Hz, 1H), 4.90 (dd, J = 5.8, 2.7 Hz, 1H), 3.13 (septet, 2H), 1.25
(s, 9H), 1.15 (d, J = 6.8 Hz, 12H);
'
3 C NMR (C6D6, 100 MHz) 6 170.6, 150.3, 149.0, 146.5, 143.5, 141.1, 129.5, 128.5, 128.0,
127.4, 125.6, 124.8, 124.7, 117.9, 111.3, 103.4, 86.3, 84.0, 55.0, 28.2, 28.0, 23.7;
IR (film) 2966, 2932, 2871, 1754, 1652, 1456, 1306, 1144 cmm;
HRMS (ESI) calcd for C32H37NOsNa (M + Nat) 538.2564, found 538.2554.
i-Pr /
0 -i
0 i-Pr
Ph \"0
(2R,3S)-2,6-Diisopropylphenyl 3-(furan-3-yl)-2,3-dihydro-5-phenylfuran-2-
carboxylate (Table 3, entry 8).
General Procedure A was followed, with (-)-bpy*, (E)-l-(3-furyl)-3-phenyl-2-propen-
1-one (198 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol).
After chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 258 mg (62%, 68% de, 85% ee); run 2, 262 mg (63%, 70%
de, 88% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 0.7 mL/min.) with tr(major) 12.5 min., tr(minor) 13.1 min.
[C] 22D = -97.1 (c = 1.00, CH2C12);
1H NMR (C6D6, 400 MHz) 6 7.72-7.70 (m, 2H), 7.14-7.00 (m, 8H), 6.23 (s, 1H), 5.27 (d, J
= 2.9 Hz, 1H), 5.21 (d, J = 5.3 Hz, 1H), 4.73 (dd, J = 5.3, 2.8 Hz, 1H), 3.12 (septet, 2H), 1.16
(d, J = 6.9 Hz, 12H);
13C NMR (C6D 6, 100 MHz) 6 170.4, 157.2, 146.4, 144.4, 141.0, 139.9, 130.7, 129.6, 129.0,
127.5, 127.3, 126.3, 124.8, 110.1, 98.5, 85.6, 45.0, 28.3, 23.7;
IR (film) 3065, 2965, 2871, 1774, 1753, 1650, 1578, 1448, 1162 cm-1;
HRMS (ESI) calcd for C27H 2804Na (M + Na ) 439.1880, found 439.1870.
i-Pr
0 0 i-Pr
Ph ,,,, 1 Ph
(2R,3R)-2,6-Diisopropylphenyl 2,3-dihydro-5-phenyl-3-(E)-styrylfuran-2-
carboxylate (Table 3, entry 9).
General Procedure A was followed, with (-)-bpy*, trans, trans-1,5-diphenylpenta-2,4-
dien-1-one (234 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1
mmol). After chromatography on silica gel (hexanes/ethyl ether 100:1), the title
compound was isolated as a colorless oil: run 1, 344 mg (76%, 76% de, 93% ee); run 2,
344 mg (76%, 74% de, 92% ee). The ee was determined on an AD-H column
(hexanes/iso-propanol 99:1, flow 0.7 mL/min.) with tr(major) 16.8 min., tr(minor) 22.4
min.
[a]22D = -176 (c = 1.00, CH 2C12);
1H NMR (C6D 6, 400 MHz) 8 7.76-7.73 (m, 2H), 7.22-7.20 (m, 2H), 7.16-7.04 (m, 9H),
6.52 (d, J = 15.7 Hz, 1H), 6.19 (dd, J = 15.7, 8.3 Hz, 1H), 5.25 (d, J = 2.8 Hz, 1H), 5.15 (d, J
= 5.5 Hz, 1H), 4.43 (ddd, J = 8.0, 5.4, 2.6 Hz, 1H), 3.18 (septet, J = 6.7 Hz, 2H), 1.18 (d, J =
6.9 Hz, 12H);
13C NMR (C6D 6, 100 MHz) 8 170.4, 157.2, 146.4, 141.0, 137.4, 132.3, 130.8, 130.2, 129.6,
129.2, 129.0, 128.3, 127.5, 127.2, 126.3, 124.7, 98.4, 84.4, 52.4, 28.3, 23.8;
IR (film) 3061, 3027, 2965, 2930, 2870, 1774, 1752, 1645, 1448, 1163, 1061 cm-;
HRMS (ESI) calcd for C31H3203Na (M + Na ) 475.2243, found 475.2258.
i-Pr/\
0 i-Pr
0
Ph #"n-Bu
(2R,3R)-2,6-Diisopropylphenyl 3-butyl-2,3-dihydro-5-phenylfuran-2-carboxylate
(Table 3, entry 10).
General Procedure A was followed, with (-)-bpy*, (E)-l-phenyl-2-hepten-l-one (188
mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 370 mg (91%, 96% de, 79% ee); run 2, 378 mg (93%, 97%
de, 76% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with tr(major) 4.1 min., tr(minor) 4.9 min.
[a]22D = -53.6 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 8 7.74-7.72 (m, 2H), 7.14-7.03 (m, 6H), 5.27 (d, J = 2.8 Hz,
1H), 5.29 (d, J = 5.3 Hz, 1H), 3.61-3.52 (m, 1H), 3.23-3.06 (m, 2H), 1.58-1.38 (m, 2H), 1.34-
1.10 (m, 16H), 0.85 (t, J = 7.1 Hz, 3H);
13C NMR (C6D6, 100 MHz) 8 170.9, 156.4, 146.5, 141.1, 131.2, 129.3, 128.9, 127.7, 127.4,
126.2, 124.7, 99.4, 84.2, 49.3, 36.1, 29.8, 28.3, 23.8, 23.3, 14.6;
IR (film) 3066, 3029, 2963, 2930, 2871, 1776, 1751, 1650, 1602, 1578, 1466, 1448 cm-';
HRMS (ESI) calcd for C27H3O 3Na (M + Na') 429.2400, found 429.2390.
i-Pr/\
0 -
0 i-Pr
Ph "i-Pr
(2R,3R)-2,6-Diisopropylphenyl 2,3-dihydro-3-isopropyl-5-phenylfuran-2-
carboxylate (Table 3, entry 11).
General Procedure A was followed, with (-)-bpy*, (E)-4-methyl-l-phenyl-2-penten-1-
one (188 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol).
After chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 330 mg (84%, 96% de, 52% ee); run 2, 338 mg (86%,
>90% de, 49% ee). The ee was determined on an OD-H column (hexanes/iso-propanol
99:1, flow 0.9 mL/min.) with tr(major) 6.4 min., tr(minor) 5.9 min.
[a]22D = -38.0 (c = 1.00, CH 2Cl2);
1H NMR (C6D6, 400 MHz) 8 7.73-7.70 (m, 2H), 7.13-7.02 (m, 6H), 5.24 (d, J = 2.9 Hz,
1H), 5.12 (d, J = 4.8 Hz, 1H), 3.45 (ddd, J = 6.4, 4.8, 3.0 Hz, 1H), 3.19 (br, 2H), 1.64 (octet, J
= 6.7 Hz, 1H), 1.28-1.06 (m, 12H), 0.90 (dd, J = 6.7, 2.2 Hz, 6H);
13C NMR (C6D6, 100 MHz) 6 171.2, 156.9, 146.5, 141.1, 131.1, 129.3, 128.9, 127.4, 126.2,
124.7, 97.3, 82.1, 56.1, 33.1, 28.3, 23.9, 23.3, 20.1, 19.8;
IR (film) 3065, 3029, 2963, 2931, 2871, 1776, 1751, 1650, 1602, 1578, 1465, 1448 cm-;
HRMS (ESI) calcd for C26H3203Na (M + Na') 415.2243, found 415.2235.
Pr
n-Hex
(2R,3R)-2,6-Diisopropylphenyl 5-hexyl-2,3-dihydro-3-phenylfuran-2-carboxylate
(Table 4, entry 1).
General Procedure B was followed, with (-)-bpy*, (E)-l-phenyl-l-nonen-3-one (216
mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (345 mg, 1.4 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 300 mg (69%, 84% de, 77% ee); run 2, 300 mg (69%, 88%
de, 73% ee). The ee was determined after reduction by LAH on an OD-H column
(hexanes/iso-propanol 98:2, flow 1.0 mL/min.) with tr(major) 17.1 min., tr(minor) 12.3
min.
[a]22D = -174 (c = 1.00, CH 2C12);
1H NMR (C6D 6, 400 MHz) 8 7.38-7.36 (m, 2H), 7.21-7.18 (m, 2H), 7.13-7.04 (m, 4H),
5.16 (d, J = 4.9 Hz, 1H), 4.71 (d, J = 2.3 Hz, 1H), 4.68 (dd, J = 4.6, 2.4 Hz, 1H), 3.13 (septet,
100
J = 6.7 Hz, 2H), 2.25 (t, J = 7.5 Hz 2H), 1.60 (quintet, J = 7.5 Hz 2H), 1.33-1.10 (m, 18H),
0.86 (t, J = 6.9 Hz, 3H);
'
3C NMR (C6D6, 100 MHz) 8 170.8, 161.1, 146.4, 144.2, 141.1, 129.5, 128.0, 127.4, 124.7,
98.6, 86.6, 54.3, 32.3, 29.6, 28.6, 28.3, 27.3, 23.9, 23.3, 14.7;
IR (film) 3065, 3029, 2962, 2930, 2871, 1776, 1754, 1673, 1602, 1493, 1456, 1248, 1144,
1096 cm-1;
HRMS (ESI) calcd for C29H3sO3Na (M + Nat) 457.2713, found 457.2733.
i-Pr
0_ 0  i-Pr
i-Pr "'Ph
(2R,3S)-2,6-Diisopropylphenyl 2,3-dihydro-5-isopropyl-3-phenylfuran-2-carboxylate
(Table 4, entry 2).
General Procedure B was followed, with (-)-bpy*, (E)-4-methyl-1-phenyl-1-penten-3-
one (174 mg, 1.0 mmol), and 2,6-diisopropylphenyl-diazoacetate (345 mg, 1.4 mmol).
After chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 300 mg (86%, 86% de, 66% ee); run 2, 300 mg (88%, 90%
de, 65% ee). The ee was determined after reduction by LAH on an OD-H column
(hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major) 11.5 min., tr(minor) 14.0
mmin.
[a]22D = -152 (c = 1.00, CH 2CI2);
1H NMR (C6D 6, 400 MHz) 8 7.36-7.34 (m, 2H), 7.20-7.16 (m, 2H), 7.13-7.04 (m, 4H),
5.15 (d, J = 4.5 Hz, 1H), 4.67-4.65 (m, 2H), 3.13 (septet, J = 6.8 Hz, 2H), 2.52 (septet, J = 6.9
Hz, 1H), 1.18 (d, J = 6.9 Hz, 6H), 1.15 (d, J= 6.9 Hz, 12H);
13C NMR (C6D6, 100 MHz) 8 170.9, 166.3, 146.4, 144.1, 141.1, 129.5, 129.0, 127.9, 127.4,
124.8, 124.7, 96.6, 86.5, 54.1, 28.3, 28.2, 23.7, 20.7;
IR (film) 3065, 3029, 2965, 2932, 2872, 1776, 1752, 1667, 1603, 1493, 1468, 1456, 1384,
1248, 1164 cm-1;
HRMS (ESI) calcd for C26H3203Na (M + Na ) 415.2243, found 415.2254.
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i-Pr
i-Pr
t-Bu
(2R,3S)-2,6-Diisopropylphenyl 5-tert-butyl-2,3-dihydro-3-phenylfuran-2-
carboxylate (Table 4, entry 3).
General Procedure A was followed, with (-)-bpy*, (E)-4-methyl-l-phenyl-l-penten-3-
one (174 mg, 1.0 mmol), and 2,6-diisopropylphenyl-diazoacetate (271 mg, 1.1 mmol).
After chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 321 mg (79%, 94% de, 69% ee); run 2, 337 mg (83%,
>90% de, 71% ee). The ee was determined after reduction by LAH on an OD-H column
(hexanes/ iso-propanol 97:3, flow 1.0 mL/min.) with tr(major) 8.6 min., tr(minor) 9.2
min.
[a] 2 2 D = -147 (c = 1.00, CH 2CI 2);
1H NMR (C6D 6, 400 MHz) 8 7.35-7.33 (m, 2H), 7.20-7.16 (m, 2H), 7.12-7.04 (m, 4H),
5.14 (d, J = 4.5 Hz, 1H), 4.69 (d, J = 2.6 Hz, 1H), 4.62 (dd, J = 4.5, 2.6 Hz, 1H), 3.13 (septet,
J = 6.9 Hz, 2H), 1.25 (s, 9H), 1.18 (d, J = 6.9 Hz, 6H), 1.15 (d, J = 6.9 Hz, 6H);
13C NMR (C6D6, 100 MHz) 6 170.9, 168.7, 146.4, 144.2, 141.1, 129.6, 128.0, 127.9, 127.4,
124.7, 96.0, 86.6, 54.1, 32.7, 28.5, 28.2, 23.8;
IR (film) 3065, 3029, 2965, 2871, 1776, 1752, 1660, 1603, 1493, 1457, 1385, 1164 cm 1;
HRMS (ESI) calcd for C26H 3203Na (M + Na ) 429.2400, found 429.2419.
0
n-Hex-- "'"Me
(2R,3S)-2,6-Diisopropylphenyl 5-hexyl-2,3-dihydro-3-methylfuran-2-carboxylate
(Taable 4, entry 4).
General Procedure A was followed, with (-)-bpy*, (E)-2-decen-4-one (154 mg, 1.0
mmol) and 2,6-diisopropylphenyldiazoacetate (345 mg, 1.4 mmol). After
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chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 291 mg (78%, >90% de, 72% ee); run 2, 305 mg (82%,
>90% de, 69% ee). The ee was determined after reduction by LAH on an OD-H column
(hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major) 7.4 min., tr(minor) 8.8
min.
[a]22D = 70.8 (c = 1.00, CH 2CI2);
1H NMR (C6D6, 400 MHz) 8 7.11-7.04 (m, 3H), 4.77 (d, J = 5.7 Hz, 1H), 4.52-4.50 (m,
1H), 3.48-3.45 (m, 1H), 3.13 (septet, J = 6.8 Hz, 2H), 2.17 (t, J = 7.4 Hz 2H), 1.55 (quintet, J
= 7.4 Hz 2H), 1.33-1.14 (m, 18H), 1.13-1.10 (d, J = 6.8 Hz, 3H), 0.84 (t, J = 6.7 Hz, 3H);
13C NMR (C6D6, 100 MHz) 8 171.0, 159.5, 146.4, 141.1, 127.3, 124.7, 100.1, 85.6, 43.8,
32.3, 29.5, 28.6, 28.3, 27.2, 23.9, 23.6, 23.3, 22.0, 14.6;
IR (film) 3067, 2963, 2930, 2871, 1778, 1751, 1674, 1459, 1245, 1161, 1095 cm 1;
HRMS (ESI) calcd for C24H3603Na (M + Na ) 395.2557, found 395.2562.
i-Pr
Ph 0
OAc i-Pr
(S)-2,6-Diisopropylphenyl 2-acetoxy-5-oxo-7-phenylheptanoate (Table 4, entry 5)
General Procedure B was followed, with (-)-bpy*, 5-phenylpent-l-en-3-one (160 mg,
1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (345 mg, 1.4 mmol). The crude
product was hydrolyzed and then acetylated. After chromatography on silica gel
(hexanes/ethyl ether 10:1), the title compound was isolated as a colorless oil: run 1, 220
mg (50%, 69% ee); run 2, 224 mg (51%, 69% ee). The ee was determined on an AD-H
column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major) 11.3 min.,
tr(minor) 9.1 min.
[a]22D = 19.1 (c = 1.02, CH 2CI 2);
1H NMR (CDC13, 400 MHz) 6 7.33-7.30 (m, 2H), 7.25-7.18 (m, 6H), 5.35 (dd, J = 8.4, 4.4
Hz, 1H), 3.01 (br, 1H), 2.96 (t, J = 7.5 Hz, 2H), 2.86 (br, 1H), 2.81 (t, J = 7.7 Hz, 2H), 2.75-
2.60 (m, 2H), 2.52-2.44 (m, 1H), 2.34-2.24 (m, 1H), 2.16 (s, 3H), 1.20 (d, J = 6.9 Hz, 12H);
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13C NMR (CDCI3 , 100 MHz) 8 208.0, 170.4, 168.8, 145.1, 141.0, 140.6, 128.7, 128.5, 127.0,
126.4, 124.1, 71.3, 44.5, 38.3, 29.9, 27.4, 25.0, 23.9, 23.0, 20.7;
IR (film) 3064, 3028, 2966, 2932, 2871, 1771, 1750, 1717, 1604, 1442, 1374, 1241, 1164 cm
1.
LCMS (ES+APCI) calcd for C27H340ONa (M + Nat) 461.3, found 461.3.
i-Pr
0 i-Pr
0O
\ "'Ph
(2R,3R)-2,6-Diisopropylphenyl 3,4,5,6-tetrahydro-3-phenyl-2H-cyclopenta[b]furan-
2-carboxylate (eq 7).
General Procedure A was followed, with (-)-bpy*, (E)-2-(phenylmethylene)
cyclopentanone (172 mg, 1.0 mmol), and 2,6-diisopropylphenyl-diazoacetate (271 mg,
1.1 mmol). After chromatography on silica gel (hexanes/ethyl ether 100:1), the title
compound was isolated as a colorless oil: run 1, 211 mg (54%, >90%, 64% ee); run 2, 203
mg (52%, >90%, 63% ee). The ee was determined after reduction by LAH on an OD-H
column (hexanes/iso-propanol 95:5, flow 1.0 mL/min.) with tr(major) 11.7 min.,
tr(minor) 8.9 min.
[Ca] 22 D = 103 (c = 1.00, CH 2C12);
1H NMR (C6D 6, 400 MHz) 8 7.32-7.31 (m, 2H), 7.20-7.16 (m, 2H), 7.12-7.04 (m, 4H),
5.53 (d, J = 5.2 Hz, 1H), 4.61 (dt, J = 4.9, 2.4 Hz, 1H), 3.15 (septet, J = 6.8 Hz, 2H), 2.28-
2.27 (m, 2H), 2.03-2.01 (m, 4H), 1.17 (d, J = 6.8 Hz, 12H);
13C NMR (C6D6, 100 MHz) 8 170.6, 164.8, 146.4, 142.5, 141.1, 129.6, 128.1, 128.0, 127.4,
124.7, 117.5, 94.7, 53.3, 28.3, 27.6, 25.3, 24.2, 23.7;
IR (film) 3064, 3029, 2964, 2932, 2868, 1776, 1753, 1712, 1602, 1494, 1455, 1217, 1162 cm
1.
HRMS (ESI) calcd for C26H 30O3Na (M + Na ) 413.2087, found 413.2091.
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i-Pr/
O 0  i-Pr
Me
(R)-2,6-Diisopropylphenyl 2,3-dihydro-4-methyl-5-phenylfuran-2-carboxylate
(entry 8).
General Procedure A was followed, with (-)-bpy*, 2-methyl-1-phenyl-2-propen-l-one
(146 mg, 1.0 mmol), and 2,6-diisopropylphenyldiazoacetate (271 mg, 1.1 mmol). After
chromatography on silica gel (hexanes/ethyl ether 100:1), the title compound was
isolated as a colorless oil: run 1, 284 mg (78%, 16% ee); run 2, 270 mg (74%, 21% ee). The
ee was determined on an OD-H column (hexanes/iso-propanol 97:3, flow 1.0 mL/min.)
with tr(major) 18.6 min., tr(minor) 16.3 min.
[a]22D = 3.33 (c = 1.00, CH 2Cl2);
1H NMR (C6D6, 400 MHz) 6 7.73-7.70 (m, 2H), 7.18-7.14 (m, 2H), 7.12-7.04 (m, 4H),
5.05 (dd, J = 10.9, 5.7 Hz, 1H), 3.13 (septet, J = 6.8 Hz, 2H), 3.06 (ddq, J = 15.8, 5.6, 1.0 Hz,
1H), 2.84 (ddq, J = 15.6, 10.9, 1.3 Hz, 1H), 1.67 (t, J = 1.3 Hz, 3H), 1.16 (d, J = 6.9 Hz, 12H);
13C NMR (C6D, 100 MHz) 6 171.4, 149.2, 146.5, 141.1, 132.1, 128.8, 127.9, 127.3, 124.7,
105.2, 76.5, 41.7, 28.2, 23.8, 12.7;
IR (film) 3064, 3027, 2965, 2930, 2870, 1774, 1756, 1682, 1602, 1496, 1460, 1249, 1165,
1065 cm -1;
HRMS (ESI) calcd for C24H28O3Na (M + Na+) 387.1930, found 387.1919.
4. Derivatization of Dihydrofurans (eq 9 and eq 3)
n-Hex OH
Ph
((2R,3S)-2,3-Dihydro-5-hexyl-3-phenylfuran-2-yl)methanol (eq 9).
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A solution of LiAlH 4 (1.0 M in Et2O; 0.23 mL, 0.23 mmol) was added dropwise to a
stirred solution of the ester (run 1, >90% de and 77% ee; run 2, >90% de and 73% ee; 100
mg, 0.23 mmol) in Et20O (5.0 mL). The reaction mixture was stirred for 10 min, and then
the reaction was quenched with 1.0 N NaOH (0.2 mL). The mixture was stirred for 5
min, and then it was filtered and concentrated. After chromatography on silica gel
(hexanes/ethyl ether 15:1), the title compound was isolated as a colorless oil: run 1, 57
mg (95%, 77% ee); run 2, 58 mg (97%, 73% ee). The ee was determined on an OD-H
column (hexanes/iso-propanol 98:2, flow 1.0 mL/min.) with tr(major) 17.1 min.,
tr(minor) 12.3 min.
[a]22D = -74.9 (c = 1.00, CH 2C12);
1H NMR (C6D6, 400 MHz) 8 7.18-7.12 (m, 4H), 7.07-7.04 (m, 1H), 4.56 (dt, J = 2.2, 1.1
Hz, 1H), 4.34 (dt, J = 6.7, 5.0 Hz, 1H), 3.83 (dq, J = 6.7, 1.9 Hz, 1H), 3.53 (t, J = 5.0 Hz, 2H),
2.12 (t, J = 7.8 Hz, 2H), 1.71 (t, J = 5.6 Hz, 1H), 1.51 (quintet, J = 7.5 Hz, 2H), 1.31-1.17 (m,
6H), 0.86 (t, J = 6.8 Hz, 3H);
'
3 C NMR (C6D 6, 100 MHz) 8 159.9, 145.4, 129.2, 128.2, 127.3, 99.4, 90.8, 64.9, 51.6, 32.3,
29.7, 28.7, 27.4, 23.3, 14.6;
IR (film) 3424, 3062, 3028, 2954, 2929, 2859, 1669, 1602, 1493, 1455, 1159 cm-1;
HRMS (ESI) calcd for C17H2402Na (M + Na ) 283.1669, found 283.1676.
i-Pr
0 n-BuO 0
Ph O
OAc i-Pr
(2R,3R)-2,6-Diisopropylphenyl 2-acetoxy-3-butyl-5-oxo-5-phenylpentanoate (eq 10)
The procedure for entry 4 of Table 3 was followed, with the ester (run 1, >90% de and
79% ee; run 2, >90% de and 76% ee; 50 mg, 0.12 mmol), 10% aq HBF4 (1.0 mL), NEt3
(0.10 mL, 0.74 mmol), DMAP (3.0 mg, 0.025 mmol), and Ac20 (0.060 mL, 0.64 mmol)
After chromatography on silica gel (hexanes/ethyl ether 20:1), the title compound was
isolated as a colorless oil: run 1, 50 mg (87%; >90% de, 78% ee); run 2, 53 mg (92%; >90%
de, 76% ee). The ee was determined on an AD-H column (hexanes/iso-propanol 99:1,
flow 1.0 mL/min.) with tr(major) 5.0 min., tr(minor) 6.3 min.
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[a]22D = -11.4 (c = 1.00, CH 2C 2);
1H NMR (CDC13, 400 MHz) 6 8.03-8.00 (m, 2H), 7.60-7.57 (m, 1H), 7.50-7.47 (m, 2H),
7.23-7.13(m, 3H), 5.54 (d, J = 2.3 Hz, 1H), 3.24-3.22(m, 2H), 3.17-3.08(m, 1H), 3.08-2.90 (m,
1H), 2.90-2.60 (m, 1H), 2.22 (s, 3H), 1.62-1.52 (m, 2H), 1.50-1.33 (m, 4H), 1.17 (d, J = 6.3
Hz, 12H), 0.94 (t, J = 6.9 Hz, 3H);
13C NMR (C6D , 100 MHz) 6 198.0, 170.6, 169.1, 145.1, 140.6, 137.2, 133.4, 128.9, 128.2,
127.0, 124.1, 73.5, 39.3, 35.4, 31.8, 29.5, 27.4, 23.7, 22.8, 20.8, 14.1;
IR (film) 3065, 2965, 2932, 2871, 1769, 1751, 1689, 1598, 1449, 1366, 1229, 1174 cm-1;
HRMS (ESI) calcd for C29H38sONa (M + Na) 489.2611, found 489.2636.
5. Application to Deoxy-C-nucleoside Synthesis (Shceme 1)
O
Ph O 2CH 2 TMS
(E)-3-(2-(Trimethylsilyl)ethoxy)-l-phenylprop-2-en-l-one.
1-Phenylprop-2-yn-l-one (650 mg, 5.0 mmol) was added dropwise to a solution of
trimethylsilylethanol (650 mg, 5.5 mmol) and N-methylmorpoline (657 mg, 6.5 mmol) in
CH2C12 (5 mL) at r.t. The reaction mixture was stirred for 2 days, and then a saturated
solution of NH 4C1 (10 mL) was added. The mixture was extracted with CH2C12 (10 mL x
3), and the combined organic layers were dried over MgSO, and concentrated. The
resulting dark brown oil was purified by column chromatography (hexanes/Et20O 8:1),
which furnished the title product (820 mg, 66%o). The reaction was not optimized.
1H NMR (CDC13, 400 MHz) 8 7.91-7.89 (m, 2H), 7.77 (d, J = 12.2 Hz, 1H), 7.54-7.52 (m,
1H), 7.50-7.44 (m, 2H), 6.35 (d, J = 12.2 Hz, 1H), 4.13-4.09 (m, 2H), 1.15-1.11 (m, 2H), 0.09
(s, 9H);
13C NMR (CDC13, 100 MHz) 6 218.2, 191.0, 164.4, 132.4, 128.6, 128.2, 102.3, 70.5, 18.1,
-1.2;
IR (film) 3064, 2953, 2896, 1664, 1601, 1586, 1575, 1447, 1381, 1250, 1192, 1172, 858, 838
cm- ;
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LCMS (ES+APCI) calcd for C14H2002SiNa (M + Na ) 271.1125, found 271.2.
Ph OH
-_TMS
((2S,3R,5S)-3-(2-(Trimethylsilyl)ethoxy)-tetrahydro-5-phenylfuran-2-yl)methanol.
General Procedure A was followed, with (-)-bpy*, (E)-3-(2-(trimethylsilyl)ethoxy)-l-
phenylprop-2-en-l-one (248 mg, 1.0 mmol), and 2,6-diisopropylphenyl-diazoacetate
(271 mg, 1.1 mmol). 1H NMR analysis of the unpurified dihydrofuran product revealed
only one diastereomer.
The unpurified product was subjected to hydrogenation (1 atm) with Pd on activated
carbon (10% w/w; 5 mg) and NEt3 (70 pL, 0.5 mmol) in MeOH (3.0 mL) for 1 h. The
reaction mixture was filtered through a silica gel (Et20O as the eluant) and concentrated.
A solution of LAH (1.0 M in Et20O; 1.0 mL, 1.0 mmol) was added to a solution of the
tetrahydrofuran in Et20O (4.0 mL). The reactio mixture was stirred for 5 minutes, and
then the reaction was quenched by adding water (0.1 mL) and stirring for 10 minutes.
The reaction mixture was dried over MgSO 4, filtered, concentrated, and purified by
column chromatography (hexanes/Et2O 5:1), which furnishes the title compound as a
colorless oil: run 1, 216 mg (73%); run 2, 236 mg (80%).
'H NMR (CDCl1, 400 MHz) 8 7.37-7.28 (m, 5H), 5.12 (dd, J = 10.5, 5.4 Hz, 1H), 4.09 (dt,
J = 4.8, 3.4 Hz, 1H), 4.02 (ddd, J = 6.3, 2.8, 1.4 Hz, 1H), 3.88 (dd, J = 11.7, 3.6 Hz, 1H), 3.72
(dd, J = 11.7, 4.9 Hz, 1H), 3.60-3.53 (m, 2H), 2.35 (ddd, J = 13.3, 5.4, 1.5 Hz, 1H), 1.97 (br s,
1H), 1.91 (ddd, J = 13.3, 10.5, 6.4 Hz, 1H), 1.00-0.96 (m, 2H), 0.05 (s, 9H);
13C NMR (CDCl3, 100 MHz) 6 141.6, 128.9, 128.2, 126.4, 85.6, 81.1, 80.8, 67.0, 64.2, 41.7,
18.8, -0.9;
IR (film) 3414, 2952, 2893, 1715, 1362, 1222, 1098, 1057 cm-;
LCMS (ES+APCI) calcd for C16H2603SiNa (M + Na+) 317.1543, found 317.2.
Ph 0 OH
OH
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(2S,3R,5S)-Tetrahydro-2-(hydroxymethyl)-5-phenylfuran-3-ol.
To a solution of ((2S,3R,5S)-3-(2-(trimethylsilyl)ethoxy)-tetrahydro-5-phenylfuran-2-
yl)methanol (50.0 mg, 0.17 mmol) in toluene (2.5 mL) was added BF3-OEt2 (23.5 AL, 0.19
mmol). The reaction mixture was stirred for 1 hour, and then the reaction was quenched
by the addition of a saturated solution of NaHCO3 (2.0 mL). The mixture was extracted
with Et20O (5 mL x 3), dried over MgSO4, and concentrated. Purification by column
chromatography (CH2C 2/MeOH 50:1) furnished the title compound as a white solid:
run 1, 30 mg (87%, 93% ee); run 2, 28 mg (85%, 94% ee). The ee was determined on an
AD-H column (hexanes/iso-propanol 95:5, flow 1.0 mL/min.) with tr(major) 28.4 min.,
tr(minor) 32.0 min.
The spectral data matched with the values reported previously.'5
[a]22 D = -44.9 (c = 1.00, CHC13);
'H NMR (CDCl1, 400 MHz) 8 7.36-7.28 (m, 5H), 5.18 (dd, J = 10.2, 5.6 Hz, 1H), 4.41 (dt,
J = 6.0, 2.4 Hz, 1H), 4.03-3.99 (m, 1H), 3.81 (dd, J = 11.6, 4.3 Hz, 1H), 3.73 (dd, J = 11.6, 5.0
Hz, 1H), 2.37 (br s, 2H), 2.25 (ddd, J = 13.3, 5.7, 1.9 Hz, 1H), 2.25 (ddd, J = 13.3, 10.2, 6.3
Hz, 1H);
'
3C NMR (CDCl3, 100 MHz) 6 141.2, 128.7, 128.1, 126.3, 87.5, 80.4, 73.9, 63.6, 44.0;
IR (film) 3274, 2940, 2832, 1490, 1452, 1358, 1102, 1054, 1028 cm;
LCMS (ES+APCI) calcd for C,,H,4O 3Na (M + Na ) 217.0835, found 217.1.
'5 (a) Calter, M. A.; Zhu, C. i. Org. Chem. 1999, 64, 1415-1419. (b) Sas, B.; Van Hemel, J; Vandenkerckhove,
J; Peys, E; Van Der Eycken, J; Van Hoof, S. U.S. Patent 007245, 2004.
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6. Absolute Stereochemistry Determination
The stereochemistry of the dihydrofurans was assigned on the basis of the synthesis
described in Section 5 and by correlation with (2R,3R)-3-methyl-5-phenylpentane-1,2-
diol. 6
O0
Ph '- Me
1.0% CuOTf
1.3% (-)-bpy*
CH 2CI2
Ph -OAr
Me
1) H2, Pd/C
2) LiBH 4, MeOH
Me
Ph OH
OH
Scheme 1
The spectral data matched with the values reported previously. 2
[a]22D = 17.3 (c = 0.83, CHC13).
16 Barrow, R. A.; Hemscheidt, T.; Liang, J.; Paik, S.; Moore, R. E.; Tius, M. A. J. Am. Chem. Soc. 1995, 117,
2479-2490.
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7. 1H NMR for Selected Compounds
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Table 2, entry 1
r
K tfl
co Il C)
r M C)Cn Kr C0! C1 C
Current Data Parameters
NAME ss3-27-2
EXPND 1
PROCNO
F2 - AcQuisition Parameters
Date_ 20050630
Time 19.04
INSTRUI spect
PA6OHO 5mm 80 09-1
PtLPROG zg30
TO 65536
SOLVENT C60S
WS 16
DS 2
SHH 8278.145 HZ
FIDRES 0.126314 HZ
AD 3.9584243 sec
RG 114
Ow 60.400 usec
OE 6.00 usec
TE 300.0 K
01 1.00000000 sec
a ......... CHANNEL f........
NUCI IN
Pt 7.90 usec
PLI 0.00 dB
SFO1 400.1324710 MHz
F2 - Processing parameters
SI 32768
SF 400.1300059 MHz
Wn EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
10 NMR plot parameters
CX 20.00 cm
FIP 10.000 pOm
FI 4001.30 Hz
F2P 0.000 Ppm
F2 0.00 Hz
PPMCM 0.50000 ppm/cm
HZCK 200.06500 Hz/cm
ppm 9 8 7 6 5
SI 2 1
4 3 2
ii,
____ __ 
Ilu.AL % d. L .JIJ J
.. . ........ .. .. ... J . . . . . . . . . . . . . . . .' . . . . . L" I . .. . . . . . . . . . . . . . . I ! , , + , *I 1 1 1
---
CO 2 Et
Ph" "'Ph
Table 2, entry 2
I l I
Current Oata Parameters
4NAME ss3-27-1
EXPNO I
PROCN0 I
F2 - Acquisition Parameters
Date. 20050630
Time 19.00
INSTRUM spect
PROBHO) 5M BBO 88-I
UJLPROS zg30
TO- 65536
SOLVENT C606
NS 16
DS 2
SH 8278.146 Hz
F IORES 0.126314 Hz
AO 3.9584243 sec
A6 64
OW 60.400 usec
DE 6.00 usec
TE 300.0 K
Di 1.00000000 sec
,,,-=== ==, CHANNEL 11 ====== ****
NUC1 14
P1 7.90 usec
l1 0.00 dB
SF01 400.1324710 MHZ
F2 -
SF
58
LB
ID NMR
CX
FIP
FI
PPMCM
HZCH
Processing parameters
32768
400.1300059 MHz
E9
0
0.30 Hz
plot parameters
20.00
10.000
4001.30
0.000
0.00
0.50000
200.06500
cmon
DOW
Hz
ppoe
Hz
ppm/cm
Hz/cm
-r 5 3 . . .......6 5 4 3 2
*11 11
C u M 7L
01O -,I -="Oi L
M 01to, 01 0 10
0. M~ 0' P1 :~
11111'1-l"r( 1
i
....-II....-.,. ......~,, ~ - - - - -~ n l-+-r-~-r- r- - -l- ~--- ------- ----
- ' ' -~ - 1--
1
-
ppm 9 B 7
--....
C o ruq
10 In M 
D 1
C3j M jj C>
Current
NAME
EXPND
PROCNO
CO 2Ph
Ph "'Ph
Table 2, entry 3
Data Parameters
ss3-27-3
F2 - Acuisition Parameters
Date- 20050630
rime 19.18
INSTRU spect
PROBHD 5mm 880 88-1
PULPROG zg30
TO 65536
SOLVENT C606
NS 16
0S 2
SWi 8278. 146 Hz
;IRES 0.126314 Hz
AQ 3.9584243 sec
G6 114
OW 60.400 usec
DE 6.00 usec
TE 300.0 K
DI 1.00000000 sec
a..v =*wU*ue CHANNEL II .......
NUCI 1H
Pt 7.90 usec
PLI 0.00 08
SF01 400.1324710 KHz
F2 - Processing Darazeters
10 MA
cx
FIP
F1
PPCM
HZCH
Ioo 0 CI-c, 
-
t ; C
32768
400.1300451 MHz
EN
0
0.30 Hz
0
1.00
plot parameters
20.00 ca
10.000 pm
4001.30 Hz
0.000 D m
0.00 HZ
0.50000 ppm/cm
200.06502 Hz/cm
'p I I rT6 5 4 3 2I I I I
6 5 4 3 2
__ Y
~ ___
i
~--~--~-~,-.-.- --~ ~-r* - l - -~-r+- -I I i l l t i . . . .. - I
ppm 9
Current Data Parameters
NAME ss3-27-4
EXPNO 3
PROCNO I
F2 - Acquisition Parameters
Date- 20050704
Time 15.45
INSTRUM spect
PROBHD 5mM BBO 5B-1
PULPROG zg30
TO 65535
SOLVENT C505
NS 16
DS 2
SWH 8278.145 Hz
FIORES 0.126314 Hz
AD 3.9584243 sec
RG 57
ON 50.400 usec
DE 6.00 usec
TE 300.0 K
DI 1.00000000 sec
-........... CHANNEL If -I001
NUCI SH
PI 7.90 usec
PLI 0.00 08
SFO1 400.1324710 MHZ
F2 - Processing parameters
SI 32768
SF 400.1300059 MHz
NON EN
SS8 0
LB 0.30 Hz
E5 0
PC 1.00
10 NMR plot parameters
CX 20.00 cm
FIP 10.000 ppa
Fi 4001.30 HZ
F2P 0.000 ppa
F2 0.00 Hz
S I Go PPMCH 0.50000 ppm/cm
M 9? HZCM 200.06500 HZ/Cmoo8 o.0 ,o/I 1c;. I ;, ;
S4 3 2I ' ' .. .ppo 987
lr7rTr-i-~-r7r rrrrr rrry-r rrrr-rrrrr~ 'i ' ' ' I ' ' ' ' ' ' I ( 1 ' ' ' ' ' ' ' ' I
major pdt from chalcone
i-Pr
0 i-Pr
Ph "'Ph
Table 2, entry 5
'I ~~I i W1~ j f
o 0
n
Current Data Parameters
NAME ss2-95
EXPNO 20
PROCNO I
F2 - AcQuisition Parameters
Date- 20050224
Time 14.11
INSTRUH spect
PROSHD 5mm BBO BB-1
PUPROG z930
TO 65536
SOLVENT C6D6
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AD 3.9584243 sec
%G 25.4
OW 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
==-== ..... CHANNEL fl 1**====
NUCI 1H
PI 7.90 usec
PLi 0.00 dB
SFOI 400.1324710 MHZ
F2 - Processing parameters
SI 32768
SF 400.1300443 MHz
WON EM
SSB 0K
to
0.30 Hz
0
1.00
10 NMR plot parazeters
CX 20.00
F1P 10.000
Fl 4001.30
F2P 0.000
f2 0.00
PPMCM 0.50000
HZCM 200.06502
cm
com
Hz
pom
H2
ppm/cm
Hz/cm
8 7
~- Tr-r)-TTT~-~-f -T II IIrR-r- III -- '-T -r-r-r-r-T-T-"- , I I I . - I - , -1 1 1 1 -1-1-t- 1 It-TT- -1-1 1I I . I
6 5 4
IiJ
L C ;
Iu cu
I I .
ppm 9
I I
3 2 1
I
, |I
IdlU ~lilC_11 ?L~ ~
Me
t-Bu / M
0 t-Bu
Ph "'Ph
Table 2, entry 6
V I
Current Date Parameters
NAME ss3-15-3
EXPNO I
PPROCNO
F2 - Acouisition Parameters
Date- 20050618
Time 23.34
INSTRUM spect
PAOBH0 5m BB0 88-1
PULPROG z9g3
TO 65536
SOLVENT C606
N5 16
05 2
SH 8278.146 HZ
FORES 0.126314 Hz
AO 3.9584243 sec
RG 101.6
DW 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
===-===.... CHANNEL fI l
NUCI 1H
P3 7.90 useC
PLI 0.00 dB
SF01 400.1324710 MHz
F2 -
SI
SF
wow
SSB
LB
GB
PC
Processing parameters
32768
400.1300446 MHz
EM
0
0.30 Hz
0
1,00
ID NHR olot oarameters
CX 20.00 cm
FIP 11.000 Dom
F1 4401.43 Hz
F2P -1.000 ppm
F2 -400.13 Hz
PPCH 0.60000 ppm/Cm
HZCM 240.07803 Hz/cm
6 5 4 3 2 1 0
Ii(O (9 nt: -
_____I_ ~
,,...,.,
I .,t Ik. I--
rrT-TI7 T - '' ''I"- ........ III , I
ppm 10 9 8 7
--
tua
CF3-chalcone pdt
Current
NAME
EXPNO
PROCNO
CO 2Ar
4-CF 3C 6H4  "'Ph
Ar = 2,6-diisopropylphenyl
Table 3, entry 2
t1/ 1 11
I 'VI n~u0 E to M
u t
C!
M
cn
Data Parameters
ss2-103
F2 - Acquisition Parameters
Date- 20050316
Time 17.35
INSTRUH spect
PR08HD 5m 680 88-1
PULPROG zg30
TO 65536
SOLVENT C6D6
NS 16
0S 2
SWH 8278.146 Hz
FIORES 0.126314 Hz
AO 3.9584243 sec
RG 32
Dw 60.400 usec
DE 6.00 usec
TE 300.0 K
Di 1.00000000 sec
a .... =.. CHANNEL fI
NUCI 1H
Pi 7.90 usec
PLI 0.00 d8
SFO 400.1324710 MHZ
F2 - Processing parameters
SI 32768
SF 400.1300443 MHz
Wow EM
5SB 0K
rujaici
0.30 Hz
1.00
10 NAR clot parameters
CX 20.00 cm
FIP 10.000 pDn
FI 4001.30 Hz
F2P 0.000 oDm
F2 0.00 Hz
PPHCM 0.50000 ppm/cm
HZCM 200.06502 Hz/cm
. . . ....... ?,----I-- I" *|-l' l-|"-t'-Tll.l i"| i i i ! •
ppm 9 8 7 4 3 2 1
__ _~ ;l~r i~Al . U-, ____
CO 2Ar
4-CIC 6H 4  "'Ph
Ar = 2,6-diisopropylphenyl
Table 3, entry 3
i I
io o'10.11Co
r£
o)01
Current
NAME
EXPRO
PROCNO
Data Parameters
ss2-225
6
5
F2 - Acquisition ParameLers
Date- 20050503
Time 21.06
INSTRUM spect
P IBHO 5m 880 B9-1
PULPROG z930
10 65535
SOLVENT C606
N5 16
SWH 8278.146 Hz
FIORES 0.12531t Hz
£A 3.9564243 sec
RG 54
DI 60.400 usac
DE 6.00 usec
TE 300.0 K
Di 1.00000000 sec
.=.------ CHANNEL fI ****
MJCt IH
Pt 7.90 uSec
PLI 0.00 dB
SF01 400.1324710 NHr
F2 -
SI
SF
558K
10 NHR
CX
FIP
FI1
FEP
FE
PPHCN
HZCM
n;
Processing parameLers
32766
400.1300443 1MHz
EN
0
0.30 HZ
0
1.00
plot parameters
20.00 cm
10.000 p"w
4001.30 Hz
0.000 ppm
0.00 Hz
0.50000 ppm/cm
200.06502 Hz/cm
. ............................ l
r T pp , I I I  . IPPM 9 87
Ilii
Ln 0 
U) t<((H
'~Ir 00 
U
U C " 
t
UC! Z.(C.;73
. ... ~ i . . . T ~ I - -I e . W l ~ . . . . . . ~ ~ . . . •
I
Ju r~
5 i5 4
O Ph
CO2 Ar4-(MeO)C 6 H4-
OAc
Ar = 2,6-diisopropylphenyl
Table 3, entry 4
]I1[ I
In r- v f" tD
ru c\ CU cu
Hf / i
~AJ
1> 0 ru
tIC! . C
M 7c
Current Data Parameters
NAME ss3-80
EXPNO 5
PROCN0 1
F2 - Acquisition Parameters
Date- 20050926
Time 15.11
INSTRUN spect
PIOBHO 5am B80 05-1
PULPROG z930
TO 65536
SOLVENT COCI3
NS 16
DS 2
SHH 8278,146 Hz
FIDRES 0.126314 Hz
AD 3.9584243 sec
DG 90.5
DO 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
............ CHANNEL fii .......
NUCI IH
P1 7.90 usec
PLI 0.00 d8
SFD 400. 2324710 MHz
F2 - Processing parameters
SI 32766
SF 400.1300059 MHz
WON EM
SSB 0
A
0.30 Hz
0
1.00
10 NMR plot parameters
CX 20.00 cm
FtP 10.000 ppm
F1 4001.30 Hz
F2P 0.000 ppm
F2 0.00 Hz
PPCM 0.50000 ppm/cm
HZcM 200.06500 Hz/cm
~II
ppm 9 B 7 6
.I~---~-' 
-
5 4 3 2
_ L - - J- . L/Ljt Vvl_
4'-Cl-chalcone major pdt
CO 2Ar
Ph-- ""4-CIC 6H4
Ar = 2,6-diisopropylphenyl
Thlp 3 entrv 5
C jJ
(QB I I~IHu
Current
NAME
EXPNO
PROCNO
Data Parameters
ss2-97
10
I
F2 - Acquisition Parameters
Date_ 20050224
Time 14.25
INSTRUN soect
PROBHO Sr 880 88-1
P.LPROG zg30
TD 65536
SOLVENT C6D6
NS 16
DS 2
s18 8278.146 HZ
;IDAES 0.126314 HZ
Ad 3.9584243 sec
RG 25.4
DH 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
- ......... CHANNEL Ifl .. =****
NUCI1 IH
P! 7.90 usec
PLI 0.00 dB
SFD1 400.1324710 MHz
Processing parameters
32768
400.1300443 MHz
EN
0
0.30 Hz
10 NMR plot parameters
Cx 20.00 cm
FIP 10,000 pom
Fl 4001.30 Hz
F2P 0.000 pem
F2 0.00 Hz
PPMCM 0.50000 ppl/ca
HZCM 200.06502 Hz/cm
. .. . . . . . . .. . . . .
ppm 9 8 7
M
in V
4'-OMe chalcone-major pot
CO 2Ar
Ph- ""4-(MeO)C 6 H4
Ar = 2,6-diisopropylphenyl
Table 3, entry 6
to Di0L /I0 - i I
IVq W-. 
Z
,ICM 0
Current Data Parameters
NAME ss2-101
EXPNO 10
PROCNO I
F2 - Acquisition Parameters
oate_ 20050224
Time 14.54
INSTRM spect
PROBHD 5mm BB0 BB-I
PULPROG zg30
10 65536
SOLVENT C6D6
NS 16
DS 2
sWH 8278.146 HZ
FIDRES 0.126314 Hz
AO 3.9584243 sec
AG 25.4
ODW 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
c av. -no, CHANNEL fi 1 ******
NUCI IH
Pl 7.90 usec
PLI 0.00 dB
SF01 400.1324710 MHz
Processing parameters
32768
400.1300443 MHz
EM
0
0.30 HZ
10D NMR plot parameters
CX 20.00 cm
FIP 10.000 ppm
f 4001.30 HZ
F2P 0.000 opm
r2 0.00 Hz
PPCHn 0.50000 pom/cm
HZCM 200.06502 HZ/cm
ppm 9 8 7
/Cu\ /i I 4co
N n ol (%j
- " . . 9 t - ; - . . . . . . . . . . . . . . I I I I . .
6 5 1
)2Ar
Ar = 2,6-diisopropylphenyl
Table 3, entry 7
Current Data Parameters
NAME ss2-235
EXPND 4
PROCNO I
F2 - Acquisition Parameters
Date- 20050509
Time 18.31
INSTRU4 spect
PROBHO 5ra 880 88-1
PULPPOG zg30
TD 65536
SOLVENT C606
NS 15
DS 2
SWH 8278.145 Hz
FIDRES 0. 126314 Hz
AD 3.9584243 sec
RG 16
DO 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
,........... CHANNEL 1t -a....
MUC1 IH
Pt 7.90 usec
PL1 0.00 dB
SF01 400.1324710 MHz
F2 - Processing parameters
SI 32768
SF 400.1300443 MHz
WOn EN
S58 0
LB 0.30 HZ
69 0
PC 1.00
10 NMR plot
CX
FtP
F1
PPMCH
HZCM
(n C
C" Co
1o c
parameters
20.00 c
10.000 ppa
4001.30 Hz
0.000 ppm
0.00 Hz
0.50000 ppe/cm
200.06502 fHz/cm
pp B 7 6 5
PPM 7 1 bL~~ '4 4 3 2
(1 a
n ci
C U -(U C>
(D
I I I f I,, , . .
3-furyl enone (away)
CO 2Ar
Ph "'3-furyl
Ar = 2,6-diisopropylphenyl
Table 3, entry 8
fI II 5 11H
IR JCB~~I . i1 i .
rs cno o
00 -
Current
NAME
EXPNO
PROCNO
Data Parameters
ss2-105
5
1
F2 - AcQuisition Parameters
Date_ 20050304
Time 15.56
INSTRFu4 Spect
PROBHD 5mm 980 88-1
PULPROG zg30
TD 65536
SOLVENT C606
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AG 3.9584243 sec
RG 64
DW 60.400 usec
DE 6.00 usec
TE 300.0 K
D01 .00000000 sec
=========-== CHANNEL i1 ========
NUC1 I1
PI 7.90 usec
PLi 0.00 dB
SF01 400.1324710 MHz
F2 -
SI
SF
WDO
SSB
Processing parameters
32768
400.1300492 MHZ
EM
0
0.30 Hz
10 NMR plot parameters
CX 20.00
FiP 10.000
F1 4001.30
F2P 0.000
F2 0.00
PPMCM 0.50000
HZCM 200.06502
Cm
ppm
Hz
Hz
ppm/cm
Hz/cm
5 4 3 2 1
t
cu 0
I coru
ppm 9 B 7 6
-~--~ I-I
. . . . . .II...
I
vinyl Ph enone-ma)or pdt
CO 2Ar
Ph 2- ,,,,pPh
Ar = 2,6-diisopropylphenyl
Table 3, entry 9
hI ii Aa
o ot o
C In(V c i
Current Data
NAME
EXPNO
PROCNO
Parameters
ss2-99
10
F2 - Acquisition Parameters
Date- 20050224
Time 14.39
INSTRUM spect
P OBHD 5m= BBO 88-1
PULPROG zg30
TO 65536
SOLVENT C606
NS 16
OS 2
5WH B278.146 Hz
FIORES 0.126314 Hz
AO 3.9584243 sec
RG 25.4
DW 60.400 usec
DE 6.00 usec
TE 300.0 K
D1 1.00000000 sec
**========== CHANNEL II anan=s2U
NUCI iH
Pt 7.90 usec
PL1 0.00 8
SF01 400.1324710 MIH
F2 - P
SI
SF
WDW
SSB
LB
GB
PC
10 NMR
CX
PIP
FI
P2P
PPMEH
HZCM4CoI- -0
rocessing parameters
32768
400.1300443 NHz
EN
0
0.30 Hz
pDot parameters
20.00 cm
10.000 ppm
4001.30 Hz
0.000 pcm
0.00 Hz
0.50000 pm/cm
200.06502 HZ/Cm
ppm 9 8 7 6
____ _ __ 
___ I _ __ -CCC-C-~----~L- ^ -I^ _ --F......... _---1-
'5- I . . . I . I I I I 1 " 1 I I 1 w I
5 4 3 2 1
w
17-~ 1
-"-
i
..
nBu(away)- major pdt
CO 2Ar
Ph - ""n-Bu
Ar = 2,6-diisopropylphenyl
Table 3, entry 10
I[I ,
Current Date Parameters
NAME ss2-115
EXPND 5
PROCNO I
F2 - Acqulsitlon Parameters
Date. 20050303
Time 15.53
INSTRUM4 spect
PROHD 5s.. BB0 9-1
PULPADS zg30
To 65536
SOLVENT C606
NS 16
OS 2
SWH 0278.146 Hi
FIORES 0.126314 HI
AO 3.9584243 sec
RG 32
DW 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
..IL f....... CHANNEL i
NUCI IH
P1 7.90 usec
PLI 0.00 dB
SFOI 400.1324710 tHoz
F2 - Processing parameters
SI 32758
SF 400.1300518 MHz
wOW EN
SSB 0L 0.30 Hz1.00ID NMR plotCX
FIP
Fi
oo 100cn
a1IIc'!loll
PPMCM
HZCH
parameters
20.00 cm
10.000 Dom
4001.30 HZ
0.000 pon
0.00 Hz
0.50000 opp/cm
200.06503 Hz/cm
ppm 9 8 7 4 3 2
1 I
CI I
-
__
Sm
c n <
ru ID
I v. .. .- -r- ~-1 --~T1~- - ~-~ - - ~ -
Ir c~
1
Current Oata Parameters
NAME ss2-119
Fi 4001.30 Hz
F2P 0.000 ppm
F2 0.00 Hz
SCU "i r- o 'n PPNCM 0.50000 ppm/cm
o C ( o 0 DW HZCM 200.05502 Hz/c.
PDm 9 8 7 6 5 4 3 2 1
i-Pr (away)
PROCNO I
F2 - Acquisition Parameters
Date_ 20050308
Time 18.55
INSTRIM spect
PROBHD 5=m 880 88-1
PULPROG zg30
TO 65536
SOLVENT C605
NS 16
OS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AG 3.9584243 sec
RG 80.6
DW 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 see
com..=.=..v= CHANNEL fI *****a
NUCI IH
PI 7.90 usec
PLI 0.00 dB
SFO1 400.1324710 NHz
F2 - Processing parameters
SI 32768
SF 400.1300446 MHZ
WON EN
SS8 0
LB 0.30 Hz
GB 0
PC 1.00
ID NMPI plot parameters
CX 20.00 cm
F1P 10.000 ppo
'rr
CO 2Ar
n-Hex "'"Ph
Ar = 2,6-diisopropylphenyl
Table 4, entry 1
f ii
Q Q2'
ioi
1'\ i 1 i
Current
NAME
EXPNO
PROCNO
Data Parameters
ss2-257
2
I
F2 - Acquisition Parameters
Date_ 20050527
Time 19.18
INSTPMJ spect
PRfOBH 5 m 880 8E-1
PULPROG zg30
TO 65536
SOLVENT C606
NS 16
DS 2
SWH 6278.146 Hz
FIORES 0.126314 Hz
AG 3.9584243 sec
PG 18
OH 60.400 usec
DE 6.00 usec
TE 300.0 K
01 1.00000000 sec
a-- ......... CHANNEL 1
NUCI IH
Pt 7.90 usec
PLi 0.00 dB
SF01 400.1324710 MHz
F2 -
SI
SF
WOW
SSB
LB
GB
10 NMR Plot pa
CX
FIP
FI
I CD IP
co r CD
C>
C 0* -M
PP14CM
HZCM
Processing parameters
32768
400.1300446 NHz
0.30 Hz
0
rameters
20.00 cm
10.000 ppm
4001.30 Hz
0.000 ppm
0.00 Hz
0.50000 ppm/cm
200.06502 Hz/cm
ppm 9 8 7 3 2
(D C)\
o I
oiim
I
--
i-Pr enone Ddt
CO 2Ar
i-Pr .. "'Ph
Ar = 2,6-diisopropylphenyl
Table 4, entry 2
V *2 -, 1
I2Ifr
Current Data
NAME
EXPNO
PROCNDO
Parameters
ss2-133
10
!
F2 - Acquisition Parameters
Date_ 20050316
Time 17.59
INSTRIM saect
PROBHD 5mm BBO 88-1
PULPROG zg30
TO 65536
SOLVENT C606
NS 16
OS 2
SWH 8278.146 Hz
FIDRES 0.125314 Hz
A0 3.9584243 sec
RG 32
0D 60.400 usec
DE 6.00 usec
TE 300.0 K
D1 1.00000000 sec
.a.-O-s==.-- CHANNEL ft - *** *
NUCI IH
Pt 7.90 usec
PL. 0.00 c0
SFO1 400.1324710 MIz
F2 -
51
SF
WOW
55
LB
GB
PC
Processing parameters
32768
400.1300443 MHz
EN
0
0.30 Hz
0
10 NMR olot
CX
FlP
F1
F2P
F2
PPHCM
HZCM
L L
C) C>I-C0u 0
1.00
parameters
20.00 cm
10.000 PPm
4001.30 Hz
0.000 0on
0.00 HZ
0.50000 ppm/cm
200.06502 tlz/cm
ppm __ 9 
_^1_ 3 2 __
kD CuC I
_I ___I I
' ' t ' ' '' 'I IW
I 
" L'- 
-- 
--
~-
I I r , t- T , TI 7 I .- I I I I I F T I r 7 -' -I
4 3 2 1ppm g
tBu (ketone side)
CO 2Ar
t-Bu- "'Ph
Ar = 2,6-diisopropylphenyl
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Chapter 3
Design, Synthesis, and Applications of
C2-Symmetric Planar-Chiral Catalysts
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A. Introduction
Chiral ferrocene ligands have become extremely important in asymmetric organic
synthesis, especially in processes catalyzed by metal complexes.' In recent years,
numerous new chiral ferrocene ligands have been developed and successfully applied
to various processes. In fact, one of the largest-scale enantioselective catalytic process in
industry is the synthesis of a precursor of the herbicide (S)-metolachlor by an
Ir/ Xyliphos-catalyzed asymmetric hydrogenation reaction.2
Besides their excellent utility, chiral ferrocene ligands have several other advantages
over other ligands. First, ferrocene compounds have a rigid scaffold and high stability,
and they can be prepared from an inexpensive starting material. Moreover, there are
well-established methods for functionalization at specific positions of ferrocene and its
derivatives.
Due to these advantages of chiral ferrocene compounds, a large number of reports
have been published on various asymmetric transition metal-catalyzed processes using
chiral ferrocenes as ligands. However, the use of these planar-chiral ferrocenes as
simple asymmetric catalysts has been mainly limited to planar-chiral DMAP derivatives
(Figure 1), developed in our group.3 Therefore, the development of other ferrocene-
based catalysts is highly desirable.
N12>Me2N
N N
Me Fe Me Me Fe Me
Me Me Me Me
Me Me
(+)-PPY* (+)-DMAP*
Figure 1. Planar-Chiral DMAP Derivatives.
For recent reviews, see: (a) Arrayas, R. G.; Adriio, J.; Carretero, J. C. Angew. Chem., Int. Ed. 2006, 45,
7674-7715. (b) Atkinson, R. C. J.; Gibson, V. C.; Long, N. J. Chem. Soc. Rev. 2004, 33, 313-328. (c) Sutcliffe,
O. B.; Bryce, M. R. Tetrahedron: Asymmetry 2003, 14, 2297-2325. (d) Colacot, T. J. Chem. Rev. 2003, 103,
3101-3118.
2 (a) Blaser, H.-U. Adv. Synth. Catal. 2002, 344, 17-31. (b) Blaser, H.-U.; Brieden, W.; Pugin, B.; Spindler, F.;
Studer, M.; Togni, A. Top. Catal. 2002, 19, 3-16.
3 For reviews, see: (a) Kizirian, J.-C. Chem. Rev. 2008, 108, 140-205. (b) Wurz, R. P. Chem. Rev. 2007, 107,
5570-5595.
142
In the last decade, studies on asymmetric reactions catalyzed by small organic
molecules have undergone an explosive expansion.4 A wide range of chiral organic
catalysts have been successfully applied to numerous reactions. We decided to develop
ferrocene-based chiral guanidines, phosphines, and tertiary amines since they can be
easily incorporated into the ferrocene structure.
There have been several reports of enantioselective organocatalysis by chiral
guanidines. In 1999, Corey reported an asymmetric Strecker reaction catalyzed by a C2-
symmetric bicyclic guanidine (eq 1 ).5b Various aryl imines and a t-butyl imine undergo
the reaction in high yield with good enantioselectivity.
Ph Ph
Np h 2 equiv HCN Ph Ph.. . >Ph
N Ph 10%catalyst HN Ph PhN (1)
toluene, -40 OCAr H Ar CN H
catalyst
up to 88% ee, 98% yield
More recently, Terada has reported highly enantioselective reactions catalyzed by
axially chiral guanidines (eq 2 and eq 3 ).5h,5i As shown from these results, chiral
guanidines have great potential as catalysts due to their high basicity and substrate
recognition ability through H-bonding. However, manipulation of the guanidine
structure is challenging because of its basicity and the lack of a simple and general
method for their synthesis.
4 For reviews, see: (a) Berkessel, A.; Groeger, H. Asymmetric Organocatalysis-From Biomimetic Concepts to
Powerful Methods for Asymmetric Synthesis; Wiley-VCH: Weinheim, 2005. (b) Seayad, J.; List, B. Org. Biomol.
Chem. 2005, 3, 719-724. (c) Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2006, 45, 1520-1543. (d)
Enantioselective Organocatalysis; Dalko, P. I., Ed.; Wiley-VCH: Weinheim, 2007.
' For some leading references, see: (a) Iyer, M. S.; Gigstad, K. M.; Namdev, N. D.; Lipton, M. J. Am. Chem.
Soc. 1996, 118, 4910-4911. (b) Corey, E. J.; Grogan, M. J. Org. Lett. 1999, 1, 157-160. (c) Ishikawa, T.; Araki,
Y.; Kumamoto, T.; Seki, H.; Fukuda, K.; Isobe, T. Chem. Commun. 2001, 245-246. (d) Kita, T.; Georgieva, A.;
Hashimoto, Y.; Nakata, T.; Nagasawa, K. Angew. Chem., Int. Ed. 2002, 41, 2832-2834. (e) Allingham, M. T.;
Howard-Jones, A.; Murphy, P. J.; Thomas, D. A.; Caulkett, P. W. R. Tetrahedron Lett. 2003, 44, 8677-8680.
(f) Sohtome, Y.; Hashimoto, Y.; Nagasawa, K. Eur. J. Org. Chem. 2006, 2894-2897. (g) Shen, J.; Nguyen, T.
T.; Goh, Y.-P.; Ye, W.; Fu, X.; Xu, J.; Tan, C.-H. J. Am. Chem. Soc. 2006, 128, 13692-13693. (h) Terada, M.;
Ube, H.; Yaguchi, Y. J. Am. Chem. Soc. 2006, 128, 1454-1455. (i) Terada, M.; Nakano, M.; Ube, H. i. Am.
Chem. Soc. 2006, 128, 16044-16045.
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O O 2% catalyst
R1 R1  R2 'NO2 Et2 0, 0 'C
Me
H
N Me
"N
H
0 0
R1  R1
up to 98% ee, 99% yield
t-Bu
Ar = -
t-Bu
catalyst
0.05% catalyst
THF, -60 OC
Ar= -
catalyst
0 0
RiR~> NR2
R' "N-NH
Boc Boc
up to 98% ee, 99% yield
-t-Bu
-t-Bu
Although chiral phosphines have been mostly used as ligands for transition metal-
catalyzed reactions, the number of studies using a phosphine as a chiral catalyst is
increasing. Axially chiral phosphines have been successfully applied to reactions of a,3-
unsaturated carbonyl compounds. We have also reported two phosphine-catalyzed
asymmetric cycloadditions (eq 4 and eq 5),6 and studies of phosphine-catalyzed
intramolecular cyclization of alcohols and amines are currently undergoing in our
group.
6 (a) Wurz, R. P.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 12234-12235. (b) Wilson, J. E.; Fu, G. C. Angew.
Chem. Int. Ed. 2006, 45, 1426-1429.
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o 0
Rl R2
R
N' Boc
Boc ' N
i.
R, N-Ts
H
,CO 2Et
CO 2Et
; C0 2Et
0
R 1
Ts
10% catalyst R N C0 2Et
CH 2CI2, r.t.
CO2Et
up to 98% ee, 86% dr
97% yield
10% catalyst
toluene, r.t.
C0 2 Et
R1
R
catalyst (5)
up to 89% ee, 97% yield
The first chiral amines employed as asymmetric catalysts were the cinchona
alkaloids, which can be isolated by extracting the bark of the cinchona tree. Cinchona
alkaloids and their tertiary amine derivatives have successfully catalyzed an array of
transformations, including Morita-Baylis-Hillman reactions (eq 6).7
0
02NH
02N&
O CF3
0 CF3
10% catalyst
DMF, -55 0C
OH 0 CF 3
Ar 0- O CF3
91% 1 e 58%R / ield
atalyst
Tertiary ammonium salts of cinchona alkaloids can act as chiral phase transfer
catalysts for reactions in biphasic medium.8 Such catalysts have been used for the
asymmetric alkylation of glycine imines, which provides an efficient synthesis of
unnatural amino acids with high enantioselectiviry (eq 7).9 Although most chiral phase
7 (a) Wabuchi, Y.; Nakatani, M.; Yokoyama, S.; Hatakeyama, S. J. Am. Chem. Soc. 1999, 121, 10219-10220.
(b) Nakano, A.; Kawahara, S.; Morokuma, K.; Nakatami, M.; Iwabuchi, Y.; Takahashi, K.; Ishihara, J.;
Hatakeyama, S. Tetrahedron 2006, 62, 381-389.
8 For reviews, see: (a) Ooi, T.; Maruoka, K. Angew. Chem. Int. Ed. 2007, 46, 4222-4266. (b) Hashimoto, T.;
Maruoka, K. Chem. Rev. 2007, 37, 506-517. (c) O'Donnell, Acc. Chem. Res. 2004, 37, 526-533.
9 Corey, E. J.; Xu, F.; Noe, M. C. J. Am. Chem. Soc. 1997, 119, 12414-12415.
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transfer catalysts have been derivatives of cinchona alkaloids, Maruoka has introduced
highly efficient and tunable spiroammonium salts (eq 8).1o
O
Ph 2C=N ~t-Bu
O
Ph2C=N-,Ot-Bu
10% catalyst
BnBr CsOH*H 20
CH2C12, -78 oC
1.0 % catalystBnBr
toluene/50% aq KOH
0 OC
O
Ph2C=N Ot-Bu
Bn
94% ee, 84% yield
catalyst
O
Ph 2C=N Ot-Bu
Bn
99% ee, 72% yield
catalyst
Ar =
Inspired by these precedent results, we chose the molecules illustrated in Figure 2 as
our target compounds. By employing C2-symmetry, we expect to simplify the synthesis,
reduce the number of possible transition states of the catalyzed reaction, and in turn
make the structural modification of catalysts more straightforward.
0 Ooi, T.; Maruoka, K. J. Am. Chem. Soc. 1999, 121, 6519-6520.
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Fe
Fe H
Fe
",P~le
R C
Fe
3
Figure 2. New C2-Symmetric Planar-Chiral Catalysts: Target Molecules.
Our synthetic strategy involves the use of a chiral directing group for
diastereoselective substitution at the ferrocene ring. Therefore, enantiomerically pure
catalysts can be obtained without resolution. Among the various directing groups
previously used in ferrocene chemistry, a chiral acetal is the most appropriate group
since it can be easily converted to an aldehyde, which is necessary for further
transformation (eq 9)." The combination of two monomers with proper functional
groups will furnish precursors for target compounds.
Fe MeO
Z
i. t-BuLi
ii. E+ FI eE MeO
" (a) Riant, O.; Samuel, O.; Flessner, T.; Taudien, S.; Kagan, H. B. I. Org. Chem. 1997, 62, 6733-6745. (b)
Riant, O.; Samuel, O.; Kagan, H. B. J. Am. Chem. Soc. 1993, 115, 5835-5836.
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Fe X-
4
B. Results and Discussion
1. Synthesis of Planar-Chiral Guanidines
Previously, Jan Paradies in our group had devised a synthesis of planar-chiral
guanidine 1 (Scheme 1).12 Starting from acetal 5, he could introduce a carboxylic acid
diastereoselectively. After deprotection of the acetal group, a Boc-protected amino
group was introduced by a two-step procedure. Reductive amination of the aldehyde
furnished the triamine, which was treated with TFA for the deprotection of the Boc
groups. However, the cyclization of free triamine 6 to form a guanidine proved to be the
most challenging step. Several strategies were tested for the formation of a guanidine,
but they failed to provide the desired product. When an isothiourea derived from
triamine 6 was heated in a microwave reactor, a C2-symmetric compound with a similar
structure to 1 but with two extra methyl groups was generated. This compound proved
to be unreactive for reactions that are catalyzed by other modified guanidines.
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12 Unpublished results.
0 i. t-BuLi, Et20
-78 OC to r.t.;
FIe MeO ii. CO2
<! 5
citric acid, H2 0
Fe CO 2H OMe 80 °C, 2h
i. CICO2Et, NEt 3
ii. NaN 3, H20
feCHO
F O9 N3
Fe o
t-BuOH
toluene, 100 0C
NH40Ac, NEt 3
NaBH(OAc) 3
DCM, rt
F CHO
F NHBocFe
S
N
H Fe
N67 TFA
I NH NH-
Fe I CH2Cl2, r.t.Boc Boc
H Fe
Fe
N
SN
2. Mel, acetone
Fe
I N NH
Fe SMe
MW, 180 0C
15 min, DMF
C2-symmetric compound
Scheme 1. Previous Synthetic Route for Guanidine 1.
Starting from these results, we could make a slight improvement by introducing an
amino group directly (eq 10). Due to the high lability of the azide-substituted ferrocene,
it had to be reduced in situ. We explored several different strategies using
aminoferrocenes with different protecting groups, however, the final cyclization steps
remained problematic.
Fe MeO
i. t-BuLi
ii. TsN 3
1. LiAIH 4
2. CbzCI, Et3N
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HCHO
FI CO2H
Fe:
H,,0
0SNH eFeCbz Me
(10)
To investigate the cyclization reaction more thoroughly, we decided to prepare
benzene-fused guanidine 7 as a model system. A synthesis of 7 has been reported in the
literature following the procedure shown in Scheme 2.13 However, due to the lability of
the azide-substituted ferrocene, this route was not applicable to our original target.
N PPh3s . N
PP H PPh3
PPh 3 PPh 3
2 equiv ArNCO
ca. 35% yield
for two steps
K~NANl
H
7
Scheme 2. Reported Synthesis of Guanidine 7.
We have tested several different strategies that had been used for the synthesis of
guanidines with different structures (Scheme 3). Unfortunately, all of these methods
failed to produce the desired product.
'3 (a) Molina, P.; Alajarin, M.; Vidal, A. J. Org. Chem. 1993, 58, 1687-1695. (b) Molina, P.; Alajarin, M.;
Vidal. A. Tetrahedron 1995, 51, 5351-5360.
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Scheme 3. Alternative Synthetic Strategies for Guanidine 7.
Although we could not find a method applicable to the synthesis of a ferrocene-
based guanidine, we could prepare benzene-fused guanidine 7 via the literature
procedure with the same efficiency (Scheme 2) and decided to prepare a chromium-
complexed planar-chiral guanidine (eq 11). To our disappointment, direct complexation
of guanidine 7 with chromium compounds only produced very unstable complexes,
and the complexation of chromium to intermediates in Scheme 3 was not beneficial
either.
N N N
N N
H
7
Cr(CO)6
or
Cr(CO) 3(NCCH 3) 3
decomposition
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2. Synthesis of Planar-Chiral Phosphines and Amines
The synthesis of C2-symmetric phosphines and amines can be achieved by
manipulation on the ferrocenyl dimer 8. Gagne has reported a dimerization of acetal 4
by diastereoselective lithiation followed by oxidative coupling mediated by
Cu(OPiv) 2.' 4" 15 When we tried this reaction, the yield ranged from 30 to 65%, and the
conversion was often incomplete even after optimization of the reaction conditions. To
address this irreproducibility, we tested several other dimerization conditions (Table 1).
Other oxidative coupling methods furnished unsatisfactory results, however, a two-step
reductive coupling of ferrocenyliodide with Cu powder provided the desired dimer in
consistently good yield.
Table 1. Reaction Optimization for the Dimerization Reaction of 5.
Fe MeO
i. t-BuLi, Et20
-78 OC to r.t.
ii. Conditions
entry Conditions Results
1 Cu(OPiv) 2 , -20 oC 30-65% yield, >20:1 dr
2 Fe(OAc) 2 , 0 oC <10%
3 a) 1,2-diiodoethane, THF, -78 °C Reduction to 5
b) NiBr 2(PPh3 )2 , Zn, Et4 NI, THF
4 a) 1,2-diiodoethane, THF, -78 OC 82%, >20:1 dr
b) Cu(0) powder, neat, 60 OC
14 Larsen, A. O.; Taylor, R. A.; White, P. S.; Gagne, M. S. Organometallics 1999, 18, 5157-5162.
5 Cu(OPiv) 2 is not commercially available.
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c
Deprotection of the acetal group produced dialdehyde 9 in excellent yield with high
purity (eq 12). Simple reductive amination of 9 with a variety of primary amines
furnished the desired planar-chiral tertiary amines. In the case of secondary amine 3i,
the direct reductive amination using ammonium acetate proceeded in low yield.
Alternatively, Pd-catalyzed removal of the allyl group from 3d produced the desired
product in good yield.
c p-TsOH
CH2C12/H 2 0 Fc"
quant.
RNH 2 , NEt 3
NaBH(OAc) 3
DCM, rt
R
Treatment of tertiary amine 3a with alkylating reagents
ammonium salts 4a and 4b (eq 13).
Fe
Me
RX, neat
I
Fe
Me %
Fe
"(12)
3 d
Me (3a), 75%
Bn (3b), 65%
i-Pr (3c), 50%
allyl (3d), 82%
CH 2CH 20H (3e), 64%
OMe (3f), 35%
OBn (3g), 30%
OH (3h), 60%
H (31), 10%
provided quaternary
(13)
RX = Mel (4a), 50%
BnBr (4b), 55%
Some of the planar-chiral amines are unstable under air; however, they can be stored
as tetrafluoroborate ammonium salts under air for months without decomposition and
then converted back to the free amines after treatment with base.
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Although tertiary amines are easily accessible through reductive amination reactions,
planar-chiral phosphines require different synthetic strategies. We anticipated that the
substitution of bisbenzylic chloride 10 with a phosphine would generate target
molecule 2 (Scheme 4). Reduction of dialdehyde 9 provided the corresponding diol in
good yield, but halogenation of the diol proved to be challenging. Under various
reaction and isolation conditions, we could only isolate cyclic ether 11. Therefore, we
decided to use the unpurified dichloride without isolation. After chlorination, the
reaction mixture was diluted with Et20O and then filtered to remove precipitates. The
filtrate was concentrated, and the residue was used for the next substitution reaction
without further purification. The test reaction with benzylamine provided 3b and
demonstrated that the formation of dichloride 10 was successful. However, reactions
with phenyl or cyclohexyl phosphine in the presence of a range of bases and solvents
produced no desired product.
Fc"
LiAIH4  e Fe
THF pyridine
85% HO HO Fe THE Fe
Fe
L Oz _10 11
Nu-H 2  Fe
base, solvent Nu = BnN (3b), 50%
~Nu Fe PhP (2a), <3%
CyP (2b), <3%
Scheme 4. Synthetic Route via Substitution of Bisbenzylic Chloride.
3. Applications of Planar-Chiral Amine Catalysts in Asymmetric Organic Synthesis
We have tested the newly prepared planar-chiral amines in various asymmetric
organic reactions. The first reaction chosen for tertiary amine catalysis was the Morita-
Baylis-Hillman (MBH) reaction. With 4-nitrobenzaldehyde and methylvinylketone as
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model substrates, we screened several reaction parameters (Table 2). As observed in
other studies,'" addition of water was beneficial to both reactivity and selectivity (entry
1 versus entry 2). Unfortunately, most of the amines were unreactive under these
conditions (entries 3-7), except for catalysts containing a hydroxy group, 3e and 3h.
Lower temperature was beneficial for both yield and ee with a CH 3CN/H 20 solvent
system (entry 8 versus entry 2)."7 However, decreasing the reaction temperature did not
increase the yield when the solvent system was a mixture of a bulky alcohol and water
(entries 9 and 10). In the presence of phenolic additives, the reactivity increased
dramatically, albeit at the cost of enantioselectivity (entries 11 and 12).
Table 2. Morita-Baylis-Hillman Reaction Catalyzed by C2-Symmetric Planar-Chiral
Tertiary Amines.
O0
H
02N&50.35 M
catalyst
0
3.0 Me
3.0 equiv
solvent
CH3 CN
CH3 CN/H20 (9:1)
CH3 CN/H 20 (9:1)
CH3 CN/H 2 0 (9:1)
CH3 CN/H20 (9:1)
CH3 CN/H20 (9:1)
CH3 CN/H 20 (9:1)
CH3 CN/H 2 0 (9:1)
i-PrOH/H2 0 (9:1)
i-PrOH/H2 0 (9:1)
t-AmylOH/H 20 (9:1)
t-AmylOH/H 20 (9:1)
temp.
r.t.
r.t
r.t.
r.t.
r.t.
r.t.
r.t.
0 OC
r.t.
0 C
r.t.
r.t.
10% catalyst
24 h
0 2N
additive
none
none
none
none
none
none
none
none
none
none
(R)-2,2'-binaphthol
(S)-2,2'-binaphthol
conv. (%)a
a Conversion determined by 1H NMR versus an internal standard. b Yield
versus an internal standard. C ee determined by chiral HPLC.
determined by 'H NMR
16 (a) Yu, C.; Liu, B.; Hu, L. J. Org. Chem. 2001, 66, 5413-5418. (b) Cai, J.; Zhou, Z.; Zhao, G.; Tang, C. Org.
Lett. 2002, 4, 4723-4725.
7 This effect has been observed before. Krishna, P. R.; Kannan, V.; Reddy, P. V. N. Adv. Synth. Catal. 2004,
346, 603-606.
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entry
1
2
3
4
5
6
7
8
9
10
11
12
3a
3a
3b
3e
3f
3g
3h
3a
3a
3a
3a
3a
3
12
43
4
50
49
26
79
80
27
98
98
ee (%)c
6
45
8
14
50
47
55
13
14
y(%)b
We also examined the use of these planar-chiral tertiary amines to the formation of 13-
lactams from ketenes (eq 14), which we have previously reported using PPY* as a
nucleophilic catalyst.'8 Unfortunately, ferrocene-based tertiary amines were unreactive
for these reactions. This result suggested that these azepines are weak nucleophiles.
O
PI Et
Ph "LEt
NTs
H Ph
10% 3a
toluene, r.t.
0
SNTs
Pht h
Et Ph
(14)
We have reported enantioselective additions of 2-t-butylphenol"9 and hydrazoic
acid 20 to ketenes, and these reactions are believed to occur through enantioselective
protonation of enolate intermediates by the conjugate acid of PPY*. In case of addition
of 2-t-butylphenol, catalyst 3a did not produce the desired product (eq 15). However,
the addition of hydrazoic acid to a ketene catalyzed by 3a proceeded in excellent yield
with modest enantioselectivity (eq 16). The stereoselectivity slightly improved with a
more sterically demanding catalyst (3c).
HO t-Bu
t-Bu
10% 3a
toluene, r.t.
(15)
10% catalyst 0
HN3  m- Phtoluene/hexanes Ph N3
-78 oC L i-Pr
H90 oC, 1 h; N OMe
MeOH 
Y Ph N OMe
75 oC, 12 h i-Pr 0
catalyst = 3a 90% yield, 25% ee
3c 85% yield, 33% ee
Secondary amine catalyst 3i was also applied to a few reactions that have been
successfully catalyzed by proline derivatives, but it showed no reactivity for these
reactions under the reported conditions.
8 Hodous, B. L.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 1578-1579.
9 Wiskur, S. L.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 6176-6177.20 Dai, X.; Nakai, T.; Romero, J. A. C.; Fu, G. C. Angew. Chem., Int. Ed. 2007, 46, 4367-4369.
156
Ph ./
Et
Ph ,, O
i-Pr
(16)
C. Conclusions and Outlook
In conclusion, we have studied the synthesis of new ferrocene-based C2-symmetric
planar-chiral catalysts, such as guanidines, phosphines, and amines. Although the
synthesis of planar-chiral guanidines and phosphines has been unsuccessful to date, we
have prepared several planar-chiral azepines along with their quaternary ammonium
salts. These planar-chiral amine catalysts were tested for a few asymmetric reactions
and showed promising preliminary results. Due to their highly modular structure, we
expect to be able to develop more effective planar-chiral amine catalysts.
In the future, we plan to devise other synthetic strategies for previously unsuccessful
targets and to prepare new catalysts with different structures. For example, we expect
to access guanidine 12 and 13 through modification of the procedures reported by
Terada (eq 1 7 ).5h5i
Fe
10
Fe
N Fe
13
(17)
Another route to phosphine 2 will be explored using dimethyl-substituted ferrocene
dimer 14, similarly to the synthesis of axially chiral phosphines (eq 18).
I
Fe
14
Fe Fe
n-BuLi RPCI2  F
Li Li Fe P Fe
2 RZ
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(18)
We also hope to introduce additional substituents on the ferrocene rings to modify
the chiral environment (eq 19).
O O M
e
Fc" It ,Fc
MeO, 8
i. t-BuLi, Et20
-78 OC to r.t.
ii. E+
In addition, the effect of an additional chiral center near the active catalytic sites will
be studied (Figure 3).
Fe
R- R
Fe
Figure 3. Planar-Chiral Amines with an Additional Chiral Center.
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D. Experimental
1. General
THF, CH 2C12, and Et20O were purified by passage through a neutral alumina column.
Unless otherwise noted, all chemicals were used as received.
Melting points were measured on a Hoover melting point apparatus and are
uncorrected.
Intermediate 5 was prepared by literature methods.'
2. Synthesis of Planar-Chiral Catalysts
0
Fe NHMeO
(S)-1-[(2S,4S)-4-(Methoxymethyl)-1,3-dioxan-2-yl]-2-
{[(Phenylmethoxy)carbonyl]aminol-ferrocene (eq 10).
An oven-dried flask was charged with the acetal 5 (200 mg, 0.63 mmol) under Ar and
dissolved in dry ether (2.0 mL). The solution was cooled to -78 'C, and t-BuLi (1.7 M in
pentane; 0.41 mL, 0.69 mmol) was added dropwise, yielding after a few min a bright
yellow precipitate. After 10 min stirring, the cooling bath was removed and the mixture
was allowed to stir at r.t. for 1h. The mixture was cooled to 0 'C, and a solution of TsN 3
(136 mg, 0.69 mmol) in dry ether (1.0 mL) was added dropwise. Once the addition was
complete, the solution was warmed to r.t. and stirred overnight. The reaction mixture
was quenched with water (3.0 mL) and extracted with ether (3 mL x 3). The combined
organic layers were dried over MgSO 4 and concentrated. The product was purified by
column chromatography (hexanes/ether 2:1) to give 187 mg (S)-1-Azido-2-[(2S,4S)-4-
(methoxymethyl)-1,3-dioxan-2-yl]-ferrocene (83%).
Riant, O; Samuel, O.; Flessner, T.; Taudien, S.; Kagan, H. B. J. Org. Chem. 1997, 62, 6733-6745.
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This azido ferrocene was dissolved in THF (5.0 mL), and the solution was cooled to
0 'C. A LiAlH 4 solution (1.0 M in ether; 0.5 mL, 0.5 mmol) was added to this solution
dropwise, and the reaction mixture was stirred for 10 min. The reaction was quenched
with a saturated Na2SO 4 solution (0.2 mL), and precipitates were filtered. The filtrate
was concentrated and dissolved in THF (5.0 mL). CbzCl (0.11 mL, 0.75 mmol) and Et 3N
(0.21 mL, 1.5 mmol) were added to the solution, and the resulting mixture was stirred
for 2 h. Volatiles were evaporated, and the residue was purified by column
chromatography (hexanes/ether 2:1) to give the title compound (152 mg, 63%).
[a] 22D = -449 (c = 0.24, CHC13);
1H NMR (CDC13, 400 MHz) 8 7.43-7.29 (m, 6H), 5.56 (s, 1H), 5.18 (s, 2H), 5.08 (s, 1H),
4.23 (dd, J = 11.4, 4.2 Hz, 1H), 4.16 (s, 5H), 4.09-4.01 (m, 2H), 3.96 (s, br, 1H), 3.91 (dt, J =
12.1, 2.5 Hz, 1H), 3.52 (d, J = 4.7 Hz, 2H), 3.37 (s, 3H), 1.81 (dq, J = 12.5, 5.1 Hz, 1H), 1.54
(d, J = 12.9 Hz, 1H);
1C NMR (CDCl3, 100 MHz) 8 153.6, 136.6, 128.5, 128.4, 128.1, 100.7, 94.9, 76.0, 75.4,
73.9, 70.0, 66.6, 63.7, 63.1, 61.1, 59.5, 27.6;
IR (film) 3384, 3092, 3033, 2926, 2875, 1731, 1547, 1485, 1455, 1384, 1360, 1275, 1218,
1147, 1100, 1057, 990, 951, 912, 819, 738, 698, 495 cm-1;
Me
,,Fc
MeO .. jO
(R,R)-2,2"-Bis[(2S,4S)-4-(methoxymethyl)-,3-dioxan-2-yl]-1,1"-biferrocene (8).
An oven-dried flask was charged with the acetal 5 (3.16 g, 10.0 mmol) under Ar and
dissolved in dry ether (30 mL). The solution was cooled to -78 oC, and t-BuLi (1.7 M in
pentane; 6.50 mL, 11.0 mmol) was added dropwise, yielding after a few min a bright
yellow precipitate. After 10 min stirring, the cooling bath was removed and the mixture
was allowed to stir at r.t. for 1h. The mixture was cooled to -78 'C, and a solution of 1,2-
diiodoethane in dry THF (15 mL) was added dropwise. Once the addition was complete,
the solution was warmed to r.t. in 30 min and quenched with water (5 mL). After
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dilution with ether, the organic phase was washed with a solution of sodium thiosulfate
(10% w/w; 30 mL), dried over MgSO4, and concentrated. The unpurified product was
purified by column chromatography (hexanes/EtOAc 5:1) to give 4.06 g (2S,4S,SFc)-4-
(methoxymethyl)-2-(a-iodoferrocenyl)-1,3-dioxane (92%).
The ferrocenyl iodide was dissolved in CH2C12 (20 mL) and freshly activated Cu
powder (31.8g, 500 mmol) was added. Immediately, the mixture was evaporated in
vacuo and refilled with Ar. The resulting mixture was heated at 60 oC for 24 h and
cooled to r.t. The mixture was diluted with CH 2C 2, filtered through celite, and
concentrated. The residue was purified by column chromatography (hexanes/EtOAc
3:1) to give 2.50 g of the title compound (86%).
The spectral data matched with the values reported previously. 14
[a] 22D = 265 (c = 0.18, CHC13);
1H NMR (CDC13, 400 MHz) 6 5.77 (s, 2H), 4.54 (dd, J = 2.4, 1.5 Hz, 2H), 4.41 (dd, J =
2.4, 1.6 Hz, 2H), 4.37-4.29 (m, 2H), 4.31 (s, 10H), 4.17 (d, J = 2.5 Hz, 2H), 4.03-3.94 (m, 4H),
3.47 (dd, J = 10.2, 5.8 Hz, 2H), 3.36 (dd, J = 10.2, 5.1 Hz, 2H), 3.33 (s, 6H), 1.81 (dq, J =
12.7, 5.7 Hz, 2H), 1.54 (dq, J = 13.2, 1.1 Hz, 2H);
13C NMR (CDC13, 100 MHz) 8 99.3, 84.9, 83.7, 76.1, 75.5, 71.4, 69.9, 67.1, 66.6, 59.4;
IR (film) 3099, 2923, 2848, 1474, 1372, 1290, 1241, 1147, 1106, 1003, 913, 819, 732, 495
-1
cm;
Representative Procedure for the Synthesis of planar-chiral amine catalysts: p-
TsOH-H20 (0.050 equiv) was added to a solution of bis(acetal) 8 (1.0 equiv) in
CH2C12/water (2:1, 0.50 M) at r.t., and the resulting mixture was vigorously stirred
overnight. The reaction mixture was extracted with CH 2C12 (10 mL x 3), and the
combined organic layers were washed with a saturated solution of NaHCO3 (10 mL)
and dried over K2CO3. After filtration and concentration, the (R,R)-2,2"-diformyl-1,1"-
biferrocene (9) was obtained with high purity and used without further purification.
RNH2-HCl (1.1 equiv) and Et3N (1.1 equiv) were added to a stirred solution of
dialdehyde 9 (1.0 equiv) in CH2C12 (0.15 M), and then NaBH(OAc)3 (5.0 equiv) was
added in small portions. The reaction mixture was stirred overnight at r.t., poured onto
ice, and basified with 1.0 N NaOH to pH 12. The mixture was extracted with Et20 (20
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mL x 3), and the combined extracts were dried over Na2SO4 and concentrated. The
residue was purified by column chromatography.
Fe
(R,R)-2,2"-[(N-Methylamino)bis(methylene)]-1,1"-biferrocene (3a).
Representative Procedure was followed, with 9 (500 mg, 1.2 mmol), MeNH2-HCl (87
mg, 1.3 mmol), Et3N (180 gL, 1.3 mmol), and NaBH(OAc) 3 (1.20 g, 5.9 mmol). After
purification by flash chromatography (hexanes/EtOAc 2:1), the title compound was
isolated as an orange solid (373 mg, 75%). The reaction was not optimized.
m.p. 166-169 'C;
[a] 2 2D = -877 (c = 0.12, CHCl1);
1H NMR (CDC13, 400 MHz) 8 4.36-4.35 (m, 2H), 4.10 (t, J = 2.4 Hz, 2H), 4.07-4.05 (m,
2H), 3.96 (s, 10H), 3.84 (d, JAB = 15.0 Hz, 2H), 3.66 (d, JAB = 15.0 Hz, 2H), 2.55 (s, 3H);
13C NMR (CDC13, 100 MHz) 6 85.6, 82.5, 69.9, 67.5, 66.3, 65.8, 58.7, 44.7;
IR (film) 3085, 2961, 2931, 2786, 2761, 1714, 1441, 1363, 1223, 1104, 813, 736 cm-1;
GCMS calcd for C23H23Fe2N (M+) 425, found 425.
Fe
Bnr(
(R,R)-2,2"-[(N-Benzylamino)bis(methylene)]-1,1"-biferrocene (3b).
Representative Procedure was followed, with 9 (140 mg, 0.33 mmol), BnNH2-HCI (52
mg, 0.36 mmol), Et 3N (50 gL, 0.36 mmol), and NaBH(OAc) 3 (347 mg, 1.7 mmol). After
purification by flash chromatography (hexanes/EtOAc 3:1), the title compound was
isolated as an orange solid (107 mg, 65%). The reaction was not optimized.
[a] 2 2D = -675 (c = 0.23, CHC13);
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1H NMR (CDC13, 400 MHz) 6 7.41-7.26 (m, 5H), 4.38 (dd, J = 2.2, 1.5 Hz, 2H), 4.11 (t, J
= 2.4 Hz, 2H), 4.00-3.96 (m, 2H), 3.95 (s, 10H), 3.88 (d, JAB = 14.9 Hz, 2H), 3.87 (s, 2H),
3.71 (d, JAB = 15.0 Hz, 2H);
13C NMR (CDCl3, 100 MHz) 6 139.6, 129.0, 128.3, 127.0, 84.5, 82.5, 69.9, 67.7, 66.3, 65.8,
60.5, 56.6;
IR (film) 3090, 3027, 2917, 2800, 1494, 1454, 1410, 1358, 1133, 1105, 1029, 1000, 911, 818,
733 cm- ;
GCMS calcd for C29H27Fe2N (M+) 501, found 501.
Fe
N Fe
i-Pr'
(R,R)-2,2"-[(N-Isopropylamino)bis(methylene)1-1,1"-biferrocene (3c).
Representative Procedure was followed, with 9 (219 mg, 0.51 mmol), i-PrNH 2 (48 L,
0.56 mmol), and NaBH(OAc)3 (540 mg, 2.6 mmol). After purification by flash
chromatography (hexanes/EtOAc 2:1), the title compound was isolated as an orange
solid (116 mg, 50%). The reaction was not optimized.
m.p. 169-171 °C;
[a] 2 2 D = -631 (c = 0.12, CHC13);
1H NMR (CDC13, 400 MHz) 6 4.33-4.31 (m, 2H), 4.09-4.05 (m, 4H), 3.96 (s, 10H), 3.80
(d, JAB = 14.7 Hz, 2H), 3.66 (d, JAB = 14.7 Hz, 2H), 3.15 (septet, J = 6.5 Hz, 1H), 1.18 (d, J =
6.5 Hz, 3H), 1.11 (d, J = 6.5 Hz, 3H);
13C NMR (CDC 3, 100 MHz) 6 86.4, 82.5, 70.1, 67.8, 66.2, 65.6, 54.9, 54.0, 19.6, 19.3;
IR (film) 3092, 2962, 1461, 1409, 1383, 1361, 1169, 1105, 1001, 911, 815, 732 cm-';
GCMS calcd for C2H 27Fe2N (M ) 453, found 453.
163
IFe
(R,R)-2,2"-[(N-Allylamino)bis(methylene)]-1,1"-biferrocene (3d).
Representative Procedure was followed, with 9 (450 mg, 1.1 mmol), allylamine (87 AL,
1.2 mmol), and NaBH(OAc) 3 (1.11 g, 5.3 mmol). After purification by flash
chromatography (hexanes/EtOAc 2:1), the title compound was isolated as an orange
solid (370 mg, 82%). The reaction was not optimized.
m.p. 112-114 'C;
[a] 22 D = -764 (c = 0.12, CHC13);
1H NMR (CDC13, 400 MHz) 6 6.01-5.89 (m, 1H), 5.24-5.19 (m, 1H), 5.19-5.16 (m, 1H),
4.35 (dd, J = 2.3, 1.4 Hz, 2H), 4.10 (t, J = 2.4 Hz, 2H), 4.04 (dd, J = 2.3, 1.4 Hz, 2H), 3.96 (s,
10H), 3.84 (d, JAB = 14.9 Hz, 2H), 3.71 (d, JAB = 14.9 Hz, 2H), 3.39-3.27 (m, 2H);
13C NMR (CDC13, 100 MHz) 6 136.4, 117.4, 84.8, 82.5, 69.9, 67.6, 66.2, 65.7, 59.5, 56.5;
IR (film) 3091, 2918, 2796, 1641, 1455, 1410, 1133, 1105, 999, 920, 817 cm-;
GCMS calcd for C25H25Fe2N (M+) 451, found 451.
Fe
HO
(R,R)-2,2"-{[N-(2-Hydroxyethyl)aminolbis(methylene))-1,1"-biferrocene (3e).
Representative Procedure was followed, with 9 (140 mg, 0.33 mmol),
2-hydroxyethylamine (22 WL, 0.36 mmol), and NaBH(OAc)3 (347 mg, 1.7 mmol). After
purification by flash chromatography (hexanes/EtOAc 2:1), the title compound was
isolated as an orange solid (96 mg, 64%). The reaction was not optimized.
m.p. 197-198 'C;
[a]22D = -974 (c = 0.18, CHC 3);
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1H NMR (CDC13, 400 MHz) 6 4.38 (dd, J = 2.4, 1.4 Hz, 2H), 4.12 (t, J = 2.4 Hz, 2H), 4.04
(dd, J = 2.2, 1.4 Hz, 2H), 3.95 (s, 10H), 3.92 (d, JAB = 15.2 Hz, 2H), 3.83 (d, JAB = 15.2 Hz,
2H), 3.64 (t, J = 5.2 Hz, 2H), 3.03 (s, 1H), 2.96-2.86 (m, 2H);
13C NMR (CDCl3, 100 MHz) 6 84.7, 82.5, 70.1, 67.5, 66.7, 66.3, 58.4, 56.1, 55.8;
IR (film) 3406, 3092, 2933, 1442, 1410, 1350, 1132, 1105, 1056, 1000, 911, 818, 730 cm-1;
GCMS calcd for C24H 25Fe 2NO (M+) 455, found 409 [(M-EtOH)+].
Fe
N Fe
MeO C
(R,R)-2,2"-[(N-Methoxyamino)bis(methylene) -1,1"-biferrocene (3f).
Representative Procedure was followed, with 9 (140 mg, 0.33 mmol), MeONH2-HCl
(30 mg, 0.36 mmol), Et3N (50 pL, 0.36 mmol), and NaBH(OAc)3 (347 mg, 1.7 mmol).
After purification by flash chromatography (hexanes/EtOAc 3:1), the title compound
was isolated as an orange solid (51 mg, 35%). The reaction was not optimized.
m.p. 214-215 'C;
[a] 22D = -389 (c = 0.13, CHCl1);
1H NMR (CDC13, 400 MHz) 6 4.34-4.30 (m, 2H), 4.18-4.10 (m, 6H), 3.98 (bs, 12H), 3.66
(s, 3H);
13C NMR (CDCl3, 100 MHz) 6 81.0, 70.3, 68.4, 66.8, 65.6, 60.9, 59.9;
IR (film) 3090, 3079, 2975, 2937, 2805, 1454, 1410, 1356, 1218, 1103, 1052, 1030, 1000,
912, 820, 811, 733 cm-1 ;
GCMS calcd for C23H 23 Fe2NO (M+) 441, found 441.
I
Fe
N Fe
BnO
(R,R)-2 12 "-[(N-Benzyloxyamino)bis(methylene)]-1,1"-biferrocene (3g).
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Representative Procedure was followed, with 9 (140 mg, 0.33 mmol), BnONH2-HC1
(58 mg, 0.36 mmol), Et3N (50 iL, 0.36 mmol), and NaBH(OAc)3 (347 mg, 1.7 mmol).
After purification by flash chromatography (hexanes/EtOAc 5:1), the title compound
was isolated as an orange solid (51 mg, 30%). The reaction was not optimized.
m.p. 116-117 'C;
[a]22D = -274 (c = 0.13, CHC13);
1H NMR (CDC13, 400 MHz) 8 7.45-7.32 (m, 5H), 4.87 (d, JAB = 11.4 Hz, 1H), 4.83 (d, JAB
= 11.4 Hz, 1H), 4.32-4.31 (m, 2H), 4.20 (d, J = 13.2 Hz, 2H), 4.11-4.09 (m, 4H), 4.08-3.94 (m,
2H), 3.93 (s, 10H);
'
3C NMR (CDCl3, 100 MHz) 8 138.1, 128.9, 128.6, 128.1, 80.9, 74.7, 70.3, 68.4, 66.8, 65.6,
61.7;
IR (film) 3091, 3030, 2909, 2828, 1455, 1364, 1289, 1220, 1105, 1032, 1000, 910, 818, 733,
697 cm-1;
GCMS calcd for C29H27Fe2NO (M+) 517, found 409 [(M-BnOH) ].
IFe
(R,R)-2,2"-[Aminobis(methylene)]-1,1"-biferrocene (3i).
To a solution of 3d (225 mg, 0.5 mm01l) in CH 2C12 (2.5 mL) were added Pd(OAc) 2 (4.5
mg, 0.02 mmol), PPh 3 (22 mg, 0.09 mmol), and N,N-dimethylbarbituric acid (234 mg, 1.5
mmol). The reaction mixture was stirred overnight at 35 'C, poured into a saturated
NaHCO3 solution, and extracted with CH 2C12 (5 mL x 3). The combined organic layers
were dried over Na2SO 4, filtered, and concentrated. After purification by column
chromatography (hexanes/EtOAc/Et 3N 5:1:0.1), the title compound was isolated as an
orange solid (201 mg, 98%).
m.p. 215-216 'C;
[a] 22D = -427 (c = 0.11, CHC13);
1H NMR (CDC13, 400 MHz) 6 4.33 (t, J = 2.0 Hz, 2H), 4.13-4.10 (m, 4H), 4.05 (d, JAB =
16.1 Hz, 2H), 3.96 (s, 10H), 3.91 (d, JAB = 16.1 Hz, 2H), 1.65 (s, 1H);
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'
3C NMR (CDCl3, 100 MHz) 6 88.3, 82.2, 69.9, 67.9, 66.6, 65.6, 51.8;
IR (film) 3451, 3091, 2913, 1642, 1444, 1409, 1217, 1104, 999, 819, 808, 780, 734, 673 cm-;
GCMS calcd for C22H 21Fe2N (M+) 411, found 411.
I
Fe
MeN Fe
Me
(R,R)-2,2"-[(N,N-Dimethylammonium)bis(methylene)]-1,1"-biferrocene iodide (4a).
N-Methyl azepine 3a (70 mg, 0.16 mmol) was mixed with Mel (0.2 mL), and the
resulting mixture was stirred overnight at room temperature. The mixture was purified
directly by column chromatography (CH2C12/EtOAc/MeOH 10:10:1) to give the title
compound (47 mg, 50%). The reaction was not optimized.
m.p. 241-243 °C;
[a] 22 D = -695 (c = 0.11, CHC13);
1H NMR (CDC13, 400 MHz) 6 4.66-4.61 (m, 4H), 4.59 (dd, J = 2.5, 1.0 Hz, 2H), 4.33 (t, J
= 2.5 Hz, 2H), 4.14 (s, 10H), 4.05 (d, JAB = 13.7 Hz, 2H), 3.45 (s, 6H);
13C NMR (CDCl3, 100 MHz) 6 86.0, 74.2, 70.9, 70.7, 69.2, 68.9, 64.5, 51.7;
IR (film) 3091, 3004, 2947, 1714, 1462, 1412, 1361, 1223, 1105, 1001, 911, 930, 733 cm';
GCMS calcd for C24H26Fe2IN (M ) 566, found 425 [(M-MeI) ].
Fe
+Br-
Me-N Fe
Bn
(R,R)-2,2"-[(N-Benzyl-N-methylammonium)bis(methylene)]-1,1"-biferrocene
bromide (4b).
N-Methyl azepine 3a (70 mg, 0.16 mmol) was mixed with BnBr (0.4 mL), and the
resulting mixture was stirred overnight at room temperature. The mixture was purified
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directly by column chromatography (CH2C 2/EtOAc/MeOH 10:10:1) to give the title
compound (54 mg, 55%). The reaction was not optimized.
m.p. 195-196 'C;
[a]22D = -517 (c = 0.11, CHC13);
'H NMR (CDC13, 400 MHz) 6 7.78-7.76 (m, 2H), 7.53-7.51 (m, 3H), 5.07 (d, J = 12.7 Hz,
1H), 4.81 (d, J = 12.6 Hz, 1H), 4.67 (d, J = 2.2 Hz, 2H), 4.62-4.49 (m, 4H), 4.40 (t, J = 2.5 Hz,
1H), 4.33 (t, J = 2.5 Hz, 1H), 4.13 (d, J = 6.5 Hz, 11H), 3.82 (d, J = 13.8 Hz, 1H), 3.26 (s,
3H);
13C NMR (CDCl3, 100 MHz) 6 133.6, 130.9, 129.6, 127.8, 86.3, 86.0, 74.5, 74.2, 71.2, 70.8,
70.7, 69.3, 69.2, 69.0, 64.5, 62.7, 60.8, 47.0;
IR (film) 3091, 2954, 1625, 1466, 1348, 1106, 1001, 923, 827, 775, 729 cm-1;
GCMS calcd for C30H30BrFe2N (M+) 595, found 425 [(M-BnBr)+].
I
Fe
(R,R)-2,2"-Bis(hydroxymethyl)-1,1"-biferrocene.
To a solution of dialdehyde 9 (224 mg, 0.5 mmol) in THF (5.0 mL) was added a
LiA1H 4 solution (1.0 M in ether; 0.5 mL, 0.5 mmol) dropwise at 0 8C. The reaction
mixture was stirred for 10 min then quenched with a saturated Na2SO 4 solution (0.2 mL).
The precipitates were filtered, and the filtrate was concentrated and purified by column
chromatography (hexanes/EtOAc 2:1) to give the title compound (190 mg, 85%). The
reaction was not optimized.
m.p. 114-116 'C;
[a]22D = -814 (c = 0.13, CHC13);
1H NMR (CDC13, 400 MHz) 8 4.48 (dd, J = 2.3, 1.5 Hz, 2H), 4.32 (dd, J = 2.4, 1.4 Hz,
2H), 4.25-4.19 (m, 16H), 3.98 (s, 2H);
'
3C NMR (CDCl3, 100 MHz) 6 87.7, 84.0, 73.2, 69.5, 69.4, 67.3, 59.4;
IR (film) 3327, 3095, 2935, 2876, 1642, 1454, 1412, 1295, 1198, 1106, 1032, 1000, 911, 817,
731 cm'-;
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GCMS calcd for C22H22Fe 20 2 (M') 430, found 412 [(M-H 20)+].
I
Fe
0 Fe
2,2'-[Oxybis(methylene)]-1,1'-biferrocene (11).
To a solution of (R,R)-2,2"-bis(hydroxymethyl)-1,1"-biferrocene (410 mg, 0.95 mmol)
and imidazole (340 mg, 5.0 mmol) in CH2C12 (10 mL) was added dichlorotriphenyl-
phosphorane (1.33 g, 4.0 mmol). The reaction mixture was stirred overnight at room
temperature and concentrated. After purification by column chromatography
(hexane/Et20O 5:1), the title compound was isolated as an orange solid (163 mg, 42%o).
The reaction was not optimized.
m.p. 191-192 oC;
[a] 22D = -443 (c = 0.11, CHC13);
1H NMR (CDCl3 , 400 MHz) 6 4.83 (d, JAB = 14.2 Hz, 2H), 4.71 (d, JAB = 14.2 Hz, 2H),
4.35 (dd, J = 2.3, 1.5 Hz, 2H), 4.14-4.12 (m, 4H), 3.98 (s, 10H);
13C NMR (CDC13, 100 MHz) 6 86.3, 82.3, 73.3, 70.2, 66.9, 66.8, 65.5;
IR (film) 3091, 2941, 2848, 1642, 1452, 1369, 1303, 1241, 1226, 1103, 1003, 918, 826, 809,
734 cm 1 ;
GCMS calcd for C2H 20Fe20O (M+) 412, found 412.
169
3. 1H NMR for Selected Compounds
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